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Chapter 1
Introduction
Computer simulation is a powerful approach to study the properties of biological
cell membrane systems. Bio-molecular simulations initially focused on proteins, have
seen a long development over two decades[1]. Groundbreaking simulations of bilayer
undulations[2] and bilayer self-assembly[3] showed that collective events can be studied
in atomic detail. Plasma membranes (PM) are ubiquitous as limiting structures of
cells, separating their contents from external environments. Many cellular functions,
including the uptake and conversion of nutrients, synthesis of new molecules, signal
transduction, and regulation of metabolic sequences, take place on the PM. In this
Thesis, our main focus has been on membrane structure and dynamics, its functions,
the bio-molecular organization, and the study of the characteristics of species such as
small-molecules and proteins when bound to the cell membranes. Before introducing
our findings and the particular issues that will be the main body of this Thesis, a brief
historical overview of several systems that we have studied is very appropriate.
1.1 General information on mammalian cell membranes
Mammalian cell membranes are complex structures protecting cellular contents, which
include a wide variety of organelles (mitochondria, nucleus, lysosomes, vacuoles, Golgi
apparatus, centrioles, ribosomes, etc.) surrounded by the cytoplasm, see Fig. 1.1.
The principal components of human cellular membranes are lipids, cholesterol
(C27H46O), and proteins, all of them surrounded by aqueous solutions including water
and salts. Water can provide the driving force for the assembly and stability of many cell
components which is fundamental in many biological processes. The water-membrane
interface has a structural effect on the water bulk as far as ≃ 2.5 nm from the membrane
according to Franzese et al.[4]. Water near biomembranes can be separated in bound
and unbound hydration water, with the two classes of water diffusing one order of
magnitude slower than bulk water[5]. Phospholipid membranes provide the framework
to biological membranes, to which other molecules (such as proteins or carbohydrates)
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Fig. 1.1 Simplified model of a bio-membrane. Water is attracted to the outsides (red)
of the membrane but is prevented from going through the non-polar interior (yellow)
layer.
attach. They consist of two leaflets of amphiphilic lipids which self-assemble due to
the hydrophobic effect[6]. Such lipids are molecules with a hydrophilic head and one
or two lipophilic (and hydrophobic) tails. When placed inside aqueous ambient they
can form three main different classes of structures: micelles, liposomes, and bilayers,
with the latest hiding the tails from water[7]. The main function of phospholipids as
building blocks of cell membranes was already discovered in 1925[8].
Phospholipids are widely distributed in animals and plants. Variation in the head-
groups leads to different kinds, such as phosphatidylcholine (PC), phosphatidylserine
(PS), phosphatidylinositol (PI), phosphatidylethanolamine (PE), phosphatidylglycerol
(PG), cardiolipin (CL), and phosphatidic acid (PA), that share some general properties,
with each group keeping their unique physical functions. For instance, PC is an impor-
tant substrate of synthesis of the neurotransmitter acetylcholine and has the function
of nourishing the brain and improving intelligence. As an example of a prototype
membrane, dimyristoylphosphatidylcholine (DMPC, C36H72NO8P ) belongs to PCs
family, basic components of lecithin, a substance forming egg yolk and soy. DMPC is
a phospholipid species employed in many experimental works since its gel to liquid
phase transition happens at a relatively low temperature (around 295.5 K)[9]. A large
number of simulations have already been published on DMPC membranes[10–17], often
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considering the influence of cholesterol in aqueous ionic environments[18–25] as well as
numerous reports based on experimental techniques (neutron scattering, X-ray, infrared
reflection absorption spectroscopy, NMR, etc.) have been published throughout the last
decades (see for instance Refs. [26–32]). Di-palmitoyl-phosphatidyl-choline (DPPC,
C40H80NO8P ) is a major constituent (about 40%) of pulmonary lungs[33]. When it
comes to the molecular structure, DPPC is observed to have the same headgroup as
DMPC but with two C16 hydrocarbon tails, and DMPC has two C14 hydrocarbon
tails. In addition, human lungs are coated with a lattice-like structure formed by
protein and lipid mixture called lung surfactant, preventing the lungs from collapsing
and protecting us from bacterial and viral infections. Extensive simulations and ex-
perimental studies have already been performed on DPPC monolayer/bilayers, often
including the influence of the cholesterol in water environments[34].
1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC, C44H84NO8P ) belongs to the
unsaturated PC family which might be important in the formation of a lipid reservoir.
Referring to DMPC, DOPC is a more typical constituent of real biological membranes
with a transition temperature (Tm) of 253.15 K. Tm of lipids is defined as the tempera-
ture required to induce a change in the lipid physical state from the ordered gel phase,
where the hydrocarbon chains are fully extended and closely packed, to the disordered
liquid crystalline phase, where the hydrocarbon chains are randomly oriented and
fluid. In PM, the lipid composition between the two leaflets is highly asymmetric
and changes dynamically to trigger environmental responses. For instance, cells that
undergo apoptosis increase the concentration of anionic PS in the outer leaflet of the
PM to signal phagocytes to approach and digest them, whereas, in healthy cells, PS
lipids are only present in the inner leaflet[35]. In between, 1,2-dioleoyl-sn-glycero-3-
phospho-L-serine (DOPS, C42H77NO10P ) with a Tm of 262.15 K is the most common
anionic lipid in the PM of mammalian cells which is preferentially targeted by the PM
intracellular surface protein KRas-4B[36] for signal transduction.
Recently people used to conduct computational and experimental researches on
component of anionic DOPS and zwitterionic DOPC bilayers and liposomes[37–40].
Determined by the method called nanoplasmonic sensing, the Tms of DMPC and
DPPC have been reported to be 296.65 K and 314.15 K, respectively, which are close
to their theoretical Tm values, i.e., 297.15 K for DMPC and 314.55 K for DPPC[9]. Tm
can be affected by hydrocarbon length, charge, unsaturation, and headgroup species in
the lipid’s structure and has an important effect on the structure of the bio-membrane.
Tm of DPPC is much higher than Tm of DMPC, the reason can be longer hydrocarbon
tails. Increasing the hydrocarbon length makes van der Waals interactions become
stronger which requires more energy to disrupt the ordered packing, thus the phase
transition temperature increases. Likewise, introducing a cis double bond into the
acyl group and charged headgroups which requires the much lower temperature to
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induce an ordered packing arrangement[9], leading to lower Tms for DOPC and DOPS
lipids[41].
The addition of sterols to a phospholipid bilayer diminishes the differences between
the fluid and gel phases. Cholesterol is a sterol, a type of lipid, playing a central role
in maintaining the structure of the membrane and regulating their functions[42, 43].
Being an amphiphilic molecule, cholesterol inserts into the membrane through its
hydroxyl group of cholesterol oriented toward the aqueous inside and aliphatic chain
associated parallel toward the acyl chains in the center of the bilayers, and it increases
the separation between choline head groups and eliminates the normal electrostatic
and hydrogen-bonding interactions. The phospholipids are arranged in such a means
that the hydrophilic head is exposed outside and the lipophilic tails are oriented
inside[44]. It induces the membrane to adopt a liquid-ordered phase with the positional
disorder and high lateral mobility[7]. Mammalian cells regulate the concentration of
cholesterol in their PM (10 ∼ 40% and endoplasmic reticulum ( ∼ 5%)[45, 46]. The
fluidity of the membrane is mainly influenced by the amount of cholesterol, in such
a way that membranes with high cholesterol contents are stiffer than those with low
amounts but keeping the appropriate fluidity for allowing normal membrane functions.
Model membranes with the constitution of cholesterol and different lipids have been
extensively studied in the literature from the experimental and also computational
points of view[47–53].
1.2 Small molecules studied in this Thesis
Besides the composition of the membrane, the role of proteins, drugs, and their
interactions with cell membrane structures are undoubtedly a relevant field of research.
Amino acids are organic compounds containing amine (-NH2) and carboxyl (-COOH)
functional groups, along with a side chain (R group) specific to each amino acid. It is
well known that amino acids can either be essential, i.e. indispensable or non-essential.
An essential amino acid cannot be synthesized de novo by the organism and should
be necessarily supplied by the diet. The nine amino acids humans cannot synthesize
are: phenylalanine, valine, threonine, tryptophan (TRP, C11H12N2O2), methionine,
leucine, isoleucine, lysine, and histidine (HIS, C6H9N3O2), and structures of some of
them are shown in Fig. 1.2.
We have devoted our interest in the amino acid TRP[54] which is commonly used
to treat insomnia and sleep orders like sleep apnea[55, 56]. TRP can act as a building
block in protein biosynthesis, while proteins are fundamentals required to sustain life.
TRP is a precursor of the neurotransmitter serotonin (SER, C10H12N2O)[57] which, in
turn, is also the precursor of the hormone melatonin (MEL, C13H16N2O2)[58]. Since
the human body cannot synthesize TRP, needed to prevent diseases and death, it
has to be acquired from the diet. Besides, it helps in the regulation of human sleep.
1.2 Small molecules studied in this Thesis | 5
N
H
OH3C
N
CH3H
O
Melatonin
O
O
NH3OH
Tyrosine
N
H
C
NH3
O
O
Tryptophan
N
H
HO NH2
Serotonin
N
N NH3
O
O
H
Histidine-E
Fig. 1.2 General structures of five small molecules studied in this Thesis.
Recently, some studies indicated promising antibacterial properties of TRP when
synthesized at polyionic membranes[59] and its major role in the preparation of the
nanoparticles which are able to control membrane disruption[60]. TRP trimers and
tetramers were reported to inhibit Dengue and Zika virus replication by interfering
with viral attachment processes[61]. TRP also has a vital role in maintaining the
structure and function of gramicidin channels at the surface of a cell membrane and
its side chain has the greatest hydrophobic surface area among all the aromatic amino
acids[62].
SER is a well-characterized neurotransmitter and hormone that is mainly produced
by enterochromaffin cells in the gut and also by neurons of the brain stem[63]. It is
primarily found in the gastrointestinal tract, blood platelets, and the central nervous
system of animals, including humans. It is thought to be a contributor to the regulation
of human mood and happiness. SER has been reported to play a role in promoting
the development of pancreatic ductal adenocarcinoma in mice by reinforcing the so-
called Warburg effect[64]. SER, in turn, can be converted to MEL in vivo, which
may help humans to the regulation of biological rhythms, to induce sleep, to work as
a strong antioxidant, and also to contribute to the protection of the organism from
carcinogenesis and neurodegenerative disorders[65]. In addition to its physiological
role, growing evidence suggests SER also regulates the connectivity of the brain by
modulating developmental cellular migration and cytoarchitecture[66].
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HIS is an alpha-amino-acid that is also used in the biosynthesis of proteins. Initially
thought essential only for infants, longer-term studies have shown it is essential for
adults also. Copper is an essential trace element required by all living organisms. Since
the discovery in 1966 of copper(II)–l-histidine species in human blood[67], extensive
research has proven HIS plays a very important role in copper transport and has been
used in the treatment of infantile hypertrophic cardioencephalomyopathy[68].
Differently, tyrosine (TYR, C9H11NO3) is a non-essential aromatic amino acid
produced by hydroxylation of phenylalanine and acts as a biochemical precursor of
dopamine and norepinephrine. It is responsible for the synthesis of melanin, thyroxin,
adrenaline, and the causative agent for genetic, hormonal, and neurological disorders. It
has been revealed that a high level of TYR in blood tissue can be used as a weathervane
to foresee and analyzes the level of certain metabolic disorders, such as obesity, insulin
resistance, and liver cancer[69].
MEL is a natural hormone secreted by the pineal gland well known to regulate
biological rhythms[70], to induce sleep[71], and that can also contribute to protecting
the organism from Alzheimer disease[65]. MEL is reported to induce/promote complex
antioxidative and DNA repair systems which make it a very good candidate for curing
several dermatoses associated with substantial oxidative damage. It helps for preventing
skin cancer, skin photo, and radioprotection and also works as an inducer of repair
mechanisms of human skin recovery from environmental damage[72, 73]. In recent
years, the community of biologists, dermatologists, and physicists have published plenty
of works on MEL and studied how it can affect the human body[74–77]. For instance,
MEL was found to have a significant effect on reducing cholesterol absorption and
causing greatly decreases in total cholesterol in membrane bilayers and concentrations
of cholesterol in the liver[78]. MEL is not only important for humans but also for
plants and animals. In particular, MEL works as a multifunctional signaling molecule
that regulates broad aspects of responses to environmental changes[79]. It has been
observed that MEL is able to cross most physiological barriers, such as the blood-brain
barrier[80, 81]. So, MEL may help to control brain function[82], and it has also
interesting immunotherapeutic potential in both viral and bacterial infections[83]. It
is also able to contribute to the protection of the organism from carcinogenesis and
neurodegenerative disorders[65, 84]. A number of works have been focused on the
structure and interactions of MEL with zwitterionic membranes[85, 86], and several
experiments and simulations suggest that small solutes such as TRP and MEL are
bound to the phosphate and carbonyl regions of phospholipid species[58, 87–89]. Other
studies based on the binding of MEL at ion channels in lymphocytes indicated an
active role of MEL in reversible blocking of the channel and its possible activity as
an immunological agent[90]. While bound to membranes in aqueous solution, strong
hydrogen-bonds between the small molecule and the phospholipids belonging to the
membrane have been located in a variety of possible configurations[91]. Permeation of
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MEL across the cell membrane has been also a subject of study and debate. Recent
studies indicated that cellular permeation rates in the pineal gland are of the order of
1.7 µm/s[92] and that they can occur by pure diffusion. Conversely, some studies found
that active processes are required for the entrance of MEL inside cancer cells[93]. f In
particular, glucose transporters (GLUT family) may play a central role in MEL uptake
and even be able to inhibit tumor growth[94]. The safety of MEL in humans has been
questioned. Andersen et al.[95] addressed that, in general, animal and human studies
documented that short-term use of MEL is safe, even in extreme doses. But mild
adverse effects, such as dizziness, headache, nausea, and sleepiness have been reported.
Also due to a lack of human studies, pregnant and breast-feeding women should not
take exogenous MEL. Plenty of experimental and computational work on mixtures of
cholesterol and MEL at phosphatidylcholine membranes has been published to analyze
the joint effects of the two species (see Refs. [96, 97]).
Since all these molecules are not chemically bound between them, not only their
local (vibrational) motions can be analyzed but also their long-range correlated mo-
tions (diffusion) can be measured and studied with all details through computer
simulations. There exist a big variety of experimental techniques useful to explore
membrane organization and molecular interactions of small probes within the mem-
brane, such as NMR, neutron diffraction, X-ray scattering or IR, Raman, and fluo-
rescence spectroscopy[54, 98–100]. Among the latest techniques, fluorescence-lifetime
microscopy[101] can be combined with spectral information to report basic informa-
tion of aspects such as metabolic profiles, photophysics, or dipolar relaxations[102].
Our efforts in the study of phospholipid membranes and their interaction with the
environment can shed light on the basic biological functions of the membrane. Also,
the knowledge of the mechanisms responsible for the exchange of small peptides and
drugs inside different cell membranes is of greatest scientific interest.
1.3 KRas-4B membrane protein
PM systems are particularly interesting when they are associated with proteins. Pro-
teins are usually big molecules that are difficult to name by the list of amino acids in
their sequences. Amino acids can be recognized using the three-letter code or one-letter
code which are developed to describe protein sequences easily. The listing of amino
acids and the corresponding three/single-letter code is shown in Table 1.1.
Recent studies have shown that the role of proteins and their interactions with
components of PM is extremely important to understand the mechanisms of protein
anchoring into the membrane that can lead to oncogenesis[103]. Ras proteins, a kind
of the membrane surface protein, are important signaling hubs frequently dysregulated
in cancer and in a group of developmental disorders called Rasopathies. GTPases are
a large family of hydrolase enzymes that bind to the nucleotide guanosine triphosphate
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Table 1.1 Table of amino acids and their abbreviations.
Full name Abbreviations (three-letter code) Abbreviations (one-letter code)
Alanine Ala A
Arginine Arg R
Asparagine Asn N
Aspartate Asp D
Cysteine Cys C
Glutamate Glu E
Glutamine Gln Q
Glycine Gly G
Histidine His H
Isoleucine Ile I
Leucine Leu L
Lysine Lys K
Methionine Met M
Phenylalanine Phe F
Proline Pro P
Serine Ser S
Threonine Thr T
Tryptophan Trp W
Tyrosine Tyr Y
Valine Val V
(GTP) and hydrolyze it to guanosine diphosphate (GDP)[104]. Ras proteins are
small molecular weight GTPases and function as GDP/GTP-regulated molecular
switches controlling pathways involved in critical cellular functions like cell proliferation,
signaling, cell growth, and anti-apoptosis pathways[105, 106]. GDP/GTP cycling is
controlled by two main classes of regulatory proteins. Guanine-nucleotide-exchange
factors (GEFs) promote the formation of the active, GTP-bound form, while GTPase-
activating proteins (GAPs) inactivate Ras by enhancing the intrinsic GTPase activity
to promote the formation of the inactive GDP-bound form[107–109]. Once activated,
GTP-bound Ras can interact with upstream regulators and activate several downstream
effectors[110]. The three Ras genes give rise to three base protein sequences: KRas,
HRas, and NRas. Over 30% of cancers are driven by mutant Ras proteins, thereinto,
one method called Catalog of Somatic Mutations in Cancer (COSMIC)[111] confirms
that HRas (3%) is the least frequently mutated Ras isoforms in human cancers, where
KRas (86%) is the predominantly mutated isoforms followed by NRas (11%)[112].
KRas can be found as two splice variants designated KRas-4A and KRas-4B. There
is significant KRas-4A expression in some tissues and it contains a palmitoylation site
at its Cys-180 that has been shown to assist membrane localization. KRas-4A is only a
small fraction (< 10%) of total KRas relative to KRas-4B isoforms and they differ only
in their flexible C-terminal membrane-targeting regions[113], no functional distinctions
among the splice variants have so far been established. KRas-4A and KRas-4B both
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have polybasic sequences that facilitate membrane-association in acidic membrane
regions[114], however, for KRas-4A it is covalently modified by a single palmitic acid.
The catalytic domain (CD), which contains the catalytic lobe (residues 1-86) and the
allosteric lobe (residues 87-166), is highly homologous and the structure is shared and
identical for both KRas isoforms. KRas-4B is distinguished from KRas-4A isoform in
the residue 181 that serves as a phosphorylation site within its hypervariable region
(HVR, residues 167-185). Fig. 1.3 reported here is adopted from Ref. [115] for a sketch
of the structure and sequence of KRas-4B. The HVR of KRas-4B contains multiple
amino-acid lysines that act as an electrostatic farnesylated switch which guarantees
KRas-4B’s association with the negatively charged phospholipids in the inner PM
leaflet. The inner PM leaflet is often enriched with anionic phospholipids, such as
phosphatidic acids (PA), phosphatidylglycerol (PG), phosphatidylinositol phosphates
(PIPs, also known as phosphoinositides), and phosphatidylserine (PS). It has been
reported that the KRas-4B activation level in diseased cells is linked to PS contents[116].
Anionic lipids could influence the membrane potential which in turn regulates the
orientation, location, and signaling ability of KRas-4B[117, 118].
A: B:
Fig. 1.3 A: Domain structures of KRas-4B along its sequence. As described in Ref.
[115], in the sequence there are hydrophobic (black), polar/glycine (green), positively
charged (blue), and negatively charged (red) residues. The same colors were used
in the ribbon representation of its secondary structure, except for the hydrophobic
residues (white). B: KRas-4B GDP-GTP cycling regulated by GAPs and GEFs.
Contributing to its focus on cancer studies, KRas-4B appears to be particularly
prone to mutations and there exists an intimate link to residue substitutions[119–123].
In KRas-4B, G12 mutations (89%) are predominant in human cancers, followed by G13
(9%) and Q61 (1%) mutations. Moreover, the G12D mutation is arguably the most
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prevalent mutation among the three frequent G12C (14%), G12D (36%), and G12V
(23%) mutations and G13D (7%) and Q61H (0.6%) mutations are also observed[124].
In addition, KRas-4B mutations could also occur at residues Glu-63, Lys-117, Asp-119,
and Ala-146 but with fewer frequency[125]. Structural studies have suggested that
mutation at these positions often enable perturbation of GTPase activity of KRas-
4B. Furthermore, the mutation within KRas-4B might exhibit significant differences
between cancer types. For instance, G12C mutation hampers GAP binding and
then controls the GTP hydrolysis to some extent[126]. In one study KRas-4B G12D
mutation is revealed to promote colon cancer, supporting the ability of KRas-4B to
initiate the formation of colon cancer[127]. Moreover, a relatively high express KRas-4B
G13 mutation in combination with high expression of the metastasis-associated in
colon cancer 1 (MACC1) indicates the poor survival for colorectal adenocarcinoma
(CRD) patients[128]. Pancreatic ductal adenocarcinoma (PDAC) is dominated by
KRas-4B G12D mutation followed by G12V, whereas Q61 and G13 mutations in
this disease are rare to be found. In contrast, the G12C mutation is a hallmark of
exposure to tobacco smoke and, accordingly, is the most common mutation in lung
adenocarcinoma (LAC)[129]. KRas-4B G12C together with G12V mutations in LAC
is able to preferentially activate the RalGDS pathway, and G12D mutation prefers the
Raf/mitogen-activated protein kinase (MAPK) and PI3K pathways[130]. Moreover,
KRas-4B has been observed to be able to be acetylated at Lys-104 which is proposed
to impair GEF-mediated activation and consequently, to suppresses the oncogenic
activity of mutationally activated KRas-4B. The observation indicates that acetylation
at Lys-104 is a negative regulatory modification[131]. Even though considerable efforts
on KRas-4B mutations have been invested in characterizing these distributions, their
impact on the cell is still poorly understood.
All Ras proteins’ signaling strongly depends on their correct localization in the cell
membrane and it is essential for activating downstream signaling pathways. KRas-4B
function, membrane-association and interaction with other proteins are regulated by
post-translational modifications (PTMs)[132–134], including ubiquitination, acetyla-
tion, phosphorylation, carboxymethylation, and prenylation.
We represent the crystal structure of KRas-4B in vivo in Fig. 1.3, but it would
still need further PTMs, that are shown in Fig. 1.4 to function properly in cells.
Firstly the prenylation reaction, catalyzed by cytosolic farnesyltrasferase (FTase) or
geranylgeranyltransferase (GGTase), proceeds through the addition of an isoprenyl
group to the Cys-185 side chain. Then farnesylated KRas-4B is ready for further
processing: hydrolysis, catalyzed by the endopeptidase enzyme called Ras-converting
enzyme 1 (RCE1), during the process the VIM motif (HVR tail composed of three
amino-acids: valine-isoleucine-methionine) of the C-terminal Cys-185 is lost in step
2, see Fig. 1.4. Later KRas-4B is transferred to the endoplasmic reticulum for car-
boxymethylation at the carboxyl terminus of Cys-185 catalyzed by isoprenylcysteine
1.3 KRas-4B membrane protein | 11
carboxyl methyltransferase (ICMT), forming a reversible ester bond. The outcome
of these modifications is the farnesylated and methylated KRas-4B (KRas-4B-FMe).
The reversible ester bond can go through decarboxymethylation, catalyzed by Preny-
lated/polyisoprenylated methylated protein methyl esterases (PMPEases) giving rise
to a farnesylated and demethylated KRas-4B (KRas-4B-Far) which is the product of
step 2 and reactant of step 3. This reversible reaction can modulate the equilibrium of
methylated/demethylated KRas-4B population in tumors and consequently can impact
downstream signaling, protein-protein interactions, or protein-lipid interactions[135].
KRas-4B
SH
O
VIM
Step 1
FTase
or
GGTase
KRas-4B
O
VIM
Step 2RCE1
S Farnesyl
KRas-4B
O
O
Step 3ICMT
S Farnesyl
KRas-4B
O
OCH3
S Farnesyl
KRas-4B-FMe
KRas-4B-Far
PMPEases
Fig. 1.4 PTMs steps of KRas-4B: prenylation, hydrolysis, carboxymethylation and
decarboxymethylation.
One of the best known reversible PTMs in HVR is phosphorylation[134, 136, 137].
There are two sites (Ser-171 and Ser-181) within HVR that could be phosphorylated.
Phosphorylation involves the addition of phosphate (PO3−4 ) group to the side chain of
the amino acid serine, then the phosphorylated serine is obtained. Phosphorylation at
Ser-181 operates a farnesyl-electrostatic switch that reduces but does not completely
inhibit membrane-association and clustering of KRas-4B, leading to redistribution to
the cytoplasm and endomembranes[133, 138, 139], whereas, phosphorylation at Ser-171
is less vital for its function[139]. Functionally, phosphorylation of KRas-4B can have
either a negative[140, 141] or positive[139, 142] regulatory effect on the tumor cell
growth, depending on the conditions[135]. For instance, from an MD simulation of
the HVR peptide with the farnesyl group (FAR) at Cys-185 of KRas-4B in two types
12 | Introduction
of model membranes, it has been observed that phosphorylation at Ser-181 prohibits
spontaneous FAR membrane insertion[143]. According to N.Agell, KRas-4B binding
with calmodulin leads to different behaviors: short or prolonged signaling whether
KRas-4B is at its phosphorylated state on residue Ser-181[139, 144]. In summary,
phosphorylation of the HVR of KRas-4B can affect its function, membrane-association,
and reacting with downstream effectors[135].
The translocation pathways of Ras proteins vary for different Ras isoforms, and sig-
naling activity of KRas-4B is dependent on its enrichment level in the PM. Phosphodiest-
eraseδ (PDEδ) has been revealed to promote effective KRas-4B signaling by sequestering
KRas-4B from the cytosol by binding the prenylated HVR and help to enhance its
diffusion to the PM throughout the cell, where it is released to activate various signaling
pathways required for the initiation and maintenance of cancer[145–148]. It is one of
the common targets considered for oncological drug development. And investigation of
the mechanistic inhibitory treatment of PDEδ has been carried out[147, 149], hoping to
identify a panel of novel PDEδ inhibitors. According to S.Dharmaiah[145], the affinity
between KRas-4B-FMe and PDEδ) is 78-fold compared with KRas-4B-Far by using ITC
(isothermal titration calorimetry) measurements and also, a 5-amino-acid-long sequence
motif in its HVR (K-S-K-T-K), which is shared by KRas-4B-Far and KRas-4B-FMe,
may enable PDEδ to bind prenylated KRas-4B-FMe. However, it doesn’t mean that
KRas-4B-Far cannot be translocated to bind membrane bilayers. In a paper published
in “Cell” in 2014[146] and another recent research in 2017[150], it was explained that
KRas-4B could also be transferred to the PM through trapping and vesicular transport
without the help of PDEδ. In the last step of carboxymethylation, there is a clear
difference in the level of the reversible carboxymethylation of Cys-185 according to
different kinds of tumor types related to KRas-4B. Interests have been focused largely
on methylated KRas-4B-FMe, however, accumulating shreds of evidence indicate that
demethylated KRas-4B-Far could play a big role in the signaling pathway that happens
on the inner leaflet of the membrane bilayers. In 2018, 91% of the oncogenic KRas-4B
and 51% of the wild-type KRas-4B can be found free from carboxymethylation in
certain colorectal cell samples[110], which implies that in the tumor cells, demethylated
KRas-4B-Far could be able to be translocated to bind the PM and functions well in its
active state. In a mouse model studied by A.Wahlstrom et al., the myeloproliferative
disease could be improved with higher demethylated KRas-4B-Far level in the cell
caused by ICMT deficiency[151], however, in a mouse model of pancreatic cancer the
disease could be accelerated. This indicates the behavior of demethylated KRas-4B-Far
could differ in different diseased cells.
While there is a relatively high abundance of KRas-4B-Far (wild-type and mutant)
lacking the methyl group of Cys-185 in tumors, the effects of demethylated KRas-4B-
Far on downstream signaling have yet to be determined[110]. Only with the genomic
sequence data can the oncologist not acknowledge the entire information in target
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selection. As a well-studied membrane protein, there is still much to learn about
KRas-4B’s structure, dynamics, function, and ways of therapeutic targeting in both
sides of clinical and theoretical aspects.
It has been reported that after these PTMs, a hydrophobic density is provided
to KRas-4B-FMe after carboxymethylation so that its enhanced protein recruitment
to the PM is revealed by most of the published works related to KRas-4B[132–135],
which is debatable. With a preference for binding to anionic lipids of KRas-4B HVR,
demethylated and farnesylated KRas-4B-Far shares the similar electrostatic potential
with an anionic head and a hydrophobic tail in its FAR same with PM lipids. We
propose that KRas-4B-Far might have more affinity for binding with anionic membrane
bilayers which needs to be explored.
After extensive studies on experimental, clinical, and theoretical aspects, one
relevant element is missing: the Free Energy Landscapes (FEL) as suggested by
R.Nussinov et. al. in 2019[152]. She emphasized the need for considering every Ras
isoform’s completeness, especially in the changes in the protein conformation. And
FEL describes the wide range of states, displays all the possible conformations that the
molecule can adopt. FEL inspires and motivates approaches to molecular biology[153]
and it helps us understand and propose testable hypotheses of how biomacromolecules
have been exploited for life. Proteins continuously interconvert between states, and
their fluctuations encode their functional behaviors under different conditions and
environments[154]. Biomolecules interconvert their structures with carrying energies
in nature. A proper physicochemical description of biological proteins is not as
single structures but as conformational ensembles with dynamic distributions of states
which change with varying conditions[153]. FEL could clarify how some mutations or
abnormal PTMs can be oncogenic by crossing lower free energy barriers between two
biologically relevant states, such as between destabilized inactive state ensemble and
active state or between an inactive state and stabilized active state ensemble.
The dynamic FEL assimilates and embodies concepts from Physics and Chemistry
which can help explain a range of biochemical mysteries, especially protein folding[155–
157], binding to membranes and other proteins, conformational orientation, etc. Free
energy change of membrane reorientation from relatively long simulations is believed
that can be estimated from the 2D probability density distribution. For example, recent
work revealed that the overall free energy surface of KRas-4B membrane-association is
rugged, indicating a large diversity of conformations including at least two sub-states
in each orientation state that differ in stability only by about 0.5-1.0 Kcal/mol and
in between, two orientations of either the three C-terminal α-helices or N-terminal
β-strands of KRas-4B catalytic domain facing the membrane are the most two common
orientations with a barrier of ∼ 1 Kcal/mol for their interconversions[158].
Tighter binding of KRas-4B-GTP with lower binding free energy than KRas-4B-
GDP has also been observed[159]. Binding free energies of KRas-4B-PDEδ were carried
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out through the surface area continuum solvation (MMGBSA) approach[160, 161]
provided in Amber16 suite[162]. Small molecules that bind and strengthen KRas-
4B-PDEδ complex followed by colorectal cancer cell growth inhibited in vitro and in
vivo[163] and their binding energies of the protein-ligand system have been explored
using the same MMGBSA approach. Binding energies could provide useful information
on selected conformations, orientations, and localizations of KRas-4B binding PMs.
However, the relevant transition states are hardly traceable.
Extremely long simulation time scales that were caused by high free energy barriers
serve as the roadblock during the investigations of the mechanism and kinetic aspects
of the conformational transitions in Ras[164]. Overcoming these barriers could be
accomplished by employing biasing potentials that drive the system towards the barrier
region along with predefined collective variables. Through enhanced path sampling
simulations, the conformational space and dynamic behavior of GTP-bound KRas-4B
can be investigated. For instance, KRas-4B was shown visiting several states, which are
the same for wild type and the oncogenic mutant Q61L and large differences of both
systems, indicating the dramatic effect of Q61L mutation on KRas-4B dynamics[165].
Calculation of the FEL of conformational sub-states of KRas-4B could be astonish-
ingly useful for medicine design for targeting KRas-4B related cancers, even though
the binding free energies between selected conformations have been studied extensively
by researchers in recent years[154, 157–159, 162]. The calculation of free energy barri-
ers between its meta-stable states is poorly considered. Insight into the underlying
biological mechanisms will play an important role in better defining ’actionability’ for
KRas-4B targets and bring new ideas to the "precision medicine"[152].
1.4 Objectives and outline
This Thesis presents the continuation and extension of a previous one, carried out by
Dr. Jing Yang in 2015[166] in this same research group at UPC, who started to work
in the modeling and simulation of phospholipid membranes in aqueous ionic solutions,
for the first time in the SIMCON research group at UPC. The main object of the study
of this Thesis is the research on the structure, dynamics, and FEL of small molecules
and proteins binding PMs. The properties of these systems have been performed using
different molecular dynamics simulations and well-tempered metadynamics simulations
that allow us to calculate different microscopic properties of the system. The Thesis is
structured as follows:
In Chapter 2 all techniques and computational packages employed in the present
Thesis have been described. After introducing the method, we have done the re-
search regarding the importance of the amino acids, neurotransmitters, hormones, and
membrane surface proteins for the correct functions of the body.
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In Chapter 3, firstly we have explored TRP’s interactions with a typical zwitterionic
phospholipid membrane formed by DPPC and cholesterol in an aqueous solution of
sodium chloride at a temperature of 323.15 K under liquid-crystalline phase conditions.
It is of central importance to elucidate their local structures and dynamics as well
as the mechanisms responsible for the access of tryptophan to the interior of the
cell. We have analyzed its mechanical properties, the local structures, and some
relevant dynamical properties such as diffusion and vibrational spectra after performing
molecular dynamics simulations. Microscopic properties such as the area per lipid, lipid
thickness, radial distribution functions, hydrogen-bonding lengths, atomic spectral
densities, and self-diffusion coefficients have been evaluated. Then four more biological
systems of small molecules binding DPPC membrane bilayers have been studied by
focusing our attention especially on the free energy barriers of the adsorption of small
molecule species: histidine, tyrosine, serotonin, and melatonin. We have computed the
radial distribution functions of all species for a variety of membrane and water-related
sites and extracted potentials of mean force through the reversible work theorem.
In Chapter 4 we have focused our efforts on the study of the binding of melatonin
at a simplified model cell membrane referring to the gradually increased interest in
melatonin in recent years. Molecular dynamics simulations of melatonin inside mixtures
of DMPC and cholesterol in NaCl solution at physiological concentration have been
performed at 303.15 K to systematically explore melatonin-cholesterol, melatonin-lipid,
and melatonin-water interactions. Properties such as the area per lipid and thickness
of the membrane as well as selected radial distribution functions, binding free energies,
angular distributions, atomic spectral densities, and translational diffusion of melatonin
are reported.
To the best of our knowledge, the free energy landscape of melatonin on membrane
surfaces is poorly studied. Free energy calculations are essential to unveil mechanisms
at the atomic scale such as binding of small solutes and their translocation across
cell membranes, eventually producing cellular absorption. We have used 1.4 µs well-
tempered metadynamics simulations to perform Gibbs free energy calculations in order
to precisely describe the characteristics of melatonin binding to specific sites in the
membrane and reveal the role of cholesterol in free energy barrier crossing. A specific
molecular torsional angle and the distance between melatonin and the center of the
membrane along the normal to the membrane Z-axis have been considered as suitable
reaction coordinates.
In Chapter 5 we shifted our interest to KRas-4B-membrane systems since KRas-4B
is a challenging target for anti-cancer drugs, in part because that the dynamic behavior
of flexible regions in the protein is difficult to characterize experimentally. To the
best of our knowledge, this is the first time of the dedicated systematic work on the
demethylated KRas-4B-Far. In order to reveal GTP’s affinity to post-translationally
modified KRas-4B-Far and its FAR group’s binding free energy barriers anchoring
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to/departing from membrane bilayers, especially for membranes with high cholesterol
content, continuous MD simulations of three KRas-4B-membrane systems have been
performed. Under the combining influence of mutation G12D, phosphorylation at
site Ser-181, and demethylation of Cys-185, KRas-4B’s behaviors in different systems
have been analyzed and results have been introduced from a Structural and energetic
perspective.
In this Thesis, we have discussed whether increasing its hydrophobic density in
the structure of KRas-4B helps anchor the PM by studying three systems of KRas-
4B-FMe and KRas-4B-Far from the atomic level. A better understanding of the
localizations of different domains of wild-type/oncogenic KRas-4B proteins on the
anionic membrane is important for its precision medicine and offering detailed free
energy landscapes of FAR and GTP could hopefully provide useful insights for this
field. In order to obtain atomistic insight into the dynamics of KRas-4B-Far, we have
depicted several stable conformations that have not been captured by experiments
through a well-tempered metadynamics method. For the first time through well-
tempered metadynamics simulation using 2 collective variables (distances along the
membrane normal between the mass centers of GTP and FAR group at Cys-185 site to
the membrane mass center) we investigated their free energy landscapes as compared
with the wild-type protein, the theoretical distinction among the mechanisms of G12D
mutation and phosphorylation of oncogenic KRas-4B-Far and wild-type KRas-4B-Far
is clarified.
Chapter 2
Methods
In this Chapter, we will describe all techniques and computational packages employed
in the present Thesis. All input files were generated from a web-based platform
called CHARMM-GUI, from which CHARMM36 and CHARMM36m force fields are
adopted and applied to small molecule-membrane bilayer systems during molecular
dynamics (MD) simulations. GROMACS and NAMD are used during standard MD
simulations for different biological systems and GROMACS and PLUMED are used
when performing well-tempered metadynamics simulations.
2.1 CHARMM-GUI web-based platform
Since its original development in 2006, CHARMM-GUI[167, 168], http://www.charmm-
gui.org, has proven to be an ideal web-based graphical user interface to build com-
plex molecular systems and prepare their input files for simulation packages such as
CHARMM (Chemistry at Harvard Macromolecular Mechanics), NAMD (Nanoscale
Molecular Dynamics), GROMACS (GROningen MAchine for Chemical Simulation),
AMBER (Assisted Model Building with Energy Refinement), GENESIS, LAMMPS,
Desmond, and OpenMM to facilitate and standardize the usage of wide-used and
advanced simulation techniques. As a well-established and reproducible simulation
protocol for state-of-the-art biomolecular simulations, CHARMM-GUI has been widely
adopted for various purposes and now contains a number of different modules de-
signed to set up a broad range of biomolecular simulation systems in Input Genera-
tor. In the year 2007, a Java applet integrated within CHARMM-GUI to induce a
novel online visualization tool based on MarvinSpace (https://chemaxon.com/marvin-
archive/4.1.6/marvin/doc/dev/space-map.html) molecular visualization software which
allows one to interactively inspect the generated molecular system at each step. In
this way, users could go back to the previous setup and regenerate the whole system
again with generally accepted standards and well-qualified methods before quitting
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the web browser. CHARMM-GUI has been used by many researchers, and it is a
well-recognized tool in the biomolecular modeling and simulation communities.
The rest of the section will be organized as follows. We describe several currently
available functional modules of CHARMM-GUI Input Generator that are designed
to set up a broad range of simulations: PDB Reader, Membrane Builder, Solution
Builder, Quick MD Simulator, Free Energy Calculator, ligand Reader & Modeler, et
cetera[168–170]. We will focus on the first three modules which were used in this
Thesis.
2.1.1 PDB Reader
Reading a PDB file into a simulation program is not straightforward and is generally
considered the first hurdle in a simulation project of a biosystem. PDB Reader is the
most basic, yet powerful web interface to convert a PDB file. It reads a PDB (Protein
Data Bank[171]) file from RCSB (http://www.rcsb.org) PDB (with PDB entry ID) or
uploads it from a local computer, then converts it to CHARMM readable format with
the following options:
• partial selection of protein chains and model selection in the case of NMR
structures,
• modification of engineered residues,
• terminal group selection,
• protonation selection,
• disulfide bond selection,
• phosphorylation selection,
• generation of a biologically functional unit
• generation of crystal packing.
For example, according to Jo et al.[168], PDB Reader automatically detects some
of the engineered residues and converts them to corresponding natural residues. How-
ever, due to the complexity of PDB files with many kinds of heteroatoms and other
engineered residues, users themselves need to check if all the residues to be read
do exist in a CHARMM topology file (currently, top_all36_prot.rtf). If there are
undetermined coordinates in selected chains, PDB Reader will simply build them using
a predetermined internal coordinate table.
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2.1.2 Membrane Builder
Simulating a realistic biomembrane system is very challenging. Since its first release in
2007, Membrane Builder[167, 168, 172–174] consists of 6 major functional sub-modules:
Bilayer Builder, HMMM Builder, Nanodisc Builder, Monolayer Builder, Micelle Builder,
and Hex Phase Builder. Here I will only introduce Bilayer Builder through which
all biosystems are generated in this Thesis. Membrane Builder, especially Bilayer
Builder, helps users to generate a series of CHARMM inputs necessary to build a
protein-membrane complex for MD simulations. Through a series of steps of generating
organic molecules plus bilayer membrane system, users need to provide validated PDB
of properly oriented structures in the first building system step and also mutation,
phosphorylation could also be carried out in step 1. After modifying the orientation
with respect to membranes and its location along the normal direction for the molecule
in step 2, water molecules and different kinds/amounts of sterols, lipids, fatty acids,
detergents, et al., which allow users to build experimentally comparable and biologically
realistic membrane systems. Based on the system size determined in step 3, positive
and negative ions will be generated in step 4. All the pieces (protein, lipid bilayer,
additional water, and ions) are assembled together in step 5. Finally and importantly
input files with appropriate formats for various MD programs could be obtained in the
last step.
Compared to other tools for protein-membrane model construction[175–179], Mem-
brane Builder is much more flexible and robust in terms of producing reasonably
packed systems which are proven to be of usage worldwide, providing simulation inputs,
various user options, and availability of various lipids. An additional advantage of
Membrane Builder is to have various functionalities available to read ligand struc-
tures and modify protein side chains with MTS reagents or unnatural amino acids
during the PDB structure reading step. E.L.Wu[173] reported new features and major
improvements: various kinds of lipids and robust and efficient algorithms could be
adopted in building realistic biological membrane systems. Membrane Builder helps
users to build sophisticated protein/membrane or membrane only systems through an
easy and automated process.
2.1.3 Solution Builder
It is common simulating DNA/RNA, ions, proteins, small molecules in a realistic
environment, especially in different aqueous solutions. Solution Builder[168, 174] of
CHARMM-GUI helps users to generate a series of input files for MD simulation of
the target molecule in aqueous solvent environments. Molecules can be solvated, for
example, relax the protein structures in a certain aqueous ionic solution (NaCl, KCl,
CaCl2, and MgCl2) or generating a simple water box only for other purposes. Solution
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Builder also guides users to define its dimension and build the water boxes in different
shapes: orthorhombic, hexagonal, octagonal, cylindrical, or spherical shapes.
The default ion concentration is 0.15 M KCl that is close to the physiological ion
concentration (C) in human body. Numbers of ions are determined by the ion-accessible
volume (V) and the total charge of the system (Qsys) as follows:
N+ = CV −Qsys/(2ez+)
N− = z+CV +Qsys/2e (2.1)
where N+ and N− are numbers of positive and negative ions respectively, e is
the charge of an electron, and z+ is the valence of the positive ion. The number of
ions roughly corresponds to the linearized Poisson-Boltzmann theory[180]. Solution
Builder allows users to visualize the solvated system to validate if the system is built
properly. Short steps of minimization are performed to remove bad contacts in step 3
and equilibrated through the later MD simulation.
2.2 Force Fields
Which force field to use in MD simulations using simulation packages? The most
common choices are various versions of AMBER[181–183], CHARMM, and Optimized
Potentials for Liquid Simulations (OPLS)[184–186]. All force fields rely on similar
functional forms, however, each one has certain strengths and weaknesses. The
CHARMM force field, adopted by this work, is the name of a widely used set of force
fields for MD. Multiple versions of each force fields are available, they all use strikingly
similar functional forms.
The potential energy function used in CHARMM force field is as follows:
Utotal =
∑
bonds
Kb(b− b0)2 +
∑
angles
Kθ(θ − θ0)2 +
∑
dihedrals
∑
j
Kφ,j [1 + cos(njφ− δj)]
+
∑
vdWi,j
εij [(
Rmin,ij
rij
)12 − (Rmin,ij
rij
)6] +
∑
Coulomb i,j
qiqj
εDrij
(2.2)
where the terms have their usual meanings. The bond and angle terms are harmonic,
with force constantsKb andKθ and equilibrium values b0 and θ0. The dihedral potential
is a sum of sinusoids with force constant Kφ,j , multiplicity n, and offset φ, and j can
range from 1 to 6. For the van der Waals (vdW) interactions, εij is the potential
energy minimum between two particles separated by rij , and Rmin,ij is the position of
this minimum. Lastly, qi and qj are the partial atomic charges for the Columbic term;
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the dielectric constant εD equals 1 in explicit solvent simulations. For CHARMM36,
The bond and angle terms are left unchanged from previous modifications[187–189].
The following objective function used to obtain all new torsional terms for CHARM-
M36 force field:
χ =
no. of QM points∑
i
[
UQMi − Umodeli
]2
(2.3)
where Ui is the energy for conformation i.
In CHARMM36 the new vdW parameters included the recently optimized oxygen
vdW parameters for the ether oxygen in the ester linkage, but methyl vdW parameters
stay the same. According to Ref [189], using CHARMM36 force field, deuterium order
parameters for carbons in the glycerol and headgroup region of the lipid are well de-
scribed, surface areas of a total 6 lipids are in very good agreement with experiment data,
and intra-molecular conformations near the glycerol moiety could be soundly described
during simulations. CHARMM36 is a significant update to the CHARMM27/27r
lipid force field[190–192]. Hydration of lipids near the carbonylglycerol section of
phospholipids is improved and it allows for the use of a tensionless ensemble (NPT)
in MD simulations. It is shown that the CHARMM36 force field leads to better
correlation with experimental data compared to the CHARMM22/CMAP force field
(sometimes referred to as CHARMM27 force field[190]) and using CHARMM36 force
field in protein simulations is suggested cause CHARMM36 force field could more
accurately treat folded proteins and equilibrium of conformations observed in partially
disordered peptides. The major improvements over CHARMM27 involve new side-
chain dihedral parameters and refined backbone CMAP potentials. In CHARMM36,
other minor improvements include revised parameters for the guanidinium moiety of
arginine, aliphatic hydrogens, and tryptophan[189]. And CHARMM36 protein force
field was found to generate a high population of left-handed α-helix (αL), inconsistent
with NMR spectroscopy and small-angle X-ray scattering experimental measurements.
CHARMM36m force field comes from the all-atom additive CHARMM36. In
CHARMM36m, the modified CHARMM36 protein parameter set (par_all36m_prot.pr-
m), which corrects oversampling of the αL conformation and gives an improved sampling
of disordered states of peptides, was available online in July 2017. Together with
top_all36_prot.rtf, all simulations involving peptides and proteins, even for folded
proteins, were improved. It also improves accuracy in generating polypeptide backbone
conformational ensembles for intrinsically disordered peptides and proteins based
on a refined backbone potential derived from reweighting calculation and a better
description of specific salt bridge interactions. It was validated by Huang et al. in
2017[185]. In the present Thesis, we employed CHARMM36 and CHARMM36m force
fields along with our research.
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2.3 Molecular Dynamics Simulations
Molecular dynamics is a computer simulation method that mimics what atoms do in real
life, assuming a given potential energy function. It provides detailed information on the
fluctuations and conformational changes of atoms and molecules in materials[193–195],
and it was firstly introduced in the late 1950s after Monte Carlo simulation[196]. The
aim of MD simulation is to trace the classical trajectory of a N particles system or to
describe its dynamics. The system has been prepared in a particular initial condition.
We wish to predict the average behavior of a system along multiple trajectories[197].
There are two main families of MD methods: ’classical’ mechanics approach to MD
simulations (molecules are treated as classical objects) and ’quantum’ or ’first-principles’
MD simulations (the quantum nature of the chemical bond is taken into account), and
the latter is outside of the scope of this Thesis.
2.3.1 Equations of motion
In classical MD it is assumed that each particle in the system behaves like a Newtonian
particle and the quantum behavior is completely ignored. The potential energy
U(r1, r2, r3, ..., rn) of N interacting particles in the system depends on their positions
ri = (xi, yi, zi). The force acting on ith atom is determined as Ref. [198]:
Fi = −▽ri U(r1, r2, r3, ..., rn) = −(
∂U
∂xi
,
∂U
∂yi
,
∂U
∂zi
). (2.4)
Time evolution of a series of particles is obtained through Newton’s Second law of
motion:
Fi = mi
d2ri(t)
dt2
(2.5)
where ri(t) = (xi(t), yi(t), zi(t)) is the position of ith atom at time t and mi is the
mass of the atom i.
In MD, in order to integrate Newton’s equations of motion, the most commonly
used and time integration algorithm is the so-called Verlet algorithm, introduced by
Verlet in 1967[199]. In order to derive it, Taylor expansion of the coordinate of a
particle around time t is adopted:
r(t+∆t) = r(t) + v(t)∆t+ F (t)2m ∆t
2 + ∆t
3
3!
...
r +O(∆t4)
similarly,
r(t−∆t) = r(t)− v(t)∆t+ F (t)2m ∆t
2 − ∆t
3
3!
...
r +O(∆t4)
2.3 Molecular Dynamics Simulations | 23
An error of order ∆t4 for the estimate of the new position exists in the two equations
above. Summing these two equations, we could obtain:
r(t+∆t) + r(t−∆t) = 2r(t) + F (t)
m
∆t2 +O(∆t4)
or
r(t+∆t) ≈ 2r(t)− r(t−∆t) + F (t)
m
∆t2 (2.6)
Where r(t) is the particle’s position at time t, ∆t is known as the time step in MD
simulation. So using
r(t+∆t)− r(t−∆t) = 2v(t)∆t+O(∆t3)
or
v(t) = r(t+∆t)− r(t−∆t)2∆t +O(∆t
2),
v(t) ≈ r(t+∆t)− r(t−∆t)2∆t (2.7)
We could derive the velocity from trajectories obtained from MD simulation which
precision is of order ∆t2.
Once the first configuration of the system is given, the following configurations of
the system can be computed, i.e. new positions and velocities also can be calculated.
After repeating the procedure many times, a series of trajectories of atomic motions will
be obtained. After analyzing meaningful trajectories of MD simulation, the movement
of atoms: velocities, positions, and orientations as a function of simulation time could
be obtained.
MD simulations are often used in comparison to and combination with many
experimental structural biology techniques, including X-ray crystallography, neutron
scattering, electron paramagnetic resonance (EPR), nuclear magnetic resonance (NMR),
IR and Raman spectroscopy, cryoelectron microscopy (cryo-EM), and Förster resonance
energy transfer (FRET). MD simulations are used both to interpret experimental
results and to guide experimental work[200]. In important published papers about
the study of proteins related to neuronal signaling[201–204]; providing the foundation
for the design of improved optogenetics tools[205], and assisting in improving drugs
targeting nervous systems[206, 207], MD simulations play an important role in the
research.
Even though MD simulations themselves are becoming much more powerful and
easier to use for non-experts over the past decades, limitations of the method still
exist. They are related to the parameter sets used and to the underlying molecular
mechanics force fields whose accuracy needs to be improved. In a wide variety of
important biomolecular processes, such as conformational change, ligand binding,
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and protein folding are difficult to be accessed within the limited time scales of the
conventional MD simulation. Most high-impact works performed using MD simulations
needed the support of supercomputer centers. Advances in computer power have
enabled microsecond simulations, but simulation timescales remain to be a challenge
which makes enabling longer-timescale simulations an active research area, among
which algorithmic improvements, parallel computing, and hardware such as GPUs and
specialized hardware, etc. are involved.
2.3.2 Periodic boundary conditions
In Biophysics and Structural Biology, MD simulation is widely applied to study
proteins, nucleic acids, cell plasma membrane systems which can provide information
on interpreting the results of certain biophysical experiments and modeling interactions
with other molecules. In Physics, MD is used to examine the dynamics of atomic-
level phenomena that can not be observed directly, such as thin-film growth, examine
physical properties of nanotechnological devices that have not or can not yet be created,
and so on. In all kinds of MD simulations, the simulation box size must be large
enough to avoid boundary condition artifacts. Boundary conditions are often treated
by choosing fixed values at the edges or by employing periodic boundary conditions
(PBCs) in which one side of the simulation loops back to the opposite side, mimicking a
bulk phase. Both may cause artifacts for the system[208]. PBCs are a set of boundary
conditions chosen for approximating a large (infinite) system by using a small part
called a unit cell. The size of the simulation box must also be large enough to prevent
periodic artifacts from occurring due to the nonphysical topology of the simulation.
One example of periodic boundary conditions can be defined according to smooth
real functions ϕ : ℜn → ℜ by
∂m
∂xm1
ϕ(a1, x2, ..., xn) =
∂m
∂xm1
ϕ(b1, x2, ..., xn),
∂m
∂xm2
ϕ(a1, x2, ..., xn) =
∂m
∂xm2
ϕ(x1, b2, ..., xn),
...,
∂m
∂xmn
ϕ(a1, x2, ..., xn) =
∂m
∂xmn
ϕ(x1, x2, ..., bn)
(2.8)
For all m = 0, 1, 2, ... and for constants ai and bi. In MD simulation, PBCs are usually
applied to simulate bulk gases, liquids, crystals or mixtures.
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2.3.3 Ensembles
Generalized ensembles, Isothermal–isobaric (NPT) ensemble, Canonical ensemble
(NVT), and Microcanonical (constant-NVE) ensemble are ensembles used in MD
simulations, among which NPT and NVT ensembles are the most used ones.
NVT is the statistical ensemble that represents the possible states of a mechanical
system with constant temperature (T ), system’s volume (V ) and the number of particles
in the system (N). The system can exchange energy with the heat bath[209], so that
states of the system along the simulation time will differ in total energy. Under the
NVT ensemble, the partition function of a bulk system with N particles and the
volume V is given by[210, 211]:
Λ =
√
2πℏ2/mkBT
Q(N,V, T ) = V
N
Λ3NN !
∫
D(V )
dq exp [−U(q)
kBT
] (2.9)
where Λ is the thermal de Broglie wavelength, U is the potential energy of the
atomic coordinates q = {q1, q2, ..., qN}, D(V ) denotes the spatial domain defined by
the containing volume. The expression for the Helmholtz free energy of the system is
thus[212]:
A(N,V, T ) = −kBT lnQ(N,V, T )
= −kBT ln V
N
Λ3NN ! − kBT ln
∫
D(V )
dq exp [−U(q)
kBT
] (2.10)
where −kBT ln V NΛ3NN ! is the free energy of an ideal gas.
The practical use of the NVT ensemble is usually justified in two ways: by assuming
that the contact is mechanically weak, or by incorporating a suitable part of the heat
bath connection into the system under analysis so that the connection’s mechanical
influence on the system is modeled within the system.
NPT is a statistical ensemble that maintains constant pressure P , temperature T
and number of particles N in the system. It is often used for measuring the equation
of state of model systems whose virial expansion for pressure cannot be evaluated,
or systems near first-order phase transitions[197]. When NPT ensemble is used, the
characteristic state function of this ensemble is the Gibbs free energy given by:
G(N,P, T ) = −kBT ln∆(N,P, T )
= −kBT ln
∫
dV exp [− PV
kBT
]exp [−A(N,V, T )
kBT
] (2.11)
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NPT ensemble is very useful in MD simulations, e.g. to model the behavior of
water at ambient conditions. Computing directly the partition function for an arbitrary
potential is impractical, and for this reason, practical routes for computing Helmholtz
free energy or Gibbs free energy typically use a reference system for which the phase-
space integral can be computed analytically, followed by one or more thermodynamic
integration steps [212].
2.3.4 Limitations of MD simulations
It is crucial to be aware of the limitations of MD in order to make reasonable use of it.
Dynamical events of important biologically processes which involve quantum effects such
as changes in the presence of important noncovalent intermediates, chemical bonding,
and tunneling of protons or electrons. Straightforward atomic force field simulations
cannot be used to model such phenomena. Even the available force fields, such as
AMBER, CHARMM, or GROMOS, have proved to be sufficiently accurate in terms
of kinetic and thermodynamic properties. Still, there is vast room for improvement.
The stability and accuracy of MD will be challenged during long-time MD simulations.
So, improving the quality of the atomic force fields is highly desirable. Relevant time
scales for biologically important processes that place limits on the desired increasing
size of simulated biological systems.
2.4 Well-tempered metadynamics simulations
After its early beginning run by Mary Ann Mansigh in 1962, MD has become a standard
tool used in many branches of Science. The problem of sampling complex free energy
landscapes, of which meta-stable states are separated by large energy barriers, has
recently attracted much attention. Also, these process of interesting events often take
place on a large timescale. A number of methods could be adopted: transition path
sampling[213], local elevation[214], steered MD[215], conformational flooding[216, 217],
umbrella sampling[218–223], adaptive force bias[224], and metadynamics[225–230].
Metadynamics is a powerful technique which has proven its effectiveness in a variety
of contexts, aiming at enhancing the sampling of the configurational space. In this
method sampling is facilitated with an additional bias potential (or force) which acts
on a selected number of degrees of freedom −→s (q): the so-called collective variables
(CVs) along the trajectory. The potential is constructed as the sum of Gaussian
functions[214]:
Vmem(χ) = kmemnχ0exp−
(χ−χ0)2
2ω2 (2.12)
where χ is the current conformation, χ0 is the conformation visited before, kmem
(>0) defining the magnitude and ω is the width of the memory penalty function, nχ0
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is the number of times this conformation has been sampled before (including the
dimension).
This potential could be expressed as follows[230–232]:
V (−→s , t) =
∑
kτ<t
W (kτ)exp (−
d∑
i=1
(si − si(q(kτ)))2
2σ2i
) (2.13)
where τ is the Gaussian deposition stride, W (kτ) the height of the Gaussian, and
σi the width of the Gaussian for the ith CV.
In the long time limit, the bias potential converges to minus the free energy as a
function of the CVs:
V (−→s , t→∞) = −F (−→s ) + C (2.14)
After a transient, the bias potential compensates the underlying free energy land-
scape and provides an estimate of its dependence on the selected CVs. However, it
is often difficult for users to decide when to terminate metadynamics simulation. In
metadynamics, the free energy does not converge to a definite value but fluctuates
around a certain result in a single run which leads to an average error which is pro-
portional to the square root of the bias potential deposition rate[232]. And the time
required to fill the free energy landscape increases when this rate is reduced.
In order to alleviate these problems and inspired by the self-healing umbrella
sampling methods, well-tempered metadynamics was introduced by Michele Parrinello
et al. (2008)[231]. In well-tempered metadynamics, the height of Gaussian is decreased
with simulation time according to:
W (kτ) =W0exp (−V (
−→s (q(kτ)), kτ)
kB∆T
) (2.15)
where kB is the Boltzmann constant, W0 is an initial Gaussian height, ∆T is an
input parameter with the dimension of a temperature. By rescaling the Gaussian
height during the simulation, the bias potential could converge in a smooth way, but it
does not fully compensate the underlying free energy in the long limit:
V (−→s , t→∞) = − ∆T
T +∆T F (
−→s ) + C (2.16)
where T is the system temperature.
When simulation time approaches the long time limit, along with CVs, an ensemble
is sampled at a temperature T +∆T . When ∆T = 0 corresponds standard MD, and
∆T →∞ to standard metadynamics. By definition, bias factor γ:
γ = ∆T
T +∆T (2.17)
so, Eq. 2.16 is changed into:
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V (−→s , t→∞) = −F (
−→s )
γ
+ C (2.18)
So, γ shall be chosen carefully for the system to escape from any local minimum
and into visiting new regions of the phase space in an effective way in the time scale if
simulation.
2.4.1 Metadynminer
Metadynamics is a highly successful enhanced sampling technique for simulation of
molecular processes and prediction of their free energy landscapes. It is as crucial as
the simulation itself to do an in-depth analysis of data obtained by this method. R is
a programming language and free software environment for statistical computing[233]
and graphics[234–236] supported by the R Foundation for Statistical Computing. The
R language is widely used among statisticians and data miners for developing statistical
software and data analysis[237, 238]. R packages are collections of functions and data
sets developed by the community. They increase the power of R by improving existing
base R functionalities, or by adding new ones. Metadynminer is one R package
for loading, reading, analyzing, and visualization of 1D and 2D hills files produced
from metadynamics simulation. It uses a fast Bias Sum algorithm by P.Hosek and
V.Spiwok[239] to calculate the free energy landscapes. Minima can be located and
plotted on the free energy landscapes. Transition states can be analyzed by the Nudged
Elastic Band (NEB) method by G.Henkelman and H.Jonsson[240]. Minimum energy
paths for transitions such as atomic and/or spin rearrangements in thermalized systems
are the transition paths of the largest statistical weight. Such paths are frequently
calculated using the NEB method[241–245], where an initial path is iteratively shifted
to the nearest minimum energy path. In order to effectively locate transition states,
to frequently calculate the minimum energy paths for transitions, and to determine
the atomistic reaction pathways, energy barriers, and binding potentials, the Nudged
Elastic Band method has been largely adopted. In this method, an initial path is
iteratively shifted to the nearest minimum energy path.
An estimation of the thermal stability of a state can be of important importance.
The lifetime of a state at a given temperature can be estimated using harmonic
transition state theory[246, 247], for some atomic, nuclear, or particle states, this
lifetime can be very short. Halftime[248, 249], calculated through the metadynminer
package, could be chosen to describe how quickly two (meta-)stable states undergo the
transition state. With this method, free energy landscapes, minima, and transition
paths can be computed.
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2.5 Simulation packages used in this Thesis
2.5.1 NAMD
NAMD is one of the typical parallel MD program designed for high-performance
simulation of large biomolecular systems. It is distributed free of charge with source
code which scales to hundreds of cores for typical simulations and beyond 500,000
cores for the largest simulations and many important papers have been published
using NAMD[250–260]. NAMD2 described in Ref. [261] is one of the programs aimed
at utilizing large parallel machines in a scalable manner. Using intelligent periodic
load balancing and maximally utilizing the available compute power are available. A
combination of algorithms and numerical techniques guarantees that energy drifts are
minimized to ensure the simulation’s accuracy. In this Thesis NAMD2.7 was adopted.
2.5.2 GROMACS
GROMACS is a versatile package to perform MD for systems with hundreds to millions
of particles. Now users could download the 5, 2016, 2018, 2019, and the latest 2020
release series of GROMACS on web pages: http://manual.gromacs.org/documentation.
GROMACS was firstly introduced by Berendsen in 1995 [262] which was primarily
designed for biochemical molecules like proteins, lipids, and nucleic acids that have a
lot of complicated bonded interactions. Also, many groups use GROMACS to simulate
non-biological systems because of its rapidness of non-bonded interactions.
In principle using the updated versions of GROMACS could give better performance
and results. Here we have employed GROMACS/5.14, GROMACS/2018.3 in different
systems. The GROMACS/2018 major release was out on January 11, 2018, in which
several useful performances have been obtained: 1, many fewer CPU cores are needed for
good performance; 2, a physical validation suite is added to verify expected properties;
3, a new dual-list dynamic-pruning algorithm for the short-ranged interactions has
been adopted to permit longer-lived outer list with less work and more dependent on a
certain parameter, et al.
2.5.3 PLUMED
PLUMED, firstly introduced in 2009, is a plugin that works with a large number of
MD codes, like NAMD, GROMACS, AMBER, LAMMPS, ABIN, CP2K, Quantum
ESPRESSO, and so on. And it can also be used together with analysis and visu-
alization tools HTMD, and VMD. More importantly PLUMED is an open-source
library implementing various free-energy methods with some of the most popular
enhanced sampling techniques for MD simulations. In addition, PLUMED offers a
large collection of CVs, for example, dihedral angles, distances, α-helical contents,
positions, components of the simulation cell, coordination numbers, different energies,
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and volumes of the simulation cell. The detailed theoretical background could be found
in Ref[263]. PLUMED 2 which has been adopted in well-tempered metadynamics
simulations in Chapter 4 shows greater flexibility and modularity and is far easier to
add new methods and CVs than the original design. With a simpler interface with the
MD engine and a single software library including tools and core facilities, it obviously
provides much better service and brings new features for the community of users and
developers.
2.5.4 VMD
Visual Molecular Dynamics (VMD)[176] is designed for modeling, visualization, and
analysis of biological systems such as proteins, lipid bilayer systems, et al. Being
released in 1995, VMD was developed for silicon graphics workstations and could also
communicate with NAMD program in MD simulations. In general, VMD is used to
read standard Protein Data Bank (PDB) files and display the contained structure and
to animate and analyze the output files of MD simulations. It also includes tools for
working with sequence data, volumetric data, and arbitrary graphics objects.
Chapter 3
Small molecules bound to di-
palmytoil-phosphatidyl-choline
bilayer membranes
In the present Chapter, microscopic structures of a fully DPPC lipid bilayer membrane
with a small biological probe embedded inside, such as α-amino acids (TRP, HIS, and
TYR), a neurotransmitter (SER) and a kind of hormone (MEL), have been analyzed
through all-atom MD simulations based on the recently parameterized CHARMM36
force field. We have focused our efforts in two directions: on one side, the study of
phospholipid membranes can help understand basic biological membrane functions
and interactions with the environment. On the other side, the role of amino acids and
drugs and their interactions with the membrane structure is undoubtedly a relevant
field of research. As it is well known, cholesterol plays a key role in the structure
of cell membranes. The effect of cholesterol on the binding of tryptophan to DPPC
membranes is of great scientific interest. The characterization of the microscopical
forces between the essential TRP and the basic components of cell membranes and
their environments (phospholipids, cholesterol, ionic species, and water) is of central
importance to elucidate their local structures and dynamics as well as the mechanisms
responsible for the access of TRP to the interior of the cell. Finally, in the last section
of this Chapter, free energy barriers associated to the binding of small-molecules at
phospholipid zwitterionic membranes inside aqueous sodium chloride solution for a
variety of species: TRP, HIS, TYR, SER, and MEL have been investigated, given their
importance for the correct function of the body.
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3.1 Preliminary study on the adsorption of tryptophan
into DPPC bilayers
To shed light on the hot topic of the uptaken of drugs and proteins through the cell
membranes in vivo, we have considered the introduction of a small biological probe into
the lipid bilayer structure: the amino acid TRP[54, 58]. Since it has to be acquired
from the diet, hence it is able to act as a building block in protein biosynthesis, while
proteins are fundamentals required to sustain life. So, given the importance of TRP, we
started our study exploring its interactions with DPPC and water in a salty solution of
sodium chloride as well as its local structure, molecular bonding, and free energy profiles.
3.1.1 Computational information
Our system has been build by means of the CHARMM-GUI web-based tool. Here
the bilayer membrane is composed of 204 lipids distributed in two leaflets of 102
flexible DPPC molecules surrounded by 4962 TIP3P[264] water (W) molecules plus 17
sodium and 17 chloride ions, corresponding to physiological concentration (0.15 M)
and one TRP molecule. Sketches of the backbone structure of DPPC and of TRP
are represented in Fig. 3.1. TRP and each DPPC molecule are described with atomic
resolution (27 and 130 sites, respectively). MD simulations were performed with the
NAMD2 simulation package[265] at a temperature of 310.15 K and the pressure of 1
atm. The simulation time step was set to 2 fs. The recently parameterized force field
CHARMM36[189], which is able to reproduce the area per lipid in excellent agreement
with experimental data, has been used. All molecular bonds have been left non-rigid,
allowing fluctuations of bond distances and angles. Van der Waals interactions were cut
off at 12Å with a smooth switching function starting at 10 Å. Long ranged electrostatic
forces were computed with the help of the particle mesh Ewald method[266], with a
grid space of about 1 Å. Electrostatic interactions were updated every time step and
periodic boundary conditions were applied in three dimensions of space. After thermal
equilibration (for about 10 ns), two 25 ns production runs were generated, with a
simulation box of size: 74.4 Å× 74.4 Å× 70.1 Å. The temperature was controlled by a
Langevin thermostat[267] with a damping coefficient of 1 ps−1, whereas the pressure
was controlled by a Nosé-Hoover Langevin barostat[268] with a damping time of 50 fs.
Finally, in order to eliminate any artificial drift of the center-of-mass of the system
in the simulations, the coordinates of lipid atoms were corrected for the motion of
the center-of-mass of the monolayer they belong[269]. In a previous simulation where
DMPC lipid bilayers were modeled[17], a wide variety of properties of the simple lipid
bilayer were satisfactorily reproduced (surface area per lipid, lateral pressure profile,
order parameter of the lipid tails, etc.), so that we have not included these verifications
here.
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Fig. 3.1 Sketches of the backbone structures of DPPC, cholesterol, and TRP. Hydrogens
bound to carbon and nitrogen are not shown. The highlighted sites of TRP (’H1’,
’H2’, ’N1’, ’N2’, ’C1’, ’C2’, ’O1’, and ’O2’) and of DPPC (’N’, ’O2’, and ’O8’) will be
referred in the text by the labels defined here. Due to the zwitterionic characteristics
of TRP, its site ’H1’ corresponds to any of the three hydrogens bound to ’N1’, which
share the positive charge. Sites ’O1’ and ’O2’ of TRP share the negative charge. Site
’C2’ is close to the center of mass of the molecule.
A general view of the system is shown in Fig. 3.2. There, for the sake of clarity,
water has been hidden so that only TRP, DPPC, and sodium and chloride ions have
been shown. We have chosen two significant configurations, one for TRP adsorbed
to sites located at the headgroup in DPPC (left side of Fig. 3.2) and another one for
water solvating TRP (right side of Fig. 3.2). We should point out that TRP tends
to stay close to the headgroup regions of the lipid chains during most time of the
simulated trajectories: An estimation over the full trajectory indicated that around
70% of time TRP is attached to DPPC.
3.1.2 Results and discussion
3.1.2.1 Stability of the system
Before addressing the structural organization of the system, we checked the stability
of the simulations and represented the contribution of all kinds of energies to the total
energy of the system (Fig. 3.3) as well as the temperature and the pressure (Fig. 3.4),
in order to ensure that our calculations were based on fully equilibrated MD runs.
On the one hand, the two main contributions to the total energy are the kinetic
and the potential terms, as usual. In a deeper level of classification, potential energy
has six contributions, namely those of: (a) molecular bonds; (b) molecular, dihedral
and improper angular terms; (c) Van der Waals and (d) electrostatic (Coulomb) terms.
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Fig. 3.2 Two snapshots of the aqueous DPPC membrane with an embedded TRP
molecule. TRP inside DPPC (left) and inside water (right). Surrounding water is not
shown for the sake of clarity. Atoms in TRP: Oxygen (red); hydrogen (white); carbon
(cyan); nitrogen (blue). Sodium ions (yellow) and chloride ions (green). DPPC are
depicted as lines.
Among all these terms, the electrostatic one is the largest by far, as expected. All
contributions of the energy are shown in the last 10 ns of the simulation run, revealing
stable profiles with fluctuations up to 3% of the average values. On the other hand,
we found some fluctuations smaller than 2% for the temperature and of about 25 bar
for the pressure. The mean pressure is zero, indicating that the bilayer is not affected
by external or internal neat forces. From experimental and theoretical works, the
expected surface tension of a lipid bilayer membrane should be zero[270–274], what it
is consistent with the fact that the thermodynamic pressure of our system fluctuates
around zero.
At the equilibration stage of the simulation, we placed TRP initially at the center
of the membrane. After a few nanoseconds, we observed that TRP moved quickly to
the water-DPPC interface and stayed there in close contact with the lipid headgroups.
The most stable configurations of TRP at the interface and when solvated by water
will be discussed below.
3.1.2.2 Structure of TRP around water and lipids
The local structure of the system can be analyzed by means of normalized atomic
radial distribution functions (RDF) g12(r). For a species ’2’ close to a tagged species
’1’, they are given by
g12(r) =
V ⟨n2(r)⟩
4N2 πr2 ∆r
, (3.1)
where n2(r) is the number of atoms of species ’2’ surrounding a given atom of
species ’1’ inside a spherical shell of width ∆r = 0.1Å. V stands for the total volume
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Fig. 3.3 Energy decomposition for the full system.
and N2 is the total number of particles of species ’2’. The four g(r)s considered were
defined for the pairs:
1. The hydrogen of TRP (’HT’, corresponding to the three hydrogens labeled ’H1’
which represents the three hydrogen atoms attached to ’N1’ atom, see Fig. 3.1)
versus the oxygen of a water molecule (’OW’);
2. The oxygens of TRP (’OT’, corresponding to the sites labeled ’O1’ and ’O2’ of
TRP, see Fig. 3.1) versus the hydrogen of a water molecule (’HW’);
3. The hydrogen of TRP ’HT’ versus the negatively charged oxygen of DPPC
(’O−’), located at the lipid headgroups (label ’O2’ in Fig. 3.1);
4. The oxygens of TRP ’OT’ versus the charged nitrogen of DPPC (’N+’), located
at the lipid’s heads (see Fig. 3.1).
The results are shown in Fig. 3.5. The four radial distribution functions show
some fluctuations in their profiles, the statistical noise observed in the association of
TRP with N+ of DPPC being more marked than for TRP-water and for TRP-O−
of DPPC. We can observe a first coordination shell in all cases, being the binding of
TRP to water the one with the highest peaks of the corresponding g(r) (those depicted
in the left column of Fig. 3.5). In such a case, a second coordination shell can be
also observed. Throughout our long simulation runs we observed periods of time of
about 5 ns where TRP was fully solvated by water, indicating that the hydration of
TRP is one stable state of the system, i.e. TRP can be fully hydrated for significant
36 | Small molecules bound to di-palmytoil-phosphatidyl-choline bilayer membranes
Fig. 3.4 Temperature and pressure fluctuations for the full system.
periods of time, essentially through hydrogen-bonding between the hydrogens of TRP
(labeled as ’H1’, ’H2’, and ’H3’ in Fig. 3.1 and the water’s oxygen. If we focus on
the TRP-DPPC binding, we can observe that the corresponding radial distribution
functions gHT−O−(r) and gOT−N+(r) (depicted in the right column of Fig. 3.5) show
marked first coordination shells and very smooth second shells. This fact indicates
that the solvation of TRP by DPPC is carried out by a few lipid chains. From our
simulation runs we observed that the average time of TRP inside the DPPC bilayer is
of the order of 10-15 ns. The structure of water around DPPC is very similar to that
of water around DMPC as it was described in the previous study[17, 275].
3.1.2.3 Hydrogen bonding of TRP with water and lipids
We can use a geometrical definition of a hydrogen bond, in the fashion as it is usually
assumed in most computer simulations of water and associated liquids (see for instance
a detailed study in Ref. [276]). It consists in considering that a hydrogen-bond is
formed between two molecules when the next two geometrical conditions are fulfilled:
1. the distance RAH between the "acceptor" molecule ’A’ and the hydrogen "donor"
atom ’H’ is smaller than RcAH ,
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Fig. 3.5 Selected radial distribution functions for TRP (T) with water(W) and DPPC
(charged sites ’N’ and ’O2’, see Fig. 3.1): OT-HW (bottom left), HT-OW (top left),
OT-N+ (bottom right) and HT-O− (top right).
2. the H-B· · ·A angle φ is lower than φc . Here ’B’ is the atom to which ’H’ is
chemically bound.
In our study, the threshold distances were taken from standard values in the
literature. So, RcAH = 3.0 Å for all types of hydrogen-bonds (HB) and the angular
cutoff was chosen to be φc = 30◦.
With this HB definition, we computed the average number of HBs between several
bonded pairs. Our results indicate that we had (on average) a number of 3.2 water-
water HBs per water molecule; around 1.9 HB for DPPC-water; about 2 HB between
TRP and DPPC and ≈ 5 HBs for water-TRP. Furthermore, we can extract additional
information from the radial distribution functions presented in Fig. 3.5. There we can
observe a sharp maximum located around 1.85Å in three cases: HT-OW, OT-HW,
and HT-O−. Since such distance is the signature of a typical oxygen-hydrogen HB,
we can safely assume that HBs have been found between TRP and water as well as
between TRP and the oxygen labeled ’O2’ (see Fig. 3.1). Given the simulation data
collected, we did find clear HB-signature peaks for TRP with oxygens ’O6’ and ’O8’ of
DPPC as well, but to a lesser extent than for oxygen ’O2’, which is the preferred site
for TRP-DPPC binding. This would indicate that TRP is also able to stay bound to
the inner part of lipid heads during significant periods of time.
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3.1.2.4 Potentials of mean force for TRP solvation
Once the local structure around TRP has been obtained, a common way to analyze
the microscopic forces acting on it is by means of the so-called potential of mean force
between species ’1’ and ’2’, namely PMF12(r), that can be readily obtained from the
pair (atom-atom) radial distribution function g12(r) given in Eq. 3.1:
PMF12(r) =W (r12) = −kBT ln g12(r), (3.2)
where kB is Boltzmann constant, T is the temperature of the system, and W (r12)
is the reversible work. This remarkable theorem can be proved by considering the
average force between two particles ’1’ and ’2’ inside the remaining system (particles
’3’, ’4’,...’N’ being the solvent). The average (over all configurations) force between
particles ’1’ and ’2’ fixed at their corresponding positions is given by:
−
〈
dU(rN )
dr⃗1
〉
r⃗1,r⃗2
=
− ∫ dr⃗3 · · · dr⃗N ( dUdr⃗1 ) e−βU∫
dr⃗3 · · · dr⃗N e−βU
= +kBT
d
dr⃗1
∫
dr⃗3 · · · dr⃗N e−βU∫
dr⃗3 · · · dr⃗N e−βU
= kBT
d
dr⃗1
ln
∫
dr⃗3 · · · dr⃗N e−βU
= kBT
d
dr⃗1
ln
(N(N − 1)(∫ dr⃗3 · · · dr⃗N e−βU∫
dr⃗1 · · · dr⃗Ne−βU
)
= kBT
d
dr⃗1
ln g(r⃗1, r⃗2), (3.3)
where β = 1/(kBT ). Also, the definition of the radial distribution function from
the statistical point of view has been assumed (see Ref. [277]).
Integration of the expression for the average force, introduced by Eq. 3.3, gives the
reversible work,
W (r12) =
∫ ∞
r12
dr1(−
〈
dV (rN )
dr1
〉
) = kBT
∫ ∞
r12
dr1
d
dr1
ln g(r1), (3.4)
Therefore, the reversible workW (r12) associated with the process by which particles
1 and 2 are moved from infinite separation to a relative separation r12 is:
W (r12) = kBT ln g(∞)− kBT ln g(r12) = −kBT ln g(r12), (3.5)
since g(∞) = 1. In this Thesis, PMFs computed as the reversible work can be
directly considered as the Gibbs free energy differences, considering r12 as the reaction
coordinate[277].
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Fig. 3.6 Potentials of mean force for water-TRP and DPPC-TRP sites. Labels as in
Fig. 3.5.
The use of a variety of methods to compute the PMF has been extensively discussed
in the literature, as it was reported for instance in Ref. [278], where up to twelve
methods based on one-dimensional coordinates were applied to the benchmark case of
a methane pair in aqueous solution. The authors concluded that the best choice is
a constraint-bias simulation combined with force averaging for Cartesian or internal
degrees of freedom. The results from unbiased simulations, as those reported in the
present work, were considered good at the qualitative level, with the PMF reasonably
well reproduced.
The use of one-dimensional reaction coordinates is simply an approximation to
the real ones[279], which may be in general multidimensional, presumably involving a
limited number of water molecules. A method that does not assume any preconceived
reaction coordinate is the so-called transition path sampling[280], with a high com-
putational cost. So, since the determination of the true reaction coordinate for the
adsorption of TRP is out of the scope of this Chapter, we will consider radial distances
between two species as order parameters useful to account for mean forces between
them, as a reasonably good approach.
The results of our calculation are displayed in Fig. 3.6. With the same order as in
Fig. 3.5, we show PMF for TRP-water at the plots in the left column and those for
TRP-DPPC in plots at the right column of Fig. 3.6. A free energy barrier is seen in
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Fig. 3.7 Snapshot of a typical TRP-DPPC bond. Note that HB exits between sites of
H1 of TRP and O8 of DPPC.
all cases, defined by a neat first minimum and a second minimum less clearly defined,
especially for TRP-DPPC interactions. In order to quantify the height of all barriers,
we included a numerical estimation of them in Table 3.1.
Table 3.1 Free energy barriers for the binding of TRP to water and DPPC. ∆F is the
size (in kBT) of the free energy barrier and
〈
r1(2)
〉
are the position of the first (second)
minima of PMF.
Pair ∆F (kBT) ⟨r1⟩ (Å) ⟨r2⟩ (Å)
HT/OW 2.0 1.8 3.2
OT/HW 2.0 1.7 3.0
HT/O−-DPPC 1.0 1.8 3.3
OT/N+-DPPC 0.7 4.0 ≈ 7.0
Here we should note that in our system kBT ∼ 0.616 kcal/mol so that the physical
values for the free energy barriers are of between 0.4 and 1.2 kcal/mol, i.e. the
same order of magnitude of the free energies of adsorption of metal ions in DMPC
membranes[275]. From the data reported in Table 3.1 we observe that the highest
barrier corresponds to the pairing of TRP and water and that the most stable (average)
distance for water closest to TRP is of about 1.7-1.8 Å , i.e. of the order of the typical
HB distance, as pointed out above in section 3.1.2.3. Conversely, the binding of TRP
to DPPC happens with lower free energy barriers and at different distances between
TRP and the binding site in DPPC. These data suggest that the configurational cost
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of the association of TRP to a lipid molecule is lower than that of the association to
water, what would explain why TRP tends to stay close to DPPC during periods of
time about three-fold longer than the mean time remaining inside the water region of
the system. To illustrate such association, we included a typical snapshot of this pair
in Fig. 3.7.
3.2 Effects of cholesterol on the binding of tryptophan
to zwitterionic membranes
Cholesterol plays a central role in maintaining the structure of the membrane and
regulating their functions. A better and detailed study of zwitterionic DPPC bilayer
membranes can help to understand their basic biological functions and interactions
with the environment. We have considered the introduction of cholesterol into the lipid
bilayer structure of TRP. TRP is able to act as a building block in protein biosynthesis,
while proteins are fundamentals required to sustain life. Given the importance of TRP,
we have explored its interactions with a typical zwitterionic phospholipid membrane
formed by DPPC and cholesterol in an aqueous solution of sodium chloride, analyzing
its mechanical properties, the local structure and some relevant dynamical properties
such as diffusion and vibrational spectra.
3.2.1 Preparing systems for simulations
Similar to section 3.1, all systems were generated through the CHARMM-GUI web-
based tool. The membrane consisted of a TRP molecule, 204 DPPC lipids, 4962
TIP3P water (W) molecules, with 17 sodium and 17 chlorine ions, corresponding to
physiological concentration (0.15 M). Eventually, some of the lipids were replaced by
cholesterol molecules in such a way that two cholesterol percentages were considered:
30 and 50%. Previous simulations with percentages of 10, 20 and 40% showed no
further relevant physical changes compared to the reported states. A benchmark state
of a cholesterol-free system (labeled as 0% throughout the paper) was also considered
at the temperature of 323.15 K, in order to ensure that the simulation was performed
at the liquid state, since the crossover temperature for pure DPPC to become liquid
has been determined to be around 314 K[281, 282].
Sketches of the backbone structure of cholesterol, TRP, and DPPC are represented
in Fig. 3.1. MD simulations in section 3.1 were performed at the fixed pressure of 1
atm and a fixed temperature of 310.15 K. The reason for considering 323.15 K for all
systems in this section is to have the system always in liquid-crystalline phases as close
as possible to the human body temperature: liquid-disordered for the cholesterol-free
case and liquid-ordered (with headgroups showing liquid-like behavior, but with tail
groups showing some gel-like state, with an ordering structure larger than that of
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headgroups) for the setups containing 30 and 50% cholesterol, when the crossover
temperature from gel to the liquid phase is below 310 K (see Ref. [281]). In all
cases, the temperature was controlled by a Langevin thermostat[267] with a damping
coefficient of 1 ps−1, whereas the pressure was controlled by a Nosé-Hoover Langevin
barostat[268] with a damping time of 50 fs.
Considering the NPT ensembles for equilibration periods for all simulations ran for
more than 50 ns. After equilibration, we recorded statistically meaningful trajectories of
more than 70 ns in all cases through several production runs. The simulation boxes had
different sizes because of cholesterol concentrations. For instance, in the cholesterol-free
system the average size was 80 Å× 80 Å× 90 Å. As cholesterol concentration increased,
the size of the system was systematically reduced. The simulation time step was
set to 2 fs. The CHARMM36 force field was adopted for all simulations. All bonds
involving hydrogens were set to fixed lengths, allowing fluctuations of bond distances
and angles for the remaining atoms. Nevertheless, during the calculation of spectral
densities (see section 3.2.2.4) all bonds including those involving hydrogens were left
flexible. Van der Waals interactions were cut off at 12 Å with a smooth switching
function starting at 10 Å. Long ranged electrostatic forces were computed using the
particle mesh Ewald method[266], with a grid space of about 1 Å. Such electrostatic
interactions were updated every time step. Finally, periodic boundary conditions were
applied in all three dimensions of space.
3.2.2 Results and discussion
3.2.2.1 General properties of all systems
A general view of half of the system at several cholesterol concentrations is shown
in Fig. 3.8. There, for the sake of clarity, water and DPPC have been depicted
with thin sticks, whereas cholesterol, TRP, and the sodium and chlorine ions have
been shown more explicitly. We should point out that TRP tends to stay close to
the headgroup regions of the lipid and cholesterol chains during most time of the
simulated trajectories[283]: An estimation over the full trajectory length (cholesterol
concentration of 30%) indicated that around 70% of time TRP is attached to DPPC
with the remaining time being mostly solvated by water. Further, in the membrane
with 30% of cholesterol, we observe that TRP at the interface is located slightly deeper
than in the case with 50% of cholesterol so that a primary effect of cholesterol is a
tendency to exclude TRP out of the water-membrane interface.
With the aim of ensuring that we are simulating the liquid phase of the model
system as well as to efficiently characterize the order of the hydrated lipid bilayer, we
computed the deuterium order parameter SCD which can be obtained from 2H NMR
experiments. This quantity was first reported by Stockton and Smith[284] and later
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Fig. 3.8 Snapshots of the aqueous DPPC and cholesterol membranes with an embedded
TRP molecule (Top: 30% of cholesterol; bottom: 50% of cholesterol). Atoms in TRP:
oxygen (red), hydrogen (white), carbon (cyan) and nitrogen (blue). DPPC and water
molecules are shown as thin sticks. Cholesterol are depicted as thick sticks. Sodium
ions (green) and chlorine ions (yellow).
on adopted by Hofsäss et al.[285] by means of an order parameter, defined for each
CH2 group as follows:
SCD =
1
2(3 < cos
2 θCD > −1), (3.6)
where θCD is the angle between the membrane normal and a CH-bond (a CD-
bond in the experiments). Brackets in Eq. 3.6 indicate an ensemble average for all
lipids. The results are shown in Fig. 3.9 for the two chains (sn1, sn2) of a DPPC
molecule at three cholesterol concentrations. The results are in good overall agreement
with both experimental[98, 286] and simulation works[285, 287] and confirm that the
system, in the simulation conditions assumed in the present work, represents well the
liquid-crystalline phase. We should note the tendency to higher ordering as cholesterol
concentration increases, what is represented by profiles of SCD having larger maxima
(around 0.2 for the cholesterol-free system versus ∼0.4 for the cholesterol-rich setups),
a similar tendency as observed by Hofsäss et al.[285] and Chiu et al.[20].
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Fig. 3.9 Order parameter |SCD| for the acyl tails for three different percentages of
cholesterol.
One primary output from any simulation of biomembranes is the area per lipid.
For a series of equilibrated MD runs at the NPT ensemble we have monitored the
surface area per lipid considering the total surface along the XY plane (plane parallel
to the bilayer surface) divided by the number of lipids plus cholesterol in one lamellar
layer[288], as defined in Eq. 3.7.
A = Lx × Ly
Nl +Nchol
(3.7)
where A is the area per lipid of the simulation box, Lx and Ly are the length of the
simulation box along x axis and y axis, and Nl and Nc are the numbers of lipids and
cholesterol in each leaflet, respectively.
The area per lipid (for the final 70 ns of all trajectories) as a function of simulation
time is shown in Fig. 3.10 and the average values are reported in Table 3.2. It should be
pointed out that these values for the area per lipid arise naturally from the relaxation
of the system at a given temperature, pressure, and number of particles and are not
an imposition to fit the experimental value. The main trend observed from our data is
that the areas decrease as cholesterol concentration increases, as expected. In addition,
fluctuations of the area per lipid in the 0% cholesterol case are larger than those of
the cholesterol-rich ensembles. We obtained an average value of 61.4 Å2 for the 0%
cholesterol system and smaller values around to 40 Å2 when cholesterol is present at
the membrane. These results are in overall good agreement with other computational
data in a wide variety of thermodynamical conditions[20, 98, 285, 289, 290] where the
values for pure DPPC ranged between 50 and 63 Å2 and the trend of decreasing areas
for increasing cholesterol percentages is clearly reported. From the experimental side,
an influential review from Nagle et al.[6] reported values of the area per lipid of pure
DPPC membranes obtained from a wide variety of methods (NMR, X-ray, and neutron
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Fig. 3.10 Area per lipid versus cholesterol contents of the system: 0%, 30% and 50%.
Dashed lines indicate average values reported in Table 3.2.
scattering) between 48 and 52 Å2 in the gel phase (293 K) and between 57 and 71 Å2
at the liquid phase (323 K). However, some of them were reported to be measured
under wrong assumptions due to artificial undulations of the membrane sets. The best
estimations were of 48 and 64 Å2 for the gel phase and liquid phase respectively, in the
cholesterol-free case. In one quite recent work, Kučerka et al.[282] found a value of 63.1
Å2 for DPPC at 323.15 K by means of X-ray and neutron scattering techniques. In the
present work, a sudden drop in the area per lipid is dramatically seen when cholesterol is
introduced in the membrane, as expected. Edholm and Nagle[289] reported a summary
of values from independent MD simulations where at the cholesterol concentration
of 30% area per lipid were around 43 Å2 and at 50% were between 37 and 39 Å2, at
323 K in all cases. As a matter of fact, the agreement with our results is qualitatively
good. Further, the results reported here are consistent with the observation that, in
DMPC membranes analyzed at 303 K, cholesterol is able to favor a phase transition
from a liquid-disordered phase to a liquid-ordered phase[291, 292], in particular when
cholesterol contents are higher than 30%.
Table 3.2 Mechanical properties of the membrane: area per lipid (A) and thickness
(∆z). Estimated errors are in parenthesis.
% of cholesterol A (Å2) ∆z (Å)
0 61.4(0.8) 39.7(0.5)
30 40.8(0.2) 48.9(0.4)
50 40.1(0.2) 47.8(0.3)
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The variations of the thickness of the membrane may give some additional clues
of the effect of cholesterol on its mechanical properties, such as its rigidity and its
capability to allow the passing of species inside and outside the cell. We have obtained
the thickness by computing the distance between the phosphate groups of the DPPC
molecules located at the two sides of the membrane. The results are also reported in
Table 3.2.
These values of the bilayer thickness are in good overall agreement with those
reported by Kučerka et al.[282]. These authors found a ∆z of 39 Å at 323 K for a
cholesterol-free sample and a tendency to decrease with increasing temperatures. In
the present work, we have obtained a value of 39.7 Å at the cholesterol-free system
and values around 48 Å when cholesterol is present in the membrane. This fact is
consistent with the findings of the area per lipid reported above where, at higher
cholesterol contents, the values have been found smaller: at large cholesterol contents
the bilayer structures are more compressed so that we have more lipid species per Å2
what would eventually produce the extension of the lipid tails (which are normally
showing a large extent of folding for the cholesterol-free system) and the corresponding
larger bilayer thickness. This is also consistent with the results shown in Fig. 3.9
where cholesterol-rich systems have tails significantly more ordered (gel-like) than
those corresponding to the cholesterol-free case.
3.2.2.2 Structure of the solvated TRP
We have evaluated the local structure of the TRP molecule solvated by water, DPPC,
and cholesterol. We will restrict ourselves to report the most relevant RDF given in
Eq. 3.1 which is also indicated as g(r) in the rest of the text, namely those defined for
the pairs:
1. The hydrogens ’H1’ of TRP (see Fig. 3.1) versus the oxygen of a water molecule
(’OW’);
2. The oxygens of TRP (’OT’, corresponding to the sites labeled ’O1’ and ’O2’, see
Fig. 3.1) versus the hydrogen of a water molecule (’HW’);
3. The hydrogens ’H1’ of TRP versus the oxygen of cholesterol (’OC’);
4. The oxygens of TRP ’OT’ versus the hydrogen of cholesterol (’HC’);
5. The hydrogens of TRP ’H1’ and ’H2’ (taken separately) versus the negatively
charged oxygens of DPPC (’O2’ and ’O8’, taken separately).
The results of the g(r) defined above are presented in Fig. 3.11 and Fig. 3.12 for
the three relevant TRP concentrations (0, 30, 50%).
All eight radial distribution functions show some fluctuations in their profiles, the
statistical noise observed in the association of TRP with cholesterol being more marked
3.2 Effects of cholesterol on the binding of tryptophan to zwitterionic membranes |
47
0
0.5
1
1.5
2
2.5
3
g H
1T
-O
W
 
(r)
0% chol.
30%
50%
0
1
2
3
g H
1T
-O
C(r
)
1 2 3 4 5 6 7
r/Å
0
1
2
3
4
5
g O
T-
H
W
 
(r)
1 2 3 4 5 6 7
r/Å
0
5
10
15
g O
T-
H
C(r
)
30% chol.
50%
Fig. 3.11 Radial distribution functions for TRP (T) with water(W) and cholesterol
(sites ’O’ and ’H’ of the hydroxyl group): H1T-OW (top left), OT-HW (bottom left),
H1T-OC (top right) and OT-HC (bottom right).
than for TRP-Water and for TRP-DPPC. The fluctuations are essentially due to the
fact that TRP is a mobile species and can be mostly solvated by DPPC or water.
However, cholesterol solvation only happens during short periods of time (see below),
which generates larger fluctuations of the corresponding g(r)s. As a general feature,
the presence of cholesterol does not affect the positions of the maxima in the g(r)
between TRP and water and between TRP and DPPC, although significant reduction
of the heights of the maxima has been observed, especially for gH1T−O2(r). We can
observe a clear first coordination shell in all cases, being the binding of TRP to DPPC
the one with the highest peaks of the g(r)s (see Fig. 3.12). In such a case, a marked
second coordination shell can be also observed. The peaks located around 1.7-1.8 Å in
all g(r) are the signature of hydrogen bonds (HB) established between TRP and water,
TRP and DPPC, and also TRP with cholesterol. Using fluorescence spectroscopy, Liu
et al.[100] obtained values for the hydrogen-bond lengths of TRP and water between
1.6 and 2.1 Å , i.e. in the same range of the values reported in the present work.
In the present work, we have not considered the usual density profiles defined
by the distance of an atomic site to the center of the lipid bilayer, and instead, we
computed radial distribution functions. The reason is twofold: (1) we are mainly
interested in the solvation structure of TRP instead of their distribution across the
bilayer and (2) RDF have the additional advantage to provide a direct route to the
estimation of free energy barriers[277] but, since reaction coordinates for probe binding
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Fig. 3.12 Radial distribution functions for TRP (T) with DPPC (charged sites ’H1’,
’H2’, ’O2’ and ’O8’, see Fig. 3.1): H1T-O2 (top left), H1T-O8 (bottom left), H2T-O2
(top right) and H2T-O8 (bottom right).
to membranes will be generally unknown and not one-dimensional but multidimensional,
methods not assuming preconceived reaction coordinates such as transition path
sampling[213, 280, 293] or, those allowing to consider several complementary collective
variables, such as metadynamics[231, 275] would be in order to obtain much more
accurate free energy landscapes for TRP adsorption. Nevertheless, their drawback is
the huge amount of computational time required in both cases and for this reason,
they are not considered in the present Chapter.
During the long simulation runs used to collect statistically meaningful properties
we observed periods of time of about 5 ns where TRP was fully solvated by water,
suggesting that hydration of TRP is one stable state of the system. Full TRP hydration
is essentially operated through hydrogen-bonding between the triplet of ’H1’ hydrogens
of TRP bound to ’N1’ (see Fig. 3.1) and the water’s oxygen or, equivalently, between
oxygens of TRP and hydrogens in water, as it is shown in the left column of Fig. 3.11.
There we can observe a sharp maximum located around 1.85Å for both gH1T−OW and
gOT−HW . When cholesterol is introduced in the systems, the binding of TRP to water
remains essentially unchanged, although the first maxima of gOT−HW shows larger
values. Firstly, this could be due to the exclusion of TRP off the interface operated by
the presence of cholesterol and, secondly, because of the binding of TRP to cholesterol
as it is shown at the right column of Fig. 3.11. Interestingly, cholesterol can form
hydrogen-bonds with TRP’s hydrogens as indicated by the first maximum of gH1T−OC
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and also with TRP’s oxygens (shown in gOT−HC). The large statistical noise in those
functions might be an indication of the short life of such HB.
Observing that TRP can establish some hydrogen-bonding with cholesterol, all
data we got suggest that TRP is also able to stay bound to the inner part of lipid
heads during significant periods of time, in agreement with previous results indicating
that in a cholesterol-free DOPC bilayer membrane TRP tends to localize strongly in
the interfacial region[89]. The preferential location of TRP at the lipid-water interface
was observed by de Jesus and Allen[58] for membrane proteins. In the present work,
we observed that the average lifetime of TRP at the interface of the DPPC bilayer is
of the order of 10 ns. Regarding TRP-DPPC binding (see Fig. 3.12) we have observed
hydrogen-bonding connections between sites ’H1’ and ’H2’ of TRP and DPPC sites
’O2’ and ’O8’ (labels according Fig. 3.1), as indicated by radial distribution functions
gH1T−O2, gH1T−O8, gH2T−O2 and gH2T−O8. Functions related to ’H1’ hydrogens in
TRP (left column of Fig. 3.12) show a clear maximum located around 1.7 Å when
bound to ’O2’ of DPPC and around 1.75 Å when bound to ’O8’ of DPPC. The presence
of cholesterol diminishes the ’H1-O2’ binding but it enhances the ’H1-O8’ one. This
suggests that the former corresponds to the most stable bond when no cholesterol in
present but that becomes weaker when the amount of cholesterol increases. Conversely,
the HB between ’H1’ and ’O8’ becomes strongest at the membrane with 50% content
of cholesterol. Then we can observe the influence of the cholesterol in the TRP-DPPC
binding as one major effect. Concerning ’H2’-DPPC binding (right column of Fig. 3.12),
we observed its existence in all analyzed setups, although the maxima are found at
slightly larger distances (around 1.9-2.0 Å ). In the same fashion as for ’H1’-DPPC
binding, the presence of cholesterol showed a significant influence on the characteristics
of ’H2’-DPPC bonds as well. Finally, the structure of water around DPPC has been
found to be very similar to that of water around DMPC as was previously described
in Ref. [17], Section III.
In order to estimate the average time intervals for the TRP-lipid association, we
display the time evolution of selected atom-atom distances in Fig. 3.13. There we can
see that typical hydrogen-bonding distances are reached in all cases. At the cholesterol-
free membrane, one of the three hydrogens of TRP bound to its ’N1’ site is almost
permanently bound to the oxygen ’O2’ of DPPC with some intervals of simultaneous
binding ("shared" hydrogen-bonds). At the two cholesterol concentrations considered
here the binding is less common, with a tendency to longer hydrogen-bonding periods
at the 30% concentration. In all cases, the typical H-bond lifetimes are of the order 1
ns, with eventual intervals of breaking and re-formation of hydrogen-bonds.
When analyzing the hydrogen-bonding of TRP with cholesterol, we have observed
that some periods of hydrogen-bonding are established between oxygen ’O2’ of TRP
and the hydroxyl’s hydrogen of cholesterol (’HC’) and that, simultaneously, one of
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Fig. 3.13 Distance distribution of selected sites in cholesterol-TRP bonding and DPPC-
TRP bonding as a function of simulation time. Percentages of cholesterol are indicated
on top of each graph. Dashed lines indicate the typical HB distance (1.8 Å ). ’H1AT’
and ’H1BT’ are two of the three hydrogens bound to the site ’N1’ of TRP, whereas
’O2’ is one of two oxygens of TRP and ’OC’ (’HC’) is the hydroxyl’s oxygen (hydrogen)
of cholesterol.
the TRP’s hydrogens (bound to ’N1’) forms some HBs with hydroxyl’s oxygen of
cholesterol. Again we see longer binding for cholesterol’s 30% concentration. The time
scale of hydrogen-bonding seems shorter than 1 ns, although more precise calculations
of hydrogen-bond lifetimes using correlation functions (see Ref. [294] for instance), are
out of the scope of this Chapter and have not been carried out.
In order to have a more detailed idea of TRP binding to the membrane, we
are reporting two characteristic snapshots of TRP linked to DPPC and cholesterol
simultaneously (see Fig. 3.14). There we can observe that either TRP can be bound
to two DPPC in different sites (’O2’ and ’O8’) and one cholesterol (right) either it
can be bound to one DPPC (site ’O2’) and to two cholesterol molecules, the first
through the hydroxyl’s hydrogen and the second through hydroxyl’s oxygen (left).
These images help to enlighten the relatively complex multiple hydrogen-bonding
connections between TRP, DPPC, and cholesterol described above and the key role of
TRP as a bridging molecule between several lipids or cholesterol chains.
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Fig. 3.14 Snapshots of typical DPPC-TRP-cholesterol bonds. Atoms in TRP colored
as in Fig. 3.8. Binding sites have been highlighted in dashed orange lines.
3.2.2.3 Diffusion of TRP and water
Microscopic dynamics of TRP and water has been extensively considered. The first
property evaluated has been the mean square displacement (MSD) of water (monitoring
oxygen’s trajectories) and of the carbon ’C2’ in TRP (see Fig. 3.1). Diffusion coefficients
of DPPC require simulations at the scale of hundreds of nanoseconds and have not
been computed here, although a detailed study on DMPC was reported earlier[17].
From the long-time slopes of both MSD, we obtained the corresponding self-diffusion
coefficients D through Einstein’s formula:
D = lim
t→∞
<
∣∣r⃗i(t)− r⃗i(0)∣∣2 >
2 d∆t , (3.8)
where r⃗i is the instantaneous position of particle i. In this general procedure,
the spatial dimension d is considered according to the type of diffusion. So, water
undertakes isotropical diffusion (d = 3) meanwhile TRP showed lateral-like diffusion
(d = 2). The results have been summarized in Table 3.3.
Table 3.3 Self-diffusion coefficients D (in cm2/s) of water and of TRP as a function of
the cholesterol’s percentage of the membrane.
D 0% 30% 50%
Water 5.03(0.01)×10−5 4.20(0.01)×10−5 4.45(0.07)×10−5
TRP 3.48(0.80)×10−7 2.91(0.35)×10−7 1.40(0.02)×10−6
In the case of water, the results include all molecules in the system regardless of
their location in the bulk or interfacial regions. In a previous work[17], we obtained D
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separately for bound water, water at interfaces and water external to the membrane
and found the mobility of water molecules being significantly faster as their distance
to the interface increased (the water outside the membrane was about 14 times faster
than water bound to lipid chains). In this work, we simply included the water diffusion
for the sake of comparison with those previous results in order to test the influence
of TRP and of cholesterol. At 0% cholesterol our results are of the same order of
magnitude as the ones obtained for the simple aqueous DMPC membrane[17] at 303
K (2.66×10−5 cm2/s) what indicates that, as expected, the presence of TRP does
not affect significantly water’s dynamics. Nevertheless, we can observe that when
cholesterol is included in the system, water tends to diffuse about 33% faster. This
can be attributed to the fact that at non-zero cholesterol concentrations, membranes
are more compact (areas per lipid are smaller) and water’s penetration in the interface
is harder to occur, producing diffusion mainly along the surface of the bilayer.
TRP’s diffusion coefficients were computed from simulation runs where TRP was
permanently at the interface. We stress this point because in our simulation runs we
observed that TRP is able to make excursions to the water bulk regions, especially
when cholesterol concentration increases. For instance, at the highest concentration of
50%, TRP will stay eventually half of the time at the water bulk and the remaining time
at the lipid-water interface. Along the periods when TRP was fully solvated by water,
we estimated that its diffusion coefficient was 3.9×10−6 cm2/s at 50% concentration of
cholesterol. The latter value is significantly higher than those corresponding to TRP
at the lipid-water interfaces (see Table 3.3).
Focusing on the diffusion of TRP when residing at the interface, the values reported
in Table 3.3 are about two orders of magnitude smaller than those of water (for
cholesterol concentration up to 30%). At the highest concentration (50%), the diffusion
of TRP becomes significantly faster. The values of D for TRP (0% cholesterol’s
concentration) are of the same order of magnitude of those of DMPC molecules[17]
(0.6×10−7 cm2/s in absence of cholesterol), although the former is about six times
smaller. This indicates that TRP’s mobility is significantly higher than that of DPPC
and this suggests that the mechanisms of diffusion of TRP would be qualitatively
different of those of lipids (it was suggested that they are due to the motion of
nanodomains or local groups of around 10 units[17] and also directly related to the
slow motion of gel-like tails in the present case). We should point out that the effect
of temperature is remarkable since, at complementary simulations at 310 K, TRP
diffusion was of about 2×10−7 cm2/s, i.e. significantly slower, due to the essentially
gel-like state of the membrane at such conditions.
Regarding the reliability of the present calculations, we should indicate that the
values reported in Table 3.3 have been obtained in the framework of the CHARMM36
force field. Whereas the number of lipids in our systems may be large enough[295] to
avoid strong side effects from periodic boundary conditions, there are some known
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deficiencies of the CHARMM36 (and the MARTINI force field among others) regarding
its reliability when computing lipid diffusion[296] to be considered. Further, Yeh and
Hummer suggested that in simulations using periodic boundary conditions, hydro-
dynamic interactions should be taken into account in order to obtain more accurate
values of D, in such a way that a correction of the order N 13 might be in order[297]. In
our case, we did not consider lipid diffusion but TRP’s. Since TRP dynamics is clearly
faster than DPPC’s, we expect that our computed D are correct in order of magnitude,
although they might presumably be affected to some extent by the deficiencies of
the force field mentioned above. Only the existence of precise experimental values
could shed light on this issue, but up to our best knowledge, no measured diffusion
coefficients of TRP in zwitterionic membranes are currently available.
3.2.2.4 Spectral densities of TRP
We have computed and analyzed the spectral densities of the TRP molecule. Ex-
perimental infrared spectra are usually obtained through the absorption coefficient
α(ω) or the imaginary part of the frequency-dependent dielectric constant[298]. These
properties are directly related to the absorption lineshape I(ω), which can be obtained
from MD simulations[299–301] in certain cases. In most cases the physically relevant
property to be computed is the so-called atomic spectral density Si(ω), defined as:
Si(ω) =
∫ ∞
0
dt < v⃗i(t)v⃗i(0) > cos(ωt) (3.9)
where v⃗i(t) is the velocity of atom i. In our case, we have obtained the spectral
density of the whole TRP molecule as the sum of the contributions of all atoms
pertaining to the molecule. In Eq. 3.9, the brackets ⟨· · · ⟩ denote equilibrium ensemble
average. Generally speaking, classical MD simulations are not able to fully reproduce
experimental absorption coefficients, these being quantum properties. However, they
can be used to locate the position of the spectral bands since, in the harmonic (oscillator)
approximation, classical and quantum fundamental frequencies are the same. The
model employed in the present work considers harmonic bond vibrations and for such a
reason we will be able to locate the positions of the main experimental spectral bands.
We are reporting the full spectral density STRP (ω) on the left side of Fig. 3.15.
Our results reveal two main spectral regions, one for frequencies below 1800 cm−1
and another one for 2700 < ω < 3400 cm−1. The agreement with available data from
infrared and Raman spectroscopy of TRP in aqueous solution reported by Leyton et
al.[99] (and references therein) is very good overall. These authors reported strong
maxima located at 128, 163, 425 (weak), 744, 1014, (1351), 1432, 1566, (1647), 2938,
3056 and 3402 cm−1. The numbers into parenthesis indicate a group of maxima
centered at the reference value indicated here. Most of these maxima are included in
the S(ω) reported in Fig. 3.15 and, at 0% cholesterol content, show excellent agreement
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Fig. 3.15 Spectral densities of the full TRP molecule (left). Full arrows indicate the
position of experimental peaks and the dashed arrow indicates a maximum of weak
intensity. Decomposition of the spectrum for the 0% cholesterol case (right), indicates
the relative contribution of several (most relevant) selected atoms. The inset reveals
the contributions of high frequencies of the two relevant groups of hydrogen atoms
(’H1’ and ’H2’).
with only three clear disagreements: (1) the Raman peak located at 163 cm−1 is
not clearly seen in STRP (ω); (2) same fact happens with band located at 1566 cm−1
(unseen) and (3) the Raman peak at the highest frequency at 3402 cm−1 is strongly
red-shifted in the computed spectral density (reported at 3276 cm−1).
Having established the reliability of the potential model and method employed
in the present work, we have obtained the partial spectra of each atom in TRP. The
results are reported on the right side of Fig. 3.15. There we gain an advantage of one
of the strongest points of MD simulations: we can discern the contribution of each
atom to the full spectrum. We should remember that frequencies below 1000 cm−1 are
usually related to rotational and vibrational motions of the molecule, those between
1000 and 1500 cm−1 are normally attributed to molecular bending motions and that
frequencies of the order of 2000-3000 wavenumbers are due to molecular stretching
motions (for liquid water, see, for instance[302]). The list of assignments of this work
is as follows:
1. The peak experimentally found at 128 cm−1 corresponds, within our framework,
to restricted translations of oxygens, since it corresponds to the high maximum
(centered at 123 cm−1) appearing at the oxygen’s spectral density. Further, it can
be also related to carbon vibrations (maxima at 95 and 210 cm−1). In summary,
we can attribute this band to ’C1-O’ vibrations (see Fig. 3.1).
2. The peak located at 163 cm−1 is not seen in our spectral decomposition.
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3. The weak band centered around 425 cm−1 is matched by the maxima at 385
cm−1 of our spectrum. This indicates that this vibration should be attributed
to a low-frequency vibration of hydrogens ’H1’ (see Fig. 3.1). Since this is a
relatively low frequency it will probably correspond to rotational motion.
4. The maximum at 744 cm−1 is located around 810 cm−1 in Fig. 3.15 and it
appears in both the contributions of atoms carbon ’C1’ and oxygens ’O’ (TRP
has two of them), suggesting a "scissoring" motion of the corresponding triplet.
5. The peak at 1014 cm−1 is found at 1045 in the present work and it is directly
related to the spectra of sites ’N1’ and ’H1’, suggesting, in this case, a bond
stretch of those particles.
6. The group of experimental bands centered around 1351 cm−1 is matched in our
spectra by one peak centered at 1225 cm−1. Connected to particles ’N1’ and one
carbon, we expect that this band should correspond to the stretch of ’N1’ along
with its carbon bond.
7. The maximum at 1432 cm−1 can be directly related to the maxima around 1410
cm−1 observed in the spectra of ’N2’ and ’H2’, suggesting that this vibration
corresponds to a bond stretch between them.
8. The next band, centered at 1566 cm−1 is not well matched by any peak of the
computed spectrum.
9. The remaining band centered at 1647 cm−1 is a group of maxima in the experi-
mental spectrum and it can be also attributed to the contribution of ’H1’ (1622
cm−1). Since the label ’H1’ accounts for the three hydrogens bound to ’N1’, it
should be attributed to a single stretching mode.
10. Finally, the three bands of highest frequency (2938, 3056, and 3402 cm−1) must
be fully attributed to stretching vibrations of hydrogens ’H1’ and ’H2’ and are
located around 3170 (shoulder), 3270, and 3690 cm−1 in our spectral densities.
The large deviations not only indicate a drawback in the characterizations of the
vibrational interactions by the force field employed here, but they also indicate
they derive from pure hydrogen vibrations.
The influence of the cholesterol in the full spectrum of TRP reported in the left
side of Fig. 3.15 is remarkable in some of the spectral bands, producing observable
frequency shifts and it essentially indicates again that cholesterol interacts with TRP
in a quite strong way and that these interactions are able to modify the vibrational
motions of their atomic components producing frequency shifts up to 66 cm−1 (case of
the band centered around 1045 cm−1 in the computed spectrum, red-shifted at the
system with 50% of cholesterol).
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3.3 Binding free energies of small-molecules in phospho-
lipid membranes
Considering the importance of the DPPC lipid, a major constituent of pulmonary lungs,
we kept using DPPC bilayer as the target membrane to study small molecules, for
example, SER, MEL, HIS, TYR, and TRP. Focusing our attention on the free energy
barriers of adsorption of small-molecule species, we have explored their interactions with
the prototypical cell membrane formed by DPPC and water in sodium chloride solution
using all-atom MD simulations, analyzing its local structure through free energy profiles
based on the reversible work theorem. Sketches of the backbone structure of small
molecules and DPPC are represented in Fig. 3.1 and Fig. 3.16.
In Fig. 3.1, the highlighted sites of TRP are ’H1’, ’H2’, ’O1’, and ’O2’; ’O2’ and
’O8’ for DPPC. In Fig. 3.16, ’H1’, ’H4’, and ’O’ atoms for SER; ’O1’, ’O2’, ’H15’, and
’H16’ for MEL; ’HC’ stands now for 3 hydrogen atoms sharing one positive charge
attached to a nitrogen atom of TYR; and same for ’H-TYR’ representing 3 ’He’ atoms
for HIS. Sites ’O1’ and ’O2’ of TRP share the negative charge, same for HIS and TYR.
All highlighted sites will be referred to in this Chapter by the labels defined here.
In order to analyze the microscopic forces relevant for the binding process by
obtaining the Gibbs free energy, here we use the potential of mean force (PMF),
described in section 3.1.2.4.
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3.3.1 Preparation of simulations
A model of a zwitterionic lipid bilayer membrane in aqueous sodium chloride solution
has been build by means of the CHARMM-GUI tool. The membrane was composed
of 204 lipids, distributed in two leaflets of 102 flexible DPPC molecules, surrounded
by TIP3P water (W) molecules (enough to ensure full hydration in all cases), with 17
sodium and 17 chlorine ions, corresponding to physiological concentration, plus one
small-molecule. In order to compare several probes of the different chemical structures
and able to perform a variety of biological functions, we considered five species: three
amino acids (TRP, HIS, and TYR), a neurotransmitter (SER), and a hormone (MEL).
We should note that these three species have a common indole ring in their structures.
MD simulations were generated through the web-based CHARMM-GUI tool and
performed with the NAMD2 simulation package at a fixed temperature of 323.15 K
and at the average pressure of 1 atm. At this temperature, the DPPC membrane is
fully at the liquid crystal state (see for instance Refs. [281, 282]). The temperature
was controlled by a Langevin thermostat with a damping coefficient of 1 ps−1. The
CHARMM36 force field was applied for all simulations. After applying the NPT ensem-
ble for equilibration periods which ran for more than 40 ns, we recorded statistically
meaningful trajectories of more than 80 ns. A typical size of the system was of 80 Å×
80 Å× 81 Å, regardless of the probe considered, since the biggest part of the membrane
was made of the same components, i.e. DPPC, water and ions in exactly the same
concentrations. The simulation time step was set to 2 fs in all cases.
All bonds involving hydrogens were fixed to constant length, allowing fluctuations
of bond distances and all sorts of angles for the remaining atoms. Van der Waals
interactions were cut off at 12Å with a smooth switching function starting at 10 Å,
as usual. Long ranged electrostatic forces were taken into account by means of the
particle mesh Ewald method, with a grid space of about 1 Å. Electrostatic interactions
were updated every time step. Finally, PBCs were applied in the three directions of
space.
3.3.2 Result and analysis
As a very first primary output, we have computed again the area per lipid for each
system. We have monitored the surface area per lipid considering the total surface
along the XY plane (plane parallel to the bilayer surface) divided by the number
of lipids in one lamellar layer[288]. The final average areas per lipid are reported in
Table 3.4. We needed to consider time scales of more than 40 ns in order to obtain a
converged area per lipid in all cases. The main trend observed is that all values are
very close to 61 Å2, in overall good agreement with other computational results[290]
where the values for pure DPPC range between 50 and 63 Å2.
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Table 3.4 Area per lipid (A) of the membrane systems. Estimated errors are in
parenthesis.
Small-molecule A (Å2)
TRP 61.4(0.8)
HIS 60.8(1.5)
TYR 60.6(1.7)
SER 61.3(1.5)
MEL 61.1(0.9)
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Fig. 3.17 Potentials of mean force for the adsorption of small-molecules to water
molecules.
After fully equilibrated simulations were produced, we obtained a series of pair
radial distribution functions g12(r) (not reported here) and applied the procedure
explained earlier (see section 3.2.2.2) in order to obtain the PMFs. The results of
PMF for water and DPPC versus small-molecules are displayed in Figs. 3.17 (water)
and 3.18 (DPPC) in units of kBT . In order to quantify the height of all barriers, we
included the corresponding numerical estimation in Table 3.4 assuming that, for the
present simulations, 1 kBT = 0.64185 kcal/mol. The values reported in Table 3.4 are
between 0.2 and 3.1 kcal/mol, i.e. of the same order of magnitude of the free energies
of adsorption of metal ions in DMPC membranes[275].
We show PMF for water’s oxygens at the plots in the left column and those for
water’s hydrogens in plots at the right side of Fig. 3.17. For oxygens of water, a
free energy barrier is seen in all cases, defined by a neat first minimum and a second
minimum clearly defined, although the barrier of water-SER is much smaller than
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those corresponding to the rest of pairings. This finding is in good agreement with the
results reported by Wood et al.[303], indicating that SER is normally anchored to the
POPC membrane whereas TRP and other zwitterions have full access to the water
region. In the case of hydrogens of water, the second minimum is not well defined for
MEL’s hydrogens ’H15’ and ’H16’ (see Fig. 3.16). The binding of small-molecules to
water reveals, as a general fact, free energy barriers of between 0.2-2.8 kBT with stable
binding distances very close to the typical hydrogen-bond (HB) distances in water,
given by the position of the first minimum of the oxygen-hydrogen radial distribution
function (1.85 Å)[276]. However, the typical energy of water-water HBs estimated
from ab-initio calculations is of about 5 kcal/mol[304], a value significantly larger than
those for the HB observed in this work.
A closer look indicates that the largest barriers correspond to HB formed by oxygens
of a small-molecule (acting as acceptors) and hydrogens of water, acting as donors.
"Reverse" hydrogen-bondings composed by hydrogens of a small-molecule (donors) and
oxygens of water (acceptors) are also possible but they are weaker than the former,
with significantly smaller free energy barriers, up to 2.3 kBT in size. In summary,
the aqueous solvation of small probes revealed similar characteristics regardless of the
type of the molecule (amino acid, neurotransmitter, and hormone), with the strongest
pairing for MEL-water and weakest for SER-water.
Table 3.5 Free energy barriers ∆F (in kcal/mol) for the binding of small-molecules to
water and to DPPC.
Probe (Active site) O-water H-water O2-DPPC O8-DPPC
TRP (O) - 1.33 - -
TRP (H1) 1.48 - 2.70 1.80
TRP (H2) - - 1.92 1.00
HIS (O) - 1.24 - -
HIS (H) 1.07 - - -
TYR (O) - 1.39 - -
TYR (H) 1.50 - 3.11 3.00
TYR (HC) - - 2.79 1.54
SER (O) - 0.18 - -
SER (H1) 0.84 - 1.90 1.56
SER (H4) - - 1.78 1.88
MEL (O1) - 1.45 - -
MEL (O2) - 1.77 - -
MEL (H15) 1.17 - - 1.16
MEL (H16) 1.18 - 1.92 0.47
Regarding the interactions of small-molecules versus lipid atomic sites and from
data reported in Table 3.5 and in Fig. 3.18, we observe the highest barrier (3.11
kcal/mol) corresponding to the pairing of TYR (through its hydroxyl’s hydrogen) with
the phosphate oxygen ’O2’ of DPPC. In decreasing order, ’HC’ of TYR and ’H1’ of
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TRP show also strong interactions with ’O2’. From a general point of view, all small
molecules but HIS are able to establish HB with ’O2’ and also with the site ’O8’ of
DPPC, much deeper in the membrane (see Fig. 3.1). It should be pointed out that the
barrier of TYR to ’O8’ is remarkable, of about 3 kcal/mol, and further indicates the
stability of TYR at the membrane, compared to the other two amino acids: MEL and
SER. As a general fact, the position of maxima of the first barrier is centered around
2.45 Å for small-molecule-’O2’ binding, whereas barriers of ligands ’H’ of TYR and
’H4’ of SER associated to the ’O8’ sites were centered around a slightly larger distance
of 2.75 Å.
The most stable distance for ’O2’ in DPPC bound to TRP is of about 1.75 Å,
i.e. the position of the first minimum of the PMF between TRP and DPPC. As it
has been stated before, such distance is of the order of the typical HB distance in
water. Interestingly, the stable position for ’O8’ sites of DPPC is centered in a wider
distribution of values between 1.7 and 2 Å. For the sake of comparison, the PMF
of TRP in a di-oleoyl-phosphatidyl-choline bilayer membrane shows a barrier of the
order of 4 kcal/mol[89], whereas the barrier for the movement of TRP (attached to a
poly-leucine α-helix) inside a DPPC membrane was reported to be of 3 kcal/mol[58].
Finally, neurotransmitters such as glycine, acetylcholine, or glutamate were reported to
show small barriers of about 0.5-1.2 kcal/mol when located close to the lipid glycerol
backbone[305].
In order to have a more detailed idea of the particular binding of some small-
molecules to the membrane, we are reporting two characteristic snapshots of SER
and TYR linked to two DPPC molecules (see Fig. 3.19). There we can observe that
the most active sites are hydrogens belonging to hydroxyl groups, bound to DPPC
at different sites (’O2’ and ’O8’ simultaneously for TYR, right and ’O2’ for SER,
left). These images are only significant configurations selected among a wide variety of
possible choices (see Table 3.5) and may help the reader to enlighten the relatively
complex multiple hydrogen-bonding connections between the small-molecules and
DPPC described above.
3.4 Conclusions
A series of molecular dynamics simulations of zwitterionic lipid bilayer membranes
in the aqueous ionic solution of NaCl with an embedded small molecule have been
performed by MD using the CHARMM36 force field. Among them, cholesterol with
different concentrations (30% and 50%) have been considered. In all simulations,
systems have been well stabilized and then meaningful production trajectories at the
time-scale of hundreds of nanoseconds are collected to analyze statistically meaningful
properties.
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Fig. 3.18 Potentials of mean force for DPPC-small molecules.
In our preliminary study on tryptophan’s adsorption to DPPC bilayer membrane
at 310.15 K, we have carefully analyzed the local structure of tryptophan associated
to water and to DPPC and evaluated the free energy of adsorption considering the
usual one-dimensional reaction coordinates based on atomic distances for selected
sites. Our data revealed the existence of a strong first coordination shell and a milder
second coordination shell for the tryptophan-water association, which translated to
deep minima in the corresponding PMFs, with energy barriers of less than 1 kcal/mol.
Conversely, the binding of tryptophan to DPPC involves a single coordination shell for
the two sites of possible association and energy barriers much lower than for the former
TRP-water, i.e. of the order of 1 kcal/mol. Tryptophan shows a clear tendency to
stay close to DPPC, during periods of time about 3 times longer than for TRP-water
association.
Continuing our preliminary study, the temperature has been increased from 310.15
K to 323.15 K for three systems at three cholesterol concentrations (0, 30, and 50%)
in order to systematically examine tryptophan-DPPC, tryptophan-cholesterol and
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Fig. 3.19 Snapshots of typical small-molecule and DPPC bonds. Serotonin-DPPC
(left, where the binding of a hydroxyl’s hydrogen with ’O2’ site is clearly seen) and
tyrosine-DPPC (right, where the binding of hydrogen ’HC’ to the ’O2’ site and of the
hydrogen from the hydroxyl group with ’O8’ site are clearly seen).
tryptophan-water interactions at liquid-crystalline phase conditions. The effect of
cholesterol on the tryptophan biding to the zwitterionic DPPC membrane has been
explored. After the systematic analysis of meaningful data, we noted relevant changes
in local structure and dynamics of tryptophan only for cholesterol concentrations above
30%. In agreement with MacCallum et al.[89], we observed that tryptophan tends to
localize strongly in the interfacial region so that crossing the membrane by diffusion with
no help of external fields or mediating particles is unlikely to happen in the time scale
of our simulations. The binding of tryptophan to DPPC involved coordination shells
for the different sites of possible association (charged oxygens ’O2’ and ’O8’ of DPPC
versus the two tagged hydrogens in TRP, namely ’H1’ and ’H2’). Also, the distribution
functions of tryptophan-cholesterol revealed stable hydrogen-bonding configurations.
These data indicate that tryptophan is able to establish stable interactions with all
classes of solvating particles (water, DPPC, and cholesterol) including a sort of bridging
between DPPC and cholesterol species. The typical hydrogen-bond distances between
tryptophan and other species have been found between 1.7-2.0 Å, in good agreement
with experimental data obtained from fluorescence measurements[100]. Tryptophan’s
self-diffusion coefficients have been found to be of the order of 1-10×10−7 cm2/s and
they are strongly dependent on the presence of cholesterol in the system. The diffusion
of tryptophan has revealed to be significantly faster than that of DPPC and slower
than that of water. The computed spectral densities, in excellent agreement with
experimental infrared and Raman data from Leyton et al.[99], allowed us to reveal the
degree of participation of each atomic site of tryptophan to the complete spectrum of
the molecule.
In the last part of this Chapter, considering the importance of studying DPPC
lipids, we kept using DPPC bilayer to study the binding free energies of small molecules:
serotonin, histidine, tyrosine, melatonin, and tryptophan at the condition of 323.15
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K and 1 atm. We found that the area per lipid was practically not influenced by
the presence of one particular probe and they were in all cases around 61 Å2, in
agreement with other computational and experimental data. The Gibbs free energy
of adsorption has been evaluated through the potentials of mean force. We have
considered the usual one-dimensional reaction coordinates based on atomic distances
for selected sites. We chose six types of particles: (1) the hydrogens labeled ’H1’ and
(2) the double-bonded oxygens ’O1’ and ’O2’ of the small molecule; (3) the three water
sites; (4) the charged oxygens labeled ’O2’ and ’O8’ of DPPC. Our data revealed the
existence of a strong first coordination shell and a milder second coordination shell for
small molecule-water structure, which correspond to two minima in the corresponding
PMFs, with energy barriers for the TRP-water association of the order of 1-2 kcal/mol.
Conversely, the binding to DPPC involves a single coordination shell for the two
sites of possible association (oxygens ’O2’ and ’O8’ of DPPC versus hydrogens in
the small-molecules) and energy barriers between 0.5-3 kcal/mol. Throughout our
simulation runs, we did not observe any event of permeation of a small-molecule across
the DPPC membrane. Concerning the essentiality of the two amino acids reported
in the present work (histidine, tryptophan), we observed that tryptophan is able to
enter the interfacial membrane, whereas histidine is not. Interestingly, tyrosine, a
non-essential amino acid shows the highest free energy barriers, indicating that it is
the most stable molecule for DPPC binding. Serotonin has revealed to be a molecule
anchored at the membrane and with a low propensity to be solvated by water, whereas
its derivative melatonin is able to equally interact with water and DPPC, showing
similarly strong free energy barriers. Due to its medical purposes, we will investigate
the dynamics of melatonin binding to the cell membranes in the next Chapter.

Chapter 4
Cellular absorption of small
molecules: molecular dynamics
and free energy landscapes of
melatonin binding at
phospholipid membranes
In this chapter we have focused our efforts on the study of the binding of MEL[306, 307]
at a simplified model cell membrane. This is a process that aims to improve our
understanding of the basic mechanisms of molecular binding and crossing of biological
membranes by small solutes and the interactions with their surroundings. In the
present work, we have considered a model membrane composed of cholesterol and
DMPC lipids, extensively studied in the literature from the experimental and also
computational points of view[47–49]. We have devoted our work to the analysis of the
structure and dynamics of MEL, following the previous Chapter, where TRP[91, 283]
and other similar solutes were simulated[308]. In order to investigate these relevant
effects of MEL on the human body and more specifically on plasma membranes, we
have focused our attention on the characterization of the structure and transport
processes of MEL at the atomic scale with the aid of MD simulations at the time-scale
of hundreds of nanoseconds.
Although the binding constant and Gibbs free energy of a probe adsorption can
be estimated from experiments[58, 89], detailed studies of the relative stability of
different bound states are still scarce in the literature. In addition, in a system
with multidimensional reaction coordinates, usually several stable states (bound con-
figurations) are separated by high free energy barriers corresponding to transition
states of the system[309, 310], making it difficult for MD simulations to sample them
66 | Cellular absorption of small molecules: molecular dynamics and free energy
landscapes of melatonin binding at phospholipid membranes
adequately[225]. Free energy calculations using enhanced sampling techniques provide
a method to address the problem and provide a great deal of understanding of the
passive diffusion phenomena of small solutes over a barrier, which requires a detailed
view of the underlying free energy landscape (FEL). However, despite of the significant
progress of free energy calculations achieved in recent years[311–313], the free energy
landscape of MEL and most of the small solutes on membrane surfaces is still mostly
unknown. The problem of computing free energy landscapes in the multidimensional
quantum or classical systems has been extensively discussed in the literature. We
have employed well-tempered metadynamics in the study of zwitterionic phospholipid
membranes that can help understand basic biological membrane functions and their
interaction with specific small molecules, such as MEL. Furthermore, we will also
discuss the role of cholesterol in the cellular absorption of small molecules.
4.1 Molecular dynamics of melatonin binding the inter-
face of DMPC lipids
4.1.1 Methods
A realistic model of DMPC-cholesterol membrane bilayers in a sodium chloride solution
has been generated using CHARMM-GUI web-based tool. The cholesterol-free system
was composed of 204 DMPC lipids molecules, 10250 TIP3P (water) molecules (allowing
flexible bonds through harmonic springs), with 21 sodium and 21 chlorine ions of
physiological concentration, along with one single MEL molecule obtained from pdb
4QOI through PDB Reader plugin of CHARMM-GUI website-based tool. From the
previous work[91], only two significant cholesterol percentages of 30% and 50% should be
considered such that the harvested data should be compared with the results obtained
for the case with 0% cholesterol. MEL locates at the interface of membrane bilayer in
all three cases at the beginning of the simulation. For the convenience, sketches of the
backbone structures of MEL, DMPC, and cholesterol are represented in Fig. 4.1. The
NAMD2 software package and the recently reparameterized CHARMM36m force field
were used in all MD simulations at a fixed temperature of 303.15 K and at the fixed
pressure of 1 atm (NPT), in order to make sure all simulations were performed at the
liquid crystal phase[43], since the transition temperature of DMPC lipid from gel to
liquid crystal phase of DMPC has been determined to be close to 297 K[9]. As usual
in such kind of the simulations[283] the temperature was regulated with a Langevin
thermostat with a damping coefficient of 1 ps−1, whereas the pressure was controlled
by a Nosé-Hoover Langevin piston with Langevin dynamics at an oscillation period of
50 fs.
All MD simulations used for analysis were operated in NPT conditions. After a
run of 150 ps for relaxation and 100 ns of equilibration periods, several production
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Fig. 4.1 Backbone structures. Sketches of molecular structures of MEL, DMPC, and
cholesterol. Part of Hydrogen-Carbon bonds not shown. The highlighted sites of MEL
(’C3’, ’C4’, ’H15’, ’H16’, ’N1’, ’N2’, ’O1’, and ’O2’) and of DMPC (’O1’, ’O2’, ’O6’,
and ’O8’) will be referred in the text by the same labels.
runs were generated and statistically meaningful trajectories of more than 100 ns were
recorded in all cases. The simulation boxes had different sizes because of different
cholesterol concentrations. For instance, the size of the cholesterol-free system was of
79 Å× 79 Å× 85 Å. A time step of 2 fs was used and periodic boundary conditions were
applied. All bonds involving hydrogens were set to fixed lengths, allowing fluctuations
of bond distances and angles for the remaining atoms. During the calculation of
spectral densities all bonds (including those involving hydrogens) were left flexible.
The cutoff for the Van der Waals interactions was of 12 Å and a switching function
was employed starting at 10 Å. Coulomb forces were computed using the particle mesh
Ewald method, with a grid space of 1 Å. Every time step electrostatic interactions
were updated. The usual periodic boundary conditions in all directions of space were
taken.
4.1.2 Results and Discussion
4.1.2.1 Physical characteristics of the membranes
In order to explore some phase-diagram states of the model systems being simulated,
as well as to efficiently characterize the ordering inside the hydrated lipid bilayer,
a procedure already employed in the previous works[17, 91, 284, 285] was used. A
deuterium order parameter SCD was defined for each CH2 group of the DMPC lipid
tails as Eq. 3.6 and average results are shown in Fig. 4.2 for both tail chains of all DMPC
lipids at the three cholesterol concentrations considered in this Chapter. SCD can be
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also obtained from 2H NMR experiments[314]. The results for the cholesterol-free case
were previously tested[17] and are in good agreement with both simulation[287, 315]
and experimental works[98, 286], confirming the liquid crystal phase was represented
well in the three systems adopted in this Chapter. We should note that as cholesterol
concentration increases in the system, the tendency to higher ordering increases too,
which is represented by profiles of SCD having larger maxima (around ∼ 0.4 for the
cholesterol-rich setups versus ∼ 0.2 for the cholesterol-free system), a tendency which
was already observed by Petrache et al.[98].
Fig. 4.2 Order parameter. |SCD| for the (sn1, sn2) acyl tails of DMPC at three different
cholesterol concentrations.
The area per lipid is definitely a relevant output from the most molecular simula-
tions of plasma membranes. We have calculated the area per lipid, as defined in Eq.
3.7, considering the membrane surface along the XY plane divided by the number of
lipids and cholesterol[288]. For continuous MD production runs, area per lipid as a
function of simulation time is reported in Fig. 4.3 whereas their average values together
with the average thickness of membranes are reported in Table 4.1. Area per lipid
decreases as cholesterol concentration increases. We obtained a value of around 62 Å2
for a cholesterol-free system and smaller values down to 40 Å2 for the system with a
concentration of cholesterol of 50%. These results are in excellent agreement with other
computational works[98, 282] where the value for pure DMPC is of about 60 Å2 at 303
K. According to the review of Nagle et al.[6], values of area per lipid of pure DMPC
membranes (303 K) can be obtained from multiple methods (neutron scattering, X-ray
and NMR) and were reported to be between 59 and 62 Å2 at the liquid phase. In our
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case, the change in the area per lipid has been observed to be more marked when the
concentration of cholesterol was above 20% (not reported). This is consistent with the
observed fact that DMPC membranes in this work experienced the phase transition
point from a liquid-disordered phase (cholesterol-free system) to a liquid-ordered phase
(systems of cholesterol 30% and 50%)[291, 292].
Fig. 4.3 Physical characteristics of the membranes. Area per lipid of systems with
different cholesterol contents: 0% (black line), 30% (blue line), 50% (red line) as a
function of simulation time. The green dashed lines indicate the average values for the
last 150 ns at each concentration.
The thickness of the membrane may provide additional clues about the influence
of cholesterol on its mechanical properties, such as rigidity and capability of allowing
the movement of species in and out of the cell. We have obtained the thickness of
the membrane ∆z by computing the distance between phosphorus atoms (P) of the
DMPC head groups from both layers.
Table 4.1 Area per lipid (A) and thickness (∆z) of the membrane for all three cholesterol
concentrations studied in this work. Estimated errors in parenthesis.
Percentage of cholesterol A (Å2) ∆z (Å)
0% 61.8(1.2) 34.9(0.6)
30% 42.1(0.5) 44.3(0.3)
50% 40.2(0.3) 44.7(0.3)
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The results of the thickness of the membrane are in good agreement with those
reported by Kučerka et al.[282] by means of X-ray and neutron scattering. These
authors reported a value of 36.7 Å at 303 K for the DMPC membrane at a cholesterol-
free system. In this Chapter, we observe a tendency to larger bilayer thickness as
cholesterol concentration increases. As was pointed out in the case of the binding of
TRP at DPPC-cholesterol membranes[91], at higher cholesterol percentages the values
of A are smaller: the larger the cholesterol contents the more compressed are the
bilayer structures. This eventually can increase the rigidity of the membrane, extending
the lipid tails, and producing larger bilayer thickness. In summary, the increase of
the rigidity of the membrane is a fact already observed by several authors from both
experimental and computational sides, such as Drolle et al.[96] or Choi et al.[97]
for cholesterol-MEL mixtures in phosphatidylcholine membranes. In their studies
these authors found out the effect of MEL reducing the thickness of the membrane
and enhancing its fluidity, a compensating effect of the condensation introduced by
cholesterol. In the present work we only considered a single MEL molecule that did
not allow us to explore the joint effects of MEL and cholesterol on the thickness of the
membrane.
The penetration of MEL in the membrane along its normal direction is also a
relevant feature. We report in Fig. 4.4 the Z-axis position of MEL from the center of
the bilayer (i.e. z = 0) using the last meaningful 80 ns of each production trajectory
in all three cases, namely, concentrations of cholesterol set at 0%, 30% and 50%. Red
symbols represent the average positions of phosphorus (P) atoms of the head groups
of DMPC along the direction normal to the membrane (Z-axis); green symbols stand
for the Z-axis distance between the center of mass of MEL and the center of DMPC
bilayers, as a function of simulation time. It stands clear that the thickness of the
DMPC bilayer membrane is increased when cholesterol is present in the membrane, in
good agreement with the results of thickness reported in Table 4.1. At 0% and 30%
cholesterol systems, MEL stays in the internal region of DMPC bilayers most of the
time, with a few occasional visits to the interface of the membrane, i.e. surroundings
of the P atoms; however, when more cholesterol is added into the system (i.e. at
50%), MEL can diffuse into water bulk and become fully solvated by water or the
head groups of DMPC without changing the size of the system too much, indicating
the competition between water and lipids to solvate MEL. These results are in good
agreement with those of Drolle et al. that reported the preferential location of MEL in
a DPPC bilayer at distances around z = 1.2 nm (see Fig. 8 of Ref.[96]), i.e. at the
crossover region between lipid head groups and the fatty acid chains. In the case of
50%, Fig. 4.4 shows that MEL has the ability of either being adsorbed by the head
groups of DMPC either to stay for long periods of time in the water bulk, so we can
expect that it is not difficult for a small molecule like MEL to cross the free energy
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Fig. 4.4 Z-axis position of MEL. Penetration of MEL inside DMPC bilayer (green
symbols indicate the position of the center of mass of MEL whereas red symbols
stand for the position of phosphorus atoms atoms in each layer) at 0%, 30%, and 50%
cholesterol concentrations.
barrier between the two states (solvated by water or solvated by the head groups of
DMPC). This latter aspect will be addressed with more details in section 4.2.
4.1.2.2 Radial distribution functions of melatonin around DMPC, water,
and cholesterol
A direct route to the characterization of the local structure of each atomic species of
the system is usually obtained by means of normalized radial distribution functions
(RDF) g12(r) for two different species ’1’ and ’2’, see Eq. 3.1. Among the wide variety
of possible RDF that could be computed, we have considered only six relevant RDF
based on the first coordination shells of ’H15’ and of ’H16’ of MEL. The remaining
RDFs indicate low maxima at distances significantly longer than the typical HB values
or show too noisy profiles which indicate that the corresponding local structures are
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not stable enough. The selected g(r)s are reported in Fig. 4.5 for the three cholesterol
percentages (0, 30, 50%).
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Fig. 4.5 Radial distribution functions. Selected radial distribution functions for hydro-
gens of MEL (’H15’ and ’H16’) with oxygens of water (’OW’), DMPC (’O2’ (representing
’O1 & O2’) and ’O6’ (representing ’O6 & O8’)) and cholesterol, belonging to hydroxyl
group (’O Chol’).
All six g(r)s show some fluctuations in their profiles, especially at the coordinates
of r = 3 Å and beyond, i.e. those corresponding to second coordination shells. We
could observe a neat first coordination shell in every case, located around 1.8-2.0 Å
that should be essentially attributed to HB between MEL and the remaining species,
cause such distance is the signature of typical oxygen-hydrogen HB in water[316].
Interestingly, the largest peak in all RDF is, by far, the one appearing at the MEL-
cholesterol association, centered at 1.9 Å when the concentration of cholesterol is
of 30%. Further, when we raised the concentration to 50% such band decreased
dramatically and its position was shifted to about 2.2 Å . The interaction of MEL
with cholesterol in DPPC bilayers, already reported by Choi et al.[97] produced a
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fluidizing effect on the membrane for a MEL concentration high enough, opposite to
the condensing effect of cholesterol.
In all the remaining cases, HB lengths are around 1.9 Å. The height of each
maximum (related to the intensity of the HB) depended strongly on the concentration
of cholesterol, as follows: (1) in the case of MEL-water association, strong HB were
observed between ’H16’ and water at 0% and 30% although at 50% they were much
weaker; (2) both ’H15’ and ’H16’ were able to form HB with the DMPC sites ’O1’
(or ’O2’, both sites sharing the negative charge); (3) finally, MEL can establish HB
between both ’H15’ and ’H16’ hydrogens with the DMPC sites ’O6’ (or ’O8’) in all
three percentages of cholesterol. These findings of HB association between MEL and
DMPC are in good agreement with those from Severcan et al.[85] who, by means of
Fourier transform infrared spectroscopy, observed the existence of hydrogen bonding
between the hydrogen in the N-H group of the furanose ring of MEL (labeled ’H16’ in
the present work) and the carbonyl (C=O) and phosphate (PO−4 ) groups in DPPC
membranes. From our findings we have observed both HB of ’H15’ and ’H16’ of MEL
with the phosphate group of DMPC (’O1’) and also with the more internal C=O
groups (’O6’ and ’O8’). Thus, the novelty here is the hydrogen bond association of
’H15’ with the two well-known acceptor groups in phosphatidyl-cholines indicated
above, together with the already reported association of ’H16’. This fact allows MEL
to be adsorbed deeper than TRP[91] at the membrane lipid bilayer with two selected
donors (’H15’ and ’H16’) as well as through ’H15-O Chol.’ bridges, which provides
a variety of structures as it will be described in full details below. Results on MEL
located close to the lipid head groups in studies of MEL inside DOPC and DPPC
membranes were found by Drolle et al.[96] by means of small-angle neutron diffraction
and MD simulations.
4.1.2.3 Estimation of Gibbs free energy differences
From a general perspective, the calculation of the Helmholtz or Gibbs free energy
differences for binding processes or for configurational changes is a difficult task and
it requires a considerable amount of computer time and a precise knowledge of the
hypersurface of the potential energy of the system[317]. This can be explored by means
of methods such as metadynamics[226, 275], hybrid quantum mechanics/molecular
mechanics methods[318] or transition path sampling[213, 280, 293, 319]. However, a
usual way to obtain free energy estimations is through the so-called potential of mean
force (PMF), which is an estimation of the Gibbs free energy difference between two
particles (’1’ and ’2’) and together with pair radial distribution function (RDF) has
been explained earlier in sections 3.1.2.4 and 3.2.2.2, respectively. The only restriction
of this method is the fact that a single radial distance is always assumed as the pre-
conceived reaction coordinate. Using this procedure on the RDF reported above, we
have estimated the height of the barriers appearing in the Gibbs free energy differences
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for MEL when bound to selected atomic sites from water, DMPC and cholesterol,
assuming that at 303.15 K the equivalence is kBT = 0.602 kcal/mol.
Table 4.2 Gibbs free energy differences PMF (in kcal/mol) for the binding of MEL
(sites ’H15’ and ’H16’) to selected atomic sites. Since ’O1’ and ’O2’ sites in DMPC
share the negative charge, their contributions have been averaged; the same situation
for ’O6’ and ’O8’.
Atomic site H15 H16
0% 30% 50% 0% 30% 50%
O-water - - - 1.08 1.20 0.42
O2-DMPC 0.48 1.69 1.14 1.45 1.56 1.62
O6-DMPC 1.99 1.87 1.93 1.14 1.87 2.23
O-chol. - 2.53 0.90 - - -
From the results in Table 4.2 we can observe that all Gibbs free energy differences
are of the order of 1 kcal/mol, in overall good agreement with preliminary calculations
(case of a cholesterol-free DPPC membrane at 323 K)[308]. Density functional theory
calculations of binding energy barriers of aqueous solvation of MEL in water clusters
have been found to be of a few kcal/mol[320]. In most cases, a single coordination
shell has been observed. As expected from the RDF reported above (see Fig. 4.5), the
highest free-energy barrier corresponds to the association of MEL with cholesterol, at
the 30% concentration, where the hydrogen bonding distance is very close to 2 Å and
tends to increase when cholesterol concentration is of 50%. Conversely, all remaining
HB distances have been found at the typical value of 1.85 Å . The MEL-water HB has
been observed, in a significant amount, for ’H16’ and not for ’H15’ and they become
very weak at the highest cholesterol concentration.
Focusing on DMPC-MEL HB, we have encountered a strong influence of cholesterol,
with the overall highest barriers at 50% concentration. The typical bindings sites were
O1-O2 (located at phosphate belonging to the head groups of DMPC) or O6-O8 (at
carbonyl species on the tail groups of DMPC). Our results indicate that the presence
of cholesterol increases the energetic cost of the binding of MEL to the membrane, with
a preferential association of MEL ’H15’ to the phosphate group of DMPC and of ’H16’
to carbonyl groups, all depicted in Fig. 4.1. This is in agreement with the preferential
location of MEL deep inside the 30% cholesterol membrane and also with the fact
that MEL can move outside the membrane more easily as cholesterol concentration
increases (see Fig. 4.4 as well as data from Refs. [96, 97]).
4.1.2.4 Angular orientations of melatonin at the membrane
In order to analyze the angular distributions of MEL at the interface of the membrane,
we have defined three dihedrals, according to Fig. 4.6.
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Fig. 4.6 Dihedral angles. Angles (a) θ, (b) Ψ and (c) ϕ defined for MEL. Top figures
correspond to "folded" and bottom figures to "extended" configurations for each dihedral.
The two snapshots (top, bottom) have been obtained from equilibrated configurations
.
We report in Fig. 4.7 angular distributions of MEL using the three selected dihedral
angles defined in Fig. 4.6. In all cases we can observe that, on average, the angular
distributions of MEL are centered around two preferential orientations, called "folded"
and "extended" configurations, that are found at all cholesterol concentrations. The
nitrogen atom involved in dihedrals θ and Ψ is the one labeled ’N1’ in Fig. 4.1, namely
the nitrogen chemically bound to the hydrogen labeled ’H15’ in Fig. 4.1. For the
dihedral angle θ, the average angles corresponding to stable configurations are of 1.08
rad (62◦, folded configuration) and 2.22 rad (127◦, extended configuration); for angle
Ψ, the two stable configurations correspond to 1.42 rad (81◦, folded) and 2.96 rad
(170◦, extended), whereas for ϕ the values are of 2.07 rad (119◦, folded) and 1.17 rad
(67◦, extended).
From the distributions reported in Fig. 4.7, we can note that the dihedral angle
θ can reach continuously all sorts of values between 0.44 and 2.70 rad, the angle ϕ
can fluctuate between 0.98 and 2.60 rad, whereas the angle Ψ is much better defined
and it reaches either value around 2.96 ± 0.18 rad or 1.42 ± 0.41 rad, regardless of
the concentration of cholesterol of the system. After analyzing 100 ns of equilibrated
trajectories (production runs), we calculated the ratios of the three dihedral angles
for equilibrated systems with different cholesterol concentrations and reported the
averages in Table 4.3.
From the results of dihedral angles θ and Ψ (see Table 4.3), we get that the
extended configuration of MEL is more favored when adding cholesterol into the
system. However, from the results of ϕ, it seems that at 50% cholesterol percentage,
MEL stays much less at its extended configuration than 0% and 30%. Considering the
behavior of MEL in all three cases (see Fig. 4.4), we found that MEL spent almost
half of the simulation time in the water bulk at the 50% cholesterol system and it
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Fig. 4.7 Angular distributions. Distribution of selected dihedral angles in MEL as a
function of simulation time, where labels (a), (b), and (c) have the same meaning as in
Fig. 4.6. Percentages of cholesterol are: 0% (black circles), 30% (red squares), and 50%
(green triangles). Dashed lines indicate average values and are a guide for the eye.
Table 4.3 Ratio of the two angular configurations for MEL in three systems with
different cholesterol concentration. "Ext." stands for "extended configuration of MEL"
and "Fol." stands for "folded configuration of MEL" in all cases.
θ Ψ ϕ
Ext. Fol. Ext. Fol. Ext. Fol.
0% 0.53 0.47 0.46 0.54 0.40 0.60
30% 0.53 0.47 0.52 0.48 0.46 0.54
50% 0.62 0.38 0.56 0.44 0.19 0.81
stayed at the interface for 0% and 30% cholesterol systems. So, we can suggest that
the dihedral angle ϕ is significantly more sensible than the other two dihedral angles
as being solvated by water. We can also suggest that introducing cholesterol into the
system could help MEL change from its folded to its extended configuration more
easily through hydrogen-bonding between MEL-DMPC and MEL-cholesterol. Also,
according to this, Ψ is an excellent candidate for being used as a collective variable
in metadynamics calculations[226, 231] of free energy landscapes for MEL binding in
biomembranes, the results of such type of calculations will be reported in section 4.2.
Our results confirm the suitability of Ψ as a collective variable.
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4.1.2.5 Diffusion of melatonin and water
Dynamics of MEL and water have been extensively explored through translational
diffusion and vibrational spectroscopy, as we will report below. Conversely, the
dynamics of lipids and cholesterol are much slower and it has not been considered here.
In particular, the mean square displacements (MSD) of water and center of mass of
MEL, defined by Eq. 3.8, have been evaluated. From the long time slopes of MSD (not
reported here), self-diffusion coefficients (D) have been calculated for three cases. The
results are reported and summarized in Table 4.4.
Table 4.4 D (in cm2/s) of MEL and of water in three systems with different cholesterol
percentages. Estimated errors in parenthesis.
D 0% 30% 50%
Water 4.0(0.1)×10−5 4.3(0.1)×10−5 4.4(0.1)×10−5
MEL 1.1(0.4)×10−7 3.9(0.6)×10−7 4.1(0.9)×10−7
For the self-diffusion of water, all water molecules in the system are included in the
results regardless of their location in the bulk or interfacial regions. At 0% cholesterol
our results are in overall agreement with the ones obtained in our research group
for the simple aqueous DMPC membrane[17] (2.7×10−5) what indicates that when
cholesterol concentration rises, water tends to diffuse slightly faster. Nevertheless, we
can observe that the presence of cholesterol and the single MEL molecule does not
affect the dynamics of water to a large extent. This could be due to the fact that with
higher cholesterol concentration in the system plasma membranes are more packed and
water cannot easily penetrate the interface of the membrane, having its main diffusion
along the instantaneous surface of the bilayer.
Diffusion coefficients for MEL are approximately two orders of magnitude smaller
than those of water and show a tendency to increase when cholesterol is mixed with
DMPC, regardless of its concentration. In Table 4.4, at 30% cholesterol the value of
D for MEL is six-fold larger than the value of D of DMPC molecules in pure DMPC
bilayer membrane systems (0.6×10−7 cm2/s), although the former is about 6.5-fold
larger. Thus, the diffusion of MEL is significantly faster than that of DMPC. This
fact would suggest that its mechanisms of diffusion may be similar to those of an
individual particle (such as in Fickian diffusion) and qualitatively different of those of
lipids, whose diffusion was observed to occur in a sort of collective way, associated in
local groups of a few units (around 5-10 units)[17].
4.1.2.6 Spectral densities of melatonin
IR spectroscopy exploits the fact that molecules absorb specific frequencies that are
characteristic of their structure and atom-atom interactions. IR spectrum is usually
obtained on a spectrometer using the attenuated total reflection sampling technique
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with a neat sample in the laboratory. Such experimental properties could also be
obtained from certain MD simulations[300, 301]. We carefully calculated the atomic
spectral density Si(ω) defined as Eq. 3.9 in section 3.2.2.4. In the present section,
we have obtained the spectral density of MEL and also of each atom site (only part
of them are shown). Since the force field employed in the present work accounts
for harmonic bond vibrations, we have been able to locate most of the positions of
main experimental spectral bands (see Ref. [91] for more details). At this point we
should remark that one powerful characteristic of computing molecular spectra in
simulations is the possibility of locating the particular atomic sites contributing to
each spectral band and thus be able to make a precise interpretation of experimental
spectra. We will report this feature below. The full spectral density SMEL(ω) and its de-
composition into atomic contributions for the 0% cholesterol case is reported in Fig. 4.8.
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Fig. 4.8 Spectral densities. SMEL(ω) of MEL (left). Positions of main experimental
peaks are indicated by full arrows (low-mid frequency range) and locations of a broad
group of frequencies (high frequency range) have been indicated with initial and final
vertical arrows linked by a horizontal double arrow. For the cholesterol-free system
(right), atomic spectra Si(ω) indicate the relative contribution of selected atoms to
SMEL(ω). Inset: high frequency region for most relevant atoms of MEL (’C3’, ’N1’,
’N2’, ’H15’, and ’H16’).
From left side of Fig. 4.8, two main spectral regions of the full IR spectrum of
MEL have been located: (1) frequencies below 1800 cm−1 and (2) frequencies of
2700 < ω < 3600 cm−1. As a general feature, the agreement of the calculated full
spectrum with available data (at 0% cholesterol concentration) from infrared and
Raman spectroscopy reported by Singh et al.[321], Fleming et al.[322], and Pieta et
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al.[323] have revealed a very good overall agreement (see the left side of Fig. 4.8),
although some discrepancies have been observed in the location of some peaks. As a
general fact, the maxima reported by the three experimental groups match each other
very well. Let us describe the comparison of experimental data with results from the
present work as follows.
In the region up to 1800 wavenumbers, the maxima with strong signatures were
located at 401, 756, 834, 926, 1353, and 1550 cm−1, according to the recent measure-
ments of Pieta et al.[323], whereas Fleming et al.[322] reported strong maxima at 404,
508, 836, 928, 1358, 1449, and 1553 cm−1. Most of these maxima are included in the
S(ω) showed in the present work (Fig. 4.8) at 0% cholesterol content. We observed
maxima at: 120, 294, 592, 714 (shoulder), 813, 1077, 1265, and 1408 cm−1. The main
disagreements are related to frequency shifts in most bands:
1. The peaks observed by us at 120 and 592 cm−1 are not seen in experimental
data (the Raman frequency range started at around 250-300 wavenumbers in all
cases);
2. The Raman band located at ∼ 400 cm−1 is found at ∼ 300 cm−1 in our spectrum;
3. The Raman bands at 756 and 834 wavenumbers are red-shifted down to 714 and
813 cm−1 in Fig. 4.8;
4. The Raman band centered at 926 wavenumbers has been found around 1077
cm−1 in Fig. 4.8;
5. The Raman bands at 1353 and 1550 cm−1 are also red-shifted to 1265 and 1408
cm−1 in the computed spectra.
In the high frequency region (2700 < ω < 3600 cm−1) the strong maxima reported
from infrared spectroscopy measurements[321] were located at 3280 and 3302 cm−1
(assigned by the authors to the N-H stretching region), whereas a group of thirteen
bands were located at the C-H stretching region, between 2826 and 3079 wavenumbers.
The computed spectra of Fig. 4.8 reveal four bands, one of them very strong at 2930
cm−1, another as a shoulder around 3070 cm−1 and two weak bands at 3210 and 3500
cm−1.
According to the overall agreement between our results and those from Raman
and infrared data, we can assume the reasonably good reliability of the potential
MEL model and method adopted in this work. Accordingly, we have computed the
partial spectra of each atom in MEL, in order to identify and assign the microscopical
participants and type of each vibrational mode. The results are depicted in the plot
on the right side of Fig. 4.8. There we computed the contribution of each individual
atom to the full spectrum at 0% cholesterol concentration. The list of assignments
and their physical meaning is as follows:
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1. The peak located at 120 cm−1 in the computed spectra is directly related to
oxygens ’O1’ and O2’ as well as nitrogen ’N1’ since it appears in the correspond-
ing spectral densities. From the previous knowledge[17, 91, 324] it should be
attributed to restricted translations of the full MEL molecule.
2. The weak band located around 294 cm−1 along with the maxima at 345 cm−1
are approximately assigned to the spectrum of ’N2’. Since this is a relatively low
frequency it will probably correspond to a rotational motion of the indole group
of the MEL molecule.
3. The maximum at 592 cm−1 directly matches a maximum of ’O2’ and this suggests
a librational motion of the ’C4-O2’ bond.
4. The maxima at 714 cm−1 (shoulder) and 813 cm−1 (attributed to the experimental
bands at 756 and 834 wavenumbers) are clearly connected to ’N-H’ vibrational
bending motions, since they are detected as maxima in the spectra of ’N2-H16’
and ’N1-H15’ pairs, respectively.
5. The band centered at 1077 cm−1 is matched in our detailed spectra by maxima
of atomic pairs ’N1-C4’ and ’O1-C3’. Being this a bending-like mode, it should
account for scissoring vibrations of the mentioned pairs.
6. The maxima at 1265 and 1408 cm−1 are observed in the partial spectra of ’C3’
and ’C4’, suggesting a stretching vibration of both carbons, the lowest frequency
band associated with ’C4’ and the highest to ’C3’.
7. In the high-frequency range, the strongest band observed by us and located at
2930 cm−1 is well matched by the peak of ’C3’ (see inset of Satom) and, according
to the previous works[17, 91] it indicates a stretching vibration of hydrogens
bound to ’C3’.
8. The shoulder at 3070 cm−1 can only be (hardly) seen at the spectral densities of
’H15’ and ’N1’.
9. Finally, the two weak maxima located around 3210 and 3500 cm−1 should
be respectively attributed to the pairs ’N1-H15’ and ’N2-H16’ as stretching
vibrational modes of the corresponding hydrogens.
When cholesterol is included in the system, we can observe at the left side of
Fig. 4.8 that some observable frequency shifts are produced, suggesting that cholesterol
is able to interact with MEL in a remarkable way, affecting the vibrational motions of
their atomic components. This is in good agreement with the fact reported above (see
section 4.1.2.2) of the HB of MEL to cholesterol, especially at the 30% concentration.
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4.2 Free energy landscapes of melatonin binding at phos-
pholipid membranes
The calculation of Helmholtz or Gibbs free energy differences for a realistic condensed
matter system is a difficult task, mainly due to the fact that the partition function of
a multidimensional system is normally unknown. In the present case, our main aim is
to obtain free energy differences in the process of binding/crossing of a small molecule
through/at the model cell membrane. This will involve configurational changes and,
consequently, it will require a considerable amount of computational time in order to
explore and obtain the precise knowledge of the hypersurface of the potential energy
of the system[317]. As reported in Chapter 2, a wide variety of methods have been
designed for the calculation of FEL. Among them, a method called "local elevation"
(Huber et al.[214]) or "conformational flooding" (Grubmüller[216]) was the initial idea
that lead to Laio and Parrinello[225, 226] to introduce the concept of metadynamics
as a method to explore multidimensional free energy surfaces of complex systems as a
function of a finite number of the so-called collective variables (CV) which are a priori
unknown. CVs are arbitrarily chosen and act as effective reaction coordinates to drive
the calculations when moving the probe between (meta-)stable states surrounded by
free energy barriers at the multidimensional configuration space. The right selection of
the CVs is crucial for the sake of the efficiency of the calculation. However, given some
drawbacks of the method, a new version was released. Well-tempered metadynamics is
a variant of metadynamics able to enhance the sampling of multiple CV dimensions.
The specific interactions of MEL with cell membranes are revealed and interpreted
from a free energy perspective, providing a quantitative characterization of the barriers
between stable states as well as of the most relevant binding states of MEL to water
and lipids. Our work employs a general methodology to define meaningful reaction
coordinates and to explore the free energy landscapes for small molecules or drugs
at complex biological interfaces which can be extended to study other interactions
of interest between such species and charged head groups in colloidal chemistry and
biology[325]. Interaction between several classes of lipids and cholesterol can play a
significant role as well[292]. In such a case, a bound state can be characterized by
variables such as the coordination number of the ions with lipid/cholesterol binding
sites and its simultaneous coordination number with water molecules[275].
We have observed from the full MD simulations of MEL in DMPC membranes
reported in section 4.1.2.4 that two orientations of MEL can be associated with three
different dihedral angles involving particular molecular directions. Surprisingly, one of
such dihedral angles, namely a given angle Ψ has shown an angular distribution clear
enough to serve as a suitable CV. This particular angle reaches the same two stable
values (1.42 ± 0.41 rad and 2.96 ± 0.18 rad) at all three cholesterol concentrations,
corresponding to two preferential molecular configurations adopted by MEL, that we
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called "folded" and "extended", respectively. The remaining dihedral angles evaluated
showed large fluctuations and were clearly inadequate as CVs.
4.2.1 Computational details
The three usual sets of lipid bilayer systems with different amounts of cholesterol (0%,
30%, 50%) have been considered. The CHARMM-GUI tool was employed to generate
the three sets of lipid bilayer systems. Each system consisted of 204 lipid chains: DMPC
lipid molecules and cholesterol, 5000 TIP3P water molecules, and sodium chloride
ions with zero total charge at human body concentration (0.15 M). Three series of
200 ns long MD simulations adopting the CHARMM36 force field were considered
for the equilibration of the systems in order to minimize and equilibrate the three
sets of MEL-membrane systems, before launching the well-tempered metadynamics
simulations. All MD runs were performed using the package GROMACS/2018.3. A
time step of 2 fs was used in all cases. The particle mesh Ewald method with a Coulomb
radius of 1.2 nm was employed to compute long-ranged electrostatic interactions. The
cutoff for Lennard-Jones interactions was set to 1.2 nm, with a switching distance of
1 nm. The pressure was controlled by a Parrinello-Rahman piston with a damping
coefficient of 5 ps−1 and temperature was controlled by a Nosé-Hoover thermostat with
a damping coefficient of 2 ps−1 [326, 327]. Standard MD simulations were performed
at the NPT ensemble at pressure 1 atm and temperature 303.15 K, well above the
transition temperature for DMPC, in order to ensure that we were simulating the
liquid crystalline state. Periodic boundary conditions in three directions of space have
been taken. The initial size of the simulation box, where Z-axis is the direction normal
to the instantaneous plane of the membrane, was as follows: (a) for the cholesterol-free
system it was of 7.9 nm × 7.9 nm × 8.5 nm; (b) for the cholesterol-rich setups it was
of 7.9 nm × 7.9 nm × 11.6 nm.
After equilibrating well the system in all cases, we have run 1.4 µs metadynamics
simulations to perform Gibbs free energy calculations of the binding states of MEL
at phospholipid membrane bilayers. Three serials of metadynamics simulations were
performed using the PLUMED2 within the joint GROMACS/2018.3-plumed tool, the
NPT ensemble of the temperature of 303.15 K and pressure of 1 atm were adopted
in all cases. Periodic boundary conditions in the three directions of space have been
considered. The size of each simulated system has been found to be the same as those
reported for MD simulations. The range of values for the positions of lipids, cholesterol,
and water molecules have been found to be exactly the same as those reported in
Fig. 4.9. We have defined two main CVs to describe the binding states of MEL: CV1
is the dihedral angle Ψ, as represented in Fig. 4.6 and CV2 is the distance zMEL−DMPC
between the center of mass of the MEL molecule and the center of the DMPC bilayer
membrane, defining Z-axis as the direction normal to the instantaneous plane of the
membrane, i.e. the plane formed by axes X and Y . From here on, we will refer to
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CV2 simply as z. We should point out that in section 4.1 we have observed that MEL
is normally bound to cholesterol and/or to the carboxyl group of DMPC and in a
less usual manner to the phosphate groups of DMPC, but forming always a dihedral
angle of ±π rad, i.e. at the extended configuration. Parameters of well-tempered
metadynamics simulations are listed in Table 4.5.
Table 4.5 Simulation parameters
Parameter 0% 30% 50%
Gaussian width of CV1 [rad] 0.35 0.35 0.35
Gaussian width of CV2 [nm] 0.30 0.30 0.25
Starting (Gaussian) hill [kJ/mol] 1.0 1.0 1.0
Deposition stride [ps] 1 1 1
Bias factor 10 10 20
Simulation time [ns] 1100 1400 1400
4.2.2 Results and discussion
4.2.2.1 Physical properties of equilibrated systems
The values for the average z-length of the full systems can be also estimated from the
density profiles, as reported in Fig. 4.9.
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Fig. 4.9 Density profiles of lipid backbone after 200 ns of MD equilibration (full lines:
0% cholesterol, dotted lines: 30% cholesterol, and dashed lines: 50% cholesterol) and
water (circles: 0% cholesterol, squares: 30% cholesterol, and triangles: 50% cholesterol)
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We can highlight several general results:
1. Water is able to access deep positions inside the membrane: up to z = ±1.3
nm at the 30% and 50% cholesterol concentrations and up to z = 0.6 nm at 0%
cholesterol, i.e. very close to the center of the membrane.
2. According to the size of the systems and density profiles, the Z-axis lengths were
8.5 nm at the cholesterol-free setup and 11.6 nm for the two setups including
cholesterol. We can observe that DMPC/cholesterol molecules can reach z values
up to ±3.2 nm in all cases. This indicates that two "bulk" water boxes of about
7.9 nm × 7.9 nm × 1.1 nm i.e. 68.65 nm3 surround the membrane for the 0%
cholesterol case and two water boxes of about 7.9 nm × 7.9 nm × 2.6 nm i.e.
162.27 nm3 enclose the membrane for the 30% and 50% cholesterol setups.
3. As the additional information, cholesterol-rich setups have membrane sizes thicker
than those at the cholesterol-free system, a feature already observed in section 4.1.
From these observations, we obtained average values of the area per lipid and
thickness of the membrane, as reported in Table 4.6. Such values are in good
agreement with the density profiles reported in Fig. 4.9. Further, the thickness
of the membranes is in good agreement with the findings of Kučerka et al.[282]
obtained by X-ray and neutron scattering, who reported a value of 3.67 nm at
303 K for the DMPC membrane at a cholesterol-free system.
Here we report the area per lipid and thickness of the membrane in all cases. Hence,
with the information reported here, we will be able to characterize and approximately
locate the states from the free energy landscapes corresponding to the water-membrane
interfaces or MEL fully solvated by water/sodium-chloride molecules. Results obtained
from well-tempered metadynamics simulations are reported in the following text[328].
Table 4.6 Area per lipid (A) and thickness (∆z) of the membrane. Estimated errors in
parenthesis.
Percentage of cholesterol A (nm2) ∆z (nm)
0% 0.587(0.011) 3.65(0.05)
30% 0.413(0.004) 4.49(0.02)
50% 0.397(0.003) 4.47(0.02)
As we can see, three systems are well equilibrated and results of area per lipid
generated using GROMACS/2018.3 are similar to results using the NAMD2 package
(shown in Table 4.1).
4.2.2.2 Study of the free energy convergence
We report in Fig. 4.11 the fluctuations of the two CVs (Ψ, zMEL−DMPC) along the
final 1 µs time span of our well-tempered metadynamics simulations. We can clearly
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Fig. 4.10 Area per lipid of systems as a function of simulation time in three cases: 0%
cholesterol (black), 30% (red), and 50% (blue). Dashed green lines indicate the average
values, which are shown in Table 4.6, of the last 150 ns at each concentration.
identify a few events where MEL permeated the membrane from one leaflet to the
other one at all three cholesterol concentrations. Two selected CVs potentially reached
all possible values within given ranges.
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Fig. 4.11 Fluctuations of the CV values as a function of time in different states: (a)
0% cholesterol (black), (b) 30% (red), and (c) 50% (blue).
On one hand, Ψ (bottom row of Fig. 4.11) shows regular fluctuation profiles,
covering all possible angular orientations in the full range Ψ ∈ [−π, π]. We note that
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at 0% and 30% cholesterol concentrations, dihedral angles around 0 are slightly less
common than at 50% cholesterol. On the other hand, the patterns of zMEL−DMPC
evolution in time (top row of Fig. 4.11) indicate that, although the whole distance span
(zMEL−DMPC ∈ [−4.3, 4.3] nm at 0%, zMEL−DMPC ∈ [−5.8, 5.8] nm at 30%, and 50%
cholesterol concentrations) can be reached, only some distances between the center of
mass of MEL and the center of the DMPC bilayer will be accessed in a regular fashion.
So, MEL is clearly biased to stay close to 1 nm away from the center of the bilayer or
around 3-4 nm, which suggest that at least two preferential Z-axis locations of MEL
should arise from free energy calculations. In addition, we can observe that only a
few crossings of the membrane center by MEL are observed, which indicates that high
free-energy barriers will prevent such crossings in a regular way.
It is usual to monitor the size of the hills of the Gaussian kernels deposited along
with the simulation. We can visualize the decrease of the Gaussian height during the
simulation and eventually displays low-height spikes. In the present case, the height of
the biased potential decreased accordingly along the simulation runs, as indicated in
Fig. 4.12. In all cases, a quasi-flat profile is already seen around 600-800 ns.
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Fig. 4.12 Well-tempered Metadynamics hills height as a function of time in different
states: (a) 0% cholesterol, (b) 30%, and (c) 50%.
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The fact that the Gaussian height is decreasing to zero should not be used as a
measure of convergence of metadynamics simulation. Therefore, in order to assess the
convergence of a metadynamics simulation, we have calculated the estimate of the free
energy as a function of simulation time. At convergence, the reconstructed profiles
should be similar. Here we report the time cumulative average of 1D free energy
profiles as defined in the main text, i.e. averaging the two leaflets and projecting onto
(integrating out) the alternative CV in a range larger than 1 microsecond in all cases.
From the results of Figs. 4.13, 4.14, and 4.15, we can see that after long cumulative
time lengths, the differences between a profile and the one immediately before are very
small (up to 2.5 kJ/mol) which lead us to fully converged free energies for the two CV
considered in the present study.
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Fig. 4.13 Time cumulative free energy profiles at the cholesterol-free system. Bottom:
CV1, top: CV2.
In order to obtain and evaluate the paths connecting two free energy minima
located on the 2D free energy surfaces reported here, we have considered the practical
guidelines reported by B.Ensing et al. in Ref. [329]. There, the authors describe
precisely how to trace the minimum free energy pathway between two stable states
in a multidimensional free energy landscape computed using metadynamics. The
process includes three steps: (a) optimizing two local minima; (b) locating a coarse
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Fig. 4.14 Time cumulative free energy profiles at the 30% cholesterol system. Bottom:
CV1, top: CV2.
path, and (c) refining the path. In all calculations, we considered between 8 and 10
points per path. The results for a series of paths between consecutive minima for the
three cholesterol concentrations considered in the present work have been depicted in
Figs. 4.16-4.18 of the manuscript and their coordinates are numerically reported in
Table 4.7. The first coordinate of each point corresponds to CV1 (angle Ψ) and the
final coordinate to CV2 (distance zMEL−DMPC).
4.2.2.3 2D Free energy landscapes
Three sets of two-dimensional (2D) well-tempered metadynamics simulations based on
the specific CVs defined above were performed to calculate free-energy surfaces of MEL
at cholesterol contents of 0%, 30%, and 50% at neutral zwitterionic DMPC membranes.
The resulting 2D free energy surfaces of MEL bound to DMPC membranes are shown
in Figs. 4.16, 4.17 and 4.18. Each state can be indexed by the two CVs. A pattern
including several regions with clear minima is present in the FEL in all cases. The
main features are the global minima of the FEL located between z ∈ [0.7, 2.5] nm and
around two distinctive values for the dihedral angle, namely those around |Ψ| ∼ [1.2, π]
rad. Such orientations are in excellent agreement with the average values of Ψ obtained
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Fig. 4.15 Time cumulative free energy profiles at the 50% cholesterol system. Bottom:
CV1, top: CV2.
from ordinary MD simulations[330] (see section 4.1.2.4 therein) and they correspond
to the two folded and extended geometries of MEL previously observed. In addition,
we observe from Figs. 4.17 and 4.18 that a membrane containing cholesterol shows the
highest free energy barrier from the interface to z ∼ 0 is of the order of 60 kJ/mol that
prevents MEL crossing membrane bilayers in a spontaneous easy way.
we should point out that the zero of each 2D plot can be arbitrarily fixed since the
physically meaningful quantities are not the absolute values of F (Ψ, z) but the free
energy differences. In the present work, the zeroes of each 2D plot have been set at the
configuration of MEL fully solvated for water, since the extracellular bulk is a common
feature of all sets, regardless of their cholesterol contents. In particular, we set the
zero free energy for values of CV2 (z positions) at ∼ 4 nm (cholesterol-free case), ∼ 5
nm (for the two cholesterol-rich cases) i.e. with MEL fully solvated by water, and the
values of CV1 corresponding to the lowest value of F, that was for Ψ = 0 in all cases.
This means that, since we did not set the zero at the absolute minimum value of F for
each 2D surface, we are reporting positive and negative values of F .
The overall range of absolute free energies reported in Figs. 4.16-4.18 is rather
wide, similar to the range reported in the work of Jämbeck and Lyubartsev[312] for
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Table 4.7 Coordinates of segments forming each path.
Minimum free energy paths
Stable states 0% cholesterol 30% cholesterol 50% cholesterol
Ψ (rad) z (nm) Ψ (rad) z (nm) Ψ (rad) z (nm)
A -3.14 0.79 -3.14 1.64 -3.10 2.17
-2.96 0.66 -2.89 1.80 -2.91 2.29
-2.64 0.77 -2.70 1.78 -2.75 2.24
-2.26 0.99 -2.37 1.64 -2.48 2.22
-1.97 0.97 -2.04 1.62 -2.25 2.08
-1.58 0.88 -1.62 1.64 -1.98 2.05
-1.32 0.73 -1.45 1.63 -1.45 1.98
B -1.17 0.88 -1.19 1.57 -1.18 2.11
-0.87 0.84 -0.81 1.66 -0.83 2.07
-0.59 0.89 -0.64 1.65 -0.49 2.12
-0.29 0.95 -0.43 1.63 -0.15 2.19
-0.09 0.97 -0.14 1.58 0.16 2.25
0.16 1.08 0.07 1.59 0.42 2.39
0.44 1.02 0.33 1.60 0.70 2.47
0.74 0.95 0.66 1.39 0.96 2.41
0.92 0.93 0.86 1.36 1.08 2.26
C 1.17 0.84 1.12 1.51 1.20 2.02
1.29 0.90 1.32 1.57 1.37 2.24
1.58 0.98 1.49 1.70 1.50 2.33
1.80 0.97 1.76 1.56 1.80 2.45
2.30 0.99 2.02 1.50 2.05 2.35
2.59 1.00 2.31 1.41 2.48 2.37
2.87 1.06 2.52 1.62 2.73 2.26
D 3.03 0.80 3.03 1.69 3.05 2.19
small-molecules (ibuprofen, aspirin, and diclofenac) around lipid bilayers, who found
free energy ranges of the order of 70 kJ/mol and barriers of around 20-40 kJ/mol. On
the other hand, we estimated from reversible work calculations (based on considering
radial distances as reaction coordinates) barriers for MEL forming or breaking hydrogen
bonds to DMPC lipids to be in between 2 and 10 kJ/mol, when MEL is located inside
the interfacial region, but free energy barriers related to orientational changes of
MEL and to global displacements of MEL to the center of the membrane or to the
extracellular bulk were not considered. Given this wide free energy range, we will focus
especially on the characterization of the free energy barriers between the particular
states of MEL at interfaces and MEL fully solvated by water, where the raw differences
are in the range of 10-25 kJ/mol.
The 2D free energy landscapes reveal that the most favorable stable states of
MEL binding to the membrane (basins A, B, C, and D) correspond to z-distances
around 0.8 nm at the cholesterol-free system, whereas such distance tends to increase
significantly around to 1.6 nm for the 30% cholesterol concentration and up to 2.2 nm
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Fig. 4.16 2D free energy landscapes F (Ψ, z) (in kJ/mol) in the cholesterol-free case.
Four stable state basins (A, B, C, and D) are indicated. TS indicates a (local) transition
state between basins A and B. The minimum free energy path is shown in dark blue,
indicating all the computed points of the path, as listed in Table 4.7. Snapshots
’A’ and ’B’ correspond to selected basins A and B on the free energy hypersurface,
respectively. In between basins A and B we can locate a transition state corresponding
to the conformational angular change of MEL between extended (basin A) and folded
(basin B) configurations. DMPC (white), sodium ions (yellow), chlorine (dark orange),
water (blue) and for MEL: carbon (cyan), nitrogen (dark blue), oxygen (red), hydrogen
(white).
when cholesterol reaches 50% of the total amount of lipids in the system. Considering
the information revealed by CV1, i.e. the torsional angle Ψ, we can distinguish two
sets of minima: (1) For |Ψ| ∼ 1.2 rad (basins B and C) and (2) for |Ψ| = π rad (basins
A, and D). These minima are related to the two preferential configurations of MEL
close to a DMPC-cholesterol bilayer (folded, extended) indicated above. According to
CV2, i.e. the distance between the center of mass of the MEL molecule and the center
of the DMPC bilayer membrane, MEL is preferentially located at the interface of the
DMPC-cholesterol bilayer (regions with 0.7 < z < 3.0 nm).
Locations of MEL outside the interface i.e. (z < 0.7 and z > 3.0 nm) show large
free energies. These regions will be considered as (1) "water-solvated" (z > 3.0 nm,
assuming that it in such regions MEL is fully solvated by the electrolyte solution
surrounding the membrane) or (2) "internal" regions of the membrane (z < 0.7 nm,
assuming that in such cases MEL is fully embedded into the body of the membrane).
In Chapter 3 of this Thesis, we observed that TRP, a molecule quite similar to MEL
(and one of its precursors) spent about 30% of unbiased MD simulation runs at the
"water-solvated" state and the remaining time adsorbed at the interface. This state
can be considered as a normal, accessible configuration of MEL. As it can be observed
in Figs. 4.16, 4.17, and 4.18 when MEL is fully solvated by water (4.2 > z > 3 nm for
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Fig. 4.17 2D free energy landscapes F (Ψ, z) (in kJ/mol) in the case of 30% cholesterol.
Minimum free energy path pictured as in Fig. 4.16. Snapshot ’TS’ corresponds to the
global TS on the free energy surface. Colors as in Fig. 4.16, with cholesterol chains
depicted in green.
Fig. 4.18 2D free energy landscapes F (Ψ, z) (in kJ/mol) in the case of 50% cholesterol.
’TS’ corresponds to the global TS on the FEL. Snapshot ’D’ corresponds to selected
basin D. Colors as in Fig. 4.17.
the cholesterol-free case, 5.7 > z > 3 nm at 30%, and 50% cholesterol) it tends to stay
in a quite high free-energy conformation, far away from the corresponding minima,
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located at the stable state basins. In this situation, MEL can change its orientational
order with a moderately low free energy cost. Something similar happens when MEL
reaches very internal regions of the membrane (z < 0.7 nm).
Since the present 2D representation includes a wide variety of low free energy states
related to conformational and structural changes, some specific numerical calculations
are in order. In particular, it is very useful to compute the so-called minimum free
energy path (MFEP), that can be determined by iteratively refine a pathway connecting
stable states that converges to the minimum free energy trajectory between them (see
References[329, 331–333]).
From MFEP we can extract information associated with the most probable trajec-
tories in the CV space followed by the system when evolving between stable states
and when eventually crossing high energy barriers that can be associated with local or
global transition states (TS) located at the free energy hypersurface. Here we assume
the canonical interpretation give by Transition State Theory of the (global) TS as a
saddle point in between two stable states located at the minimum free energy path and
having the largest energy[334, 335]. In the following list, we will report the size of free
energy barriers at two given states. These barriers can be compared to experimental
data (see for instance Ref. [333]). The main features and numerical estimations can
be summarized as follows:
1. Measuring the value of the absolute free energy directly from the 2D plots, we
can identify the approximated location of TS revealed by the MFEP:
(a) In Fig. 4.16, the local maximum labeled TS is at the pair of coordinates
(Ψ = −1.97 rad, z = 0.97 nm);
(b) The global TS in Fig. 4.17 is located at (Ψ = −0.14 rad, z = 1.60 nm) and
(c) The global TS in Fig. 4.18 corresponds to (Ψ = 0.16 rad, z = 2.42 nm).
2. We can estimate the location and values of the free energy barriers between
the significant states of "MEL at interface" and "water-solvated" (taken in all
cases at z = 4 nm) respectively for each cholesterol concentration. Let us note
coordinates as (CV1 in rad, CV2 in nm):
(a) At 0% cholesterol, MEL at interface corresponds to the coordinate (-π, 0.79)
and when water-solvated corresponds to (-π, 4.0), with a barrier is of 25.3
kJ/mol;
(b) At 30% cholesterol, the two coordinates are (-1.19, 1.64) and (-1.19, 4.0)
with a barrier of 14.1 kJ/mol;
(c) At 50% cholesterol, the two coordinates are (-π, 2.27) and (-π, 4.0) with a
barrier of 9.1 kJ/mol.
94 | Cellular absorption of small molecules: molecular dynamics and free energy
landscapes of melatonin binding at phospholipid membranes
3. Other relevant free energy barriers are located between the free energy minima
(let us take basin ’A’ as the reference) and the center of the membrane (z = 0)
in all cases, with values of the order of 40 kJ/mol (0% cholesterol) and of 50
kJ/mol (30% cholesterol and 50% cholesterol). These barriers are difficult to be
crossed spontaneously by MEL, but they are interesting in order to estimate the
amount of free energy such that MEL can permeate the membrane. As expected,
when cholesterol is present in the membrane, the barriers are considerably higher
than for the cholesterol-free case.
4. Concerning angular-related barriers, there is a relevant one between the two
angular stable states of MEL (basins A and B), i.e. folded (|Ψ| = 1.17 rad) and
extended (|Ψ| = π) conformations of 18.8 kJ/mol for the cholesterol-free case,
19.7 kJ/mol at 30%, and 17.6 kJ/mol at 50% cholesterol concentrations. This
corresponds to MEL at the interface. This conformational barrier corresponds to
surmount the local TS indicated in Fig. 4.16. The corresponding barrier when
MEL is solvated by water is of 18.3 kJ/mol.
5. Other TS can be obtained for the conformational change between angles Ψ =
−1.17 rad and Ψ = 1.17 rad (i.e. between basins B and C in Figs. 4.17 and 4.18).
The corresponding barriers are of 22.0 kJ/mol (30% cholesterol) and 28.3 kJ/mol
(50% cholesterol). These can be considered the absolute TS of the system since
they show the maximum free energy along the reaction coordinate, indicated by
the MFEP. The equivalent global TS of Fig. 4.16 (0% cholesterol), has a barrier
of 26.5 kJ/mol. In all cases, MEL crossing of a TS can be carried out through an
intermediate configuration of MEL with Ψ = 0, as represented in the snapshot
reported in Fig. 4.17. When MEL is solvated by water, the corresponding barrier
is of about 21 kJ/mol for each case.
The visible shifts to larger distances z of basins A, B, C, and D shown in Figs. 4.16-
4.18 clearly reveal that the binding competitiveness of lipid head groups has been
diminished by cholesterol contents and that the affinity of MEL to DMPC membranes
becomes less favorable as cholesterol concentration increases, which is in agreement with
previous experiments and simulations on MEL and cholesterol at variable concentrations
close to DOPC and DPPC membranes[96, 97], where it was observed that cholesterol
helps a membrane to increase its thickness, reduce its area per lipid, whereas MEL
operates in the reverse way and tends to decrease the thickness of the membrane and
increase its area per lipid.
In order to show characteristic molecular configurations of MEL when located at
the interface of the membrane, two characteristic snapshots at 0% and 30% cholesterol
concentrations are reported in Fig. 4.19. We have included in the figure only MEL
and its closest solvating lipids, namely two DMPC at 0% and one DMPC plus one
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cholesterol at 30%. Both configurations correspond to the dihedral angle Ψ = π and to
z distances of 0.8 (0%) and 1.6 nm (30%). With the aid of these snapshots we can see
that MEL is able to be simultaneously bound to both DMPC and cholesterol chains
through HBs. The binding sites were determined to be oxygens ’O6’ of DMPC and
the oxygen from the hydroxyl group of cholesterol and hydrogens ’H15’ and ’H16’ of
MEL (see Reference[330] for further details).
Fig. 4.19 Snapshots of representative bound states for MEL at the interface of the
membrane. Colors of MEL as in Fig. 4.6. Colors for DMPC/cholesterol: carbon (cyan),
nitrogen (dark blue), oxygen (red), hydrogen (white). Hydrogen bonds indicated as
green solid lines. Left: case of 0% cholesterol concentration, with MEL bound to two
DMPC molecules; Right: case of 30% cholesterol concentration, with MEL bound to
one DMPC plus one cholesterol molecule.
According to point (1) of the list above, the energetic cost for MEL to move from
the interface to the water-solvated region diminishes when cholesterol concentration
increases. This means that cholesterol favors MEL to move outside the membrane and
eventually to stay in the outer regions of the interface. To understand these changes, we
should remember the well-known condensing effect of cholesterol on lipid bilayers, which
produces higher membrane rigidity and ordering[336]. Interestingly, such transition in
the binding behavior of MEL at cholesterol ≈ 30% might be correlated with the phase
transition point of DMPC-cholesterol membranes, in which membranes change from a
liquid-disordered phase to a liquid-ordered phase[291, 337]. Concerning the angular
configurations, our results indicate that changing from extended to folded forms does
not require to surmount a high energy barrier, but one of about 19 kJ/mol when MEL
is located at the interface of the membrane. Gibbs free energy barriers of about 15
kJ/mol have been also obtained in simulations of the translocation of ethanol across a
lipid bilayer membrane[338].
96 | Cellular absorption of small molecules: molecular dynamics and free energy
landscapes of melatonin binding at phospholipid membranes
4.2.2.4 1D Free energy profiles
As an alternative to the 2D FEL and MFEP reported above, we considered the
calculation of 1D free energy profiles as a function of only one of the two CV. This will
allow us to directly compute free energy differences for meaningful MEL conformations,
especially for MEL at the interface and at the center of the membrane. In Figs. 4.20
and 4.21 we represent the dependence of the integrated binding free energy F (s1) on
one CV for membranes with three cholesterol concentrations after integrating out the
second CV according to Refs. [312, 339]:
F (s1) = −kBT ln
[ ∫
e−β F (s1,s2) ds2∫
e−β F (s1,s2) ds1ds2
]
, (4.1)
where s1 and s2 are the CVs, β = 1/(kBT ), kB is the Boltzmann constant and T is
the temperature. This means that all possible paths for the CV labeled as s2 have
been averaged. F (s1) reveals additional information about the most stable states only
as a function of one CV. This also allows us to compare the relative stability of MEL
at setups with different cholesterol contents separately as a function of z or Ψ. These
barriers can be also directly compared to experimental findings[312].
In Fig. 4.20, we set the zero of each free energy at the extracellular bulk (z = 4 nm
at 0% cholesterol and at z = 5 nm at 30% and 50%), as we did in the 2D free energy
surfaces. Since in Fig. 4.21 the spatial dependence has been integrated out, we have
fixed the zero to the minimum free energy in each case.
In agreement with the preliminary findings reported in the previous section, the
observed behavior is that the position of stables states of MEL depends on the contents
of cholesterol in the membrane: minima of F (z) are located at z = 0.8 nm for 0%
cholesterol, at z = 1.6 nm for 30% cholesterol, and at z = 2.2 nm for 50% cholesterol.
From plots in Figs. 4.20 and 4.21 we can obtain meaningful free energy barriers, i.e.
free energy differences related to particular processes. We can highlight the following:
1. MEL needs about 25.5 kJ/mol to move from inside the interface of the membrane
to the water-solvent regions at 0% cholesterol concentration, whereas it requires
14.3 kJ/mol at 30% cholesterol and 16.7 kJ/mol at 50% cholesterol (Fig. 4.20).
The net effect of cholesterol is to reduce the energetic cost of MEL moving across
the membrane from the interface to the aqueous solvent.
2. The barrier that needs to be surmounted for MEL to move from the interface
to the center of the membrane is significantly high, between 40 (0%) and 50
kJ/mol (30% and 50%) (see Fig. 4.20). Even though these large numbers can be
a drawback of the method employed here, it is very clear that in the process of
crossing the membrane from one leaflet to the other, cholesterol enhances the
free energy cost. We expect that increasing temperature[338] or pressure[92] it
would be possible to observe the crossing of such barriers by MEL.
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Fig. 4.21 Integrated free energy F(Ψ) for 0%, 30% and 50% cholesterol.
3. Further, in order to reach a folded configuration (|Ψ| = 1.17 rad) from the
extended configuration (|Ψ| = π rad) (Fig. 4.21), MEL has to surmount barriers
of 18.4 (0%), 15.7 (30%), and 17.3 kJ/mol (50%). This means that for MEL it is
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quite easy to adjust its molecular geometry in order to exchange its configuration
between two orientational stable states. We should add that in standard molecular
dynamics[330], it is easy to observe that MEL can change its configuration varying
the dihedral angle Ψ and that it can move from interfaces of the DMPC-cholesterol
membrane bilayer to the water-solvated region and vice-versa.
4. Finally, the access to the conformational structure with Ψ = 0 demands to
surmount a barrier of about 25 kJ/mol from a folded configuration. We should
point out that this is essentially the cost of crossing a global TS because in such
a case the coordinate z changes very little (see point (5) of the list reported in
section 4.2.2.3).
In processes such as interactions of MEL with free radicals[340], it has been
estimated from DFT methods that Gibbs free energy changes from vacuum to aqueous
solution were in between 33 and 670 kJ/mol. For the mechanism of MEL nitrosation
(reaction of MEL with nitric oxide)[341] the Hartree-Fock estimated free energies were
of 50-59 kJ/mol in vacuo. Further, the Gibbs free energy of MEL binding to the
protein calmodulin has been estimated to be around 36 kJ/mol, 3-fold larger than
the experimental value[342]. These findings indicate the difficulty of obtaining precise
values of free energy barriers. Thus, these numerical estimations report values for
different binding processes of a similar order of magnitude to the results presented in
this work. From the experimental side, Florio et al.[343] used a variety of techniques
such as a combination of two-color resonant two-photon ionization, laser-induced
fluorescence excitation, resonant ion-dip infrared spectroscopy, fluorescence-dip infrared
spectroscopy, and UV-UV hole-burning spectroscopy, to explore the conformational
preferences of an isolated MEL molecule under molecular beams. In such a system,
these authors found MEL three trans and two cis conformers showing a free energy
gap of about 12.5 kJ/mol, quite close to the values obtained in the present work
for the conformational angular changes (folded to extended and vice-versa). Finally,
Florio and Zwier[320], analyzed the solvation of MEL by water clusters using infrared
and ultraviolet spectroscopy and found barriers of about 63 kJ/mol for the cis/trans
isomerization process. All these findings indicate the difficulty of obtaining precise
values of free energy barriers in general and for processes where MEL is involved,
in particular. Thus, some of these numerical estimations report values for different
binding and conformational processes of the order of magnitude similar to the results
presented in this Chapter.
4.3 Conclusions
In this Chapter, results of all-atom molecular dynamics simulations of a bilayer
membrane made up with the zwitterionic phospholipid DMPC at three cholesterol
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concentrations (0%, 30%, and 50%) including a single MEL molecule, all in aqueous
NaCl ionic solution at 303 K and at the fixed pressure of 1 atm have been reported.
In the first part, our main interest was focused on the local structure and angular
distributions of MEL, especially when associated with DMPC and cholesterol molecules.
After this, the Gibbs free energy differences of MEL binding onto different membrane
bilayer interfaces have been evaluated through the potentials of mean force. As a
general fact, MEL is able to establish HBs with water, cholesterol, and DMPC lipids.
Typical HB through different sites between MEL-DMPC and MEL-cholesterol have
been observed.
Two relevant MEL structures have been observed from angular distributions:
"folded" and "extended" configurations. We defined three different dihedral angles to
account for the two preferential angular configurations. Dihedral Ψ defined in Fig. 4.6
has revealed to be a meaningful order parameter (i.e. may act as a reliable reaction
coordinate) to describe the dynamics of MEL, with preferential angles of ∼ 1.42 rad
and ∼ 2.96 rad. We suggest that introducing cholesterol into the system could help
MEL change from its folded configuration to the extended configuration more easily,
using HBs between MEL-DMPC and MEL-cholesterol. The self-diffusion coefficient of
MEL was found to be of the order of 10−7 cm2/s and the presence of cholesterol in
the system has little influence on it. The spectral densities of MEL computed in this
work are in overall good agreement with experimental Raman and infrared data and
have revealed the degree of participation of each atomic site of MEL to complete its
whole molecular spectrum giving some clues to understand the microscopic origin of
molecular vibrations and also giving evidence of the good reliability of the model we
adopted in the present work.
Nevertheless, in the time span of 200 ns of auxiliary MD simulations, we did not
record any spontaneous crossing of MEL through the DMPC membrane. Given the open
debate on the mechanisms of MEL permeation through cells (see References[93, 94]),
our results appear to be in qualitative disagreement with the reported experimental
permeability of MEL across the pineal gland plasma membrane[92], of the order of 1.7
µm/s. We believe that the disagreement is essentially due to the pressure difference
between both sides of the plasma membrane applied in the experiments by Yu et
al.[92] and that we did not consider in the present work where, as indicated in SI,
we performed our simulations at the NPT ensemble considering a constant pressure
of 1 atm at the two sides of the membrane and for the whole system. In addition,
the experimental setups consider real plasma membranes containing a large variety of
species such as large trans-membrane proteins that we have not considered here, and
that may favor the crossing of the membrane by MEL. Finally, in the recent work of
Wang et al.[338] small solutes such as glycerol, caffeine, iso-propanol, or ethosuximide
were simulated nearby a model cell membrane. These authors found that, in order
to observe trans-membrane crossings of such small solutes in the time length of a
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simulation at the atomic level of description, they needed to run trajectories of 10 µs
at low temperatures (310 to 330 K) or, alternatively, raise the temperatures to more
than 400 K (for simulation times of 1 µs).
To the best of our knowledge, we conducted the first quantitative characterization
to date of the binding states of MEL at model DMPC-cholesterol phospholipid cell
membranes through the calculation of free energy landscapes. With the help of the
well-tempered metadynamics simulations we have calculated 2D free energy landscapes
and located the binding stable states and several (local and global) transition states of
the system. Zero of all free energies were set at the extracellular bulk, i.e. for MEL
fully solvated by water and the ionic solution. Two CVs have been considered: dihedral
angle Ψ and the distance zMEL−DMPC between the center of mass of MEL and of the
center of the lipid bilayer (given by z = 0). Our results indicate that MEL can be
bound to the internal side of the membrane, at distances z ∼ 1− 2 nm, and in several
stable state configurations where the dihedral |Ψ| = 1.17 rad and |Ψ| = π rad. From
the calculation of the minimum free energy paths, we have observed that the most
probable trajectory of MEL is along with the interface of the membrane, changing its
conformation between extended and folded configurations by means of surmounting
free energy barriers of about 15-20 kJ/mol. In addition, the methodology employed in
the present work allowed us to locate several global and local TS of the system and to
estimate the values of their free energy barriers.
When cholesterol is added to the system, it helps pull MEL escape from the
interface of the membrane to being solvated by water/sodium chloride molecules
more easily by decreasing its corresponding free energy barriers. The effect is more
marked as the concentration of cholesterol rises. The energetic cost for MEL to leave
the interface of the membrane and to be fully solvated by water/sodium chloride
molecules (z-distances around 4 nm), has been estimated to be of between 10 and
25 kJ/mol. The less common situation was found to be with MEL accessing regions
around the center of the membrane, process requiring to cross free energy barriers
above 40 kJ/mol. We believe that the findings presented in this Chapter could be of
practical use in designing new reaction coordinates (such as for instance coordination
numbers of MEL) for multidimensional, more accurate free energy calculations able
to explore a wide variety of relevant small solute species of biochemical interest such
as amino acids, neurotransmitters, drugs or hormones. The same methodology can
be applied to systems of larger size such as big peptides or proteins: for instance, a
detailed study of the absorption and binding of the oncogenic protein KRas-4B in
DOPC/DOPS/cholesterol membranes is currently under investigation in our laboratory.
Detailed results will be reported in the next Chapter.
Chapter 5
Structural and energetic aspects
on the anchoring of wild-type
and oncogenic KRas-4B proteins
at model cell membranes
As I described in section 1.3 of this Thesis, Ras is a family of related proteins which
is expressed in all animal cell lineages and organs. They play an essential role in
signal transduction pathways which ultimately turn on genes involved in cell growth,
differentiation, and survival so that overactive Ras signaling can lead to cancer[344].
As a surface protein anchored in the inner leaflet of the cell membrane, Ras proteins
are normally in the inactive state. They are activated following an incoming signal
from their upstream regulators. Among Ras proteins, KRas-4B has been found being
expressed at higher levels in lung, colorectal, and pancreatic cancer cells[112, 120, 345].
These insights suggest the importance of fully understanding the regulation of the
oncogenic KRas-4B activity when binding to the membrane.
Accumulating evidence indicates that demethylated and farnesylated KRas-4B-Far
could play an important role in the signaling pathway that happens on the inner
leaflet of the membrane bilayers. KRas-4B-Far has been reported to be able to be
transferred to bind the inner PM leaflet[146, 346, 347]. While there is a relatively
high abundance of KRas-4B-Far (wild-type and oncogenic) in tumors, the effects
on downstream signaling have yet to be determined[110]. While most efforts have
been focused on the characterization of the methylated KRas-4B-FMe binding to the
PM[117, 142, 146, 158, 348, 349], the study on the KRas-4B-Far is an emerging area
of research. According to Barcelo at el.[142], phosphorylation at Ser-181 of oncogenic
KRas is required for tumor growth. Three sequences of the KRas-4B proteins are
listed in Fig. 5.1, in which in the present Thesis we applied mutation G12D at Gly-12
and phosphorylation at Ser-181 (PHOS) for oncogenic ones.
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Sequence of wt. KRAS4B-Far:
Sequence of onc. KRAS4B-Far:
Sequence of onc. KRAS4B-FMe:
Fig. 5.1 Three sequences of different KRas-4B structures. Mutated sites are in red
color. Here Cf denotes the farnesylated Cys-185 and Sp represents the phosphorylated
Ser-181 (see Fig. 5.3). Methyl group of KRas-4B-FMe is in blue color.
Our work in this Chapter shall provide essential information in gaining a precise
understanding of the effects of oncogenic mutations on the effects of localization of
oncogenic mutations in KRas-4B proteins. Understanding the structural specifics of
KRas-4B in its GTP-bound form will help to design the oncogenic KRas-4B inhibitors.
Finding a method of stabilizing the interactions between KRas-4B and the membrane
with a good knowledge of the structural mechanisms at the atomic level might be a
promising target for anticancer drug discovery. Also, the GTP affinity of KRas-4B
is reported to be extremely high, with a dissociation constant (Kd) at around 10−11
mol/L[350], yet the corresponding binding free energy has been poorly explored. On its
own, genomic sequence data may not provide the entire information to the oncologist
in the targets selection. The idea of calculation of free energy landscapes is compelling
and this enables us to map many possible conformations in which the protein could
populate at the interface of the cell membrane. The treatment recommendations might
derive from the FEL calculation. Insight into the underlying biological mechanisms of
protein-membrane binding could foster molecular targeting in a significant way[152].
Ras association with membranes is not a one-way street and they undergo a cycle
of delivery to the PM followed by returning to endomembranes for recycling[351]. In
this Chapter we have applied well-tempered metadynamics to reveal GTP’s affinity to
KRas-4B and lipids and FAR’s binding free energy barriers of anchoring to/departure
from the membrane bilayers from a free energy perspective, especially for membranes
with the high cholesterol content. The calculations reported here offer very detailed
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FELs of FAR and GTP of different KRas-4B sequences, hoping to provide novel and
useful insights for this field.
5.1 Methods
We conducted MD simulations of model cell membranes constituted by DOPC (56%),
DOPS (14%), and cholesterol (30%) for three systems including a KRas-4B protein (see
below). Each system contains a total of 304 lipid molecules and one protein in aqueous
solution, yielding a system size of 222,000 atoms. All MD inputs were generated using
the CHARMM-GUI membrane builder and CHARMM36m force field. The crystal
structures of KRas-4B with a partially disordered hypervariable region (pdb 5TB5)
and GTP (pdb 5VQ2) were used to generate full-length KRas-4B proteins. Both pdb
files were downloaded from RCSB PDB Protein Data Bank[352]. Three sets of the
full-length KRas-4B proteins (oncogenic KRas-4B-FMe and KRas-4B-Far, wild-type
KRas-4B-Far) and a GTP molecule were solvated in a water box, with runs of 20 ns
that generated fully equilibrated setups. KRas-4B was set anchoring to the membrane
at the beginning of simulation in each system. Systems were solvated and KCl added
to a final concentration of 0.15 M which serves as the intracellular liquid, and final
systems contained about 60,000 H2O. The TIP3P model was used for water molecules.
All systems were energy minimized for 5000 steps followed by three 125 ps simulations
and then four other 500 ps equilibrium runs while gradually reducing the harmonic
constraints on the systems. Production runs were performed with an NPT ensemble
for 1 µs. The pressure and temperature were set as 1 atm and 310.15 K, respectively,
well above the corresponding Tm for DOPC and DOPS lipids, in order to ensure that
we were simulating the liquid crystalline state using the GROMACS/2018.3 software
package. Time steps of 2 fs were used in all production simulations and the particle
mesh Ewald method with a Coulomb radius of 1.2 nm was employed to compute the
long-ranged electrostatic interactions. The cutoff for Lennard-Jones interactions was
set to 1.2 nm. The pressure was controlled by a Parrinello-Rahman piston with a
damping coefficient of 5 ps−1 and the temperature was controlled by a Nosé-Hoover
thermostat with a damping coefficient of 1 ps−1. Periodic boundary conditions in
three directions of space have been taken.
After equilibrating well the system in two cases of wild-type/oncogenic KRas-4B-
Far from the production runs of 1 µs for each system, we switched to run another 1 µs
well-tempered metadynamics simulations to perform Gibbs free energy calculations
of the KRas-4B binding at anionic phospholipid membrane bilayers from the last
configuration of MD simulations. Well-tempered metadynamics simulations were
performed using the PLUMED2 within the joint GROMACS/2018.3-plumed tool. The
NPT ensemble of the temperature of 310.15 K and the pressure of 1 atm was adopted
in all cases. Periodic boundary conditions in the three directions of space have been
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considered. Two CVs were considered to describe the conformational changes along
with free energy paths. CV1 is the distance "gtp" between the center of mass of GTP
and the center of mass of the membrane, and CV2 is the distance "far" between the
farnesyl group of Cys-185 and the center of mass of the membrane along with the
direction normal to the membrane center as depicted in Fig. 5.2. And "wt." and
"onc." represent the "wild-type" and "oncogenic", respectively in all Figures and Tables
reported throughout this Chapter.
CV2 CV1
Z
YX
Fig. 5.2 Graphical expressions of two CVs. the CD of KRas-4B (cyan), the HVR
(green), GTP (red) and FAR (purple) are shown here.
Parameters of well-tempered metadynamics simulations are are listed in Table 5.1.
Table 5.1 Metadynamics simulation parameters.
System onc. KRas-4B-Far wt. KRas-4B-Far
Gaussian width of CV1 [nm] 0.10 0.10
Gaussian width of CV2 [nm] 0.35 0.35
Starting (Gaussian) hill [kJ/mol] 2.0 1.2
Deposition stride [ps] 1 1
Bias factor 10 5
Simulation time [ns] 1000 1000
5.2 Results and discussion | 105
5.2 Results and discussion
5.2.1 Molecular dynamics of the KRas-4B binding at anionic mem-
branes
5.2.1.1 Physical characteristics of the membrane in two systems
In order to explore the structural characteristics of the anchoring of the KRas-4B
proteins at anionic membranes, several physical properties of the membrane have been
calculated. Selected sketches of the structures of DOPC, DOPS, cholesterol, GTP, et
al. are represented in Fig. 5.3.
FARFAR
Fig. 5.3 Sketches of the backbone structures of cholesterol, GTP, DOPC, DOPS, and
Cys-185 sites are shown here. Parts of Hydrogen-Carbon bonds aren’t shown. The
highlighted and renamed sites in red color will be referred to in the text.
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A deuterium order parameter SCD was defined for each CH2 and CH groups of the
DOPC lipid tails as Eq. 3.6 and averaged results are shown in Fig. 5.4 for both tail
chains of all DOPC lipids in all KRas-4B systems studied in this Thesis. The order
parameters of the first half of the chain of DOPC are directly related to the area per
lipid, whereas the whole chain is directly related to its length, i.e. to the thickness of
the membrane bilayers. By comparing with SCD results of pure DOPC bilayers, the
tendency has a great agreement with results provided in Refs.[353, 354] in all cases.
Given the addition of 30% cholesterol in all systems studied in this Chapter, at 1 atm
and 310.15 K the liquid phase was safely reached in all cases, since the transition
temperature of DOPC Tm = 253.15 K and for DOPS Tm = 262.15 K[41].
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Fig. 5.4 Averaged SCD for sn-1, sn-2 chains of DOPC in all systems.
Area per lipid is often used as the key parameter when assessing the validity of
MD simulations. It has been proposed that a good test for such validation is the
comparison of the area per lipid and thickness of the membrane with experimental
data obtained from scattering density profiles[355]. For continuous MD production
runs the area per lipid, defined in Eq. 3.7, as a function of simulation time, has been
reported in Fig. 5.5 and their averaged values together with the related thickness and
the averaged values are reported in Table 5.2.
Table 5.2 Area per lipid A and thickness ∆z of the anionic membrane for all the
KRas-4B systems studied in this Chapter. Estimated errors in parenthesis.
Systems A (nm2) ∆z (nm)
wt. KRas-4B-Far 0.523 (0.007) 4.35 (0.05)
onc. KRas-4B-Far 0.525 (0.006) 4.23 (0.04)
onc. KRas-4B-FMe 0.524 (0.006) 4.34 (0.05)
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Fig. 5.5 Area per lipid of systems with different KRas-4B sequences as a function of
simulation time. The blue dashed line indicates the average value for each system of
the second half of the total 1000 ns production runs.
Obviously, different sequences of KRas-4B do not have much influence on the area
per lipid of the membrane. X-ray results obtained for the DOPC lipid[356] suggested
that temperature has a pronounced effect on the lipid area. As temperature increases,
the fluorine atom oscillates more perpendicularly to its bonds. So increasing the
temperature of the system leads to an increased area per lipid of certain phosphatidyl-
choline lipids as it was observed for temperatures below 420 K[357]. In Chapter 4 we
have observed that adding cholesterol to the membrane could decrease its area per
lipid and increase its thickness, which we call the condensing effect. Upon the addition
of cholesterol, the area per lipid decreases more than one would expect from ideal
mixing[22]. According to an earlier research[358], in the case of relative high cholesterol
concentration, 10 ∼ 20% smaller area per lipid will be considered to be reasonable and
close to equilibrium ones. From our work reported in section 4.1.2.1, compared to pure
DMPC bilayer, the area per lipid of DMPC with cholesterol (30%) has been decreased
by 32% from 0.62 to 0.42 nm2, see Table 4.1. In the regime (≤ 30%), the area per lipid
has been reported to decrease sharply as cholesterol is added into the system[46]. As
obtained from the analysis of X-ray scattering in the low angle and wide-angle regions
at 303 K, the area per lipid of the membrane composed of DOPC:cholesterol (7:3) was
reported by Nagle et al.[359] with a value of 0.544 nm2 which is close to the value we
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are reporting here for all systems. The DOPS bilayer was found to be thicker than the
DOPC bilayer with a correspondingly smaller cross-sectional area which gives a smaller
value of area per lipid and DOPS is suggested to have a condensing effect on DOPC
bilayers as well[358]. We obtained a value of 0.52 nm2 which is 26.7% less than the
experimental value of 0.71 nm2 for area per lipid of DOPC/DOPS (4:1) at 297 K[40]
and is consistent with the experimental analysis by Nagle et al. The reason shall be the
contribution of the joint effect of raising the system temperature and condensing effect
by the addition of cholesterol and DOPS molecules. Adding cholesterol to the bilayer
has much more influence on the area per lipid than raising the system temperature
and the substitution of DOPS.
The thickness of the membrane may provide additional clues about its mechanical
properties, such as rigidity and capability of allowing the anchoring/release of FAR from
the membrane. Together with locations of FAR and GTP along with the membrane
normal, a better understanding of how deep FAR and GTP insert into the anionic
membrane could be achieved. We have obtained the thickness of the membrane ∆z by
computing the mean distance between phosphorus atoms of the DOPC head groups
from both leaflets. From Table 5.2 we could see that ∆z of the oncogenic KRas-4B-Far
system has decreased slightly. Since we suppose that interactions between the mutated
KRas-4B-Far and lipid head groups might play a role in the decreasing of thickness, a
detailed explanation will be provided in the next section. Reported by E.Novakova[360],
for DOPC/DOPS (4:1) bilayers at 303 K the experimental value of thickness is of
∆z = 3.94 nm. The results make much sense when compared with the experimental
values confirming cholesterol’s condensation effect on DOPC/DOPS membrane bilayers.
Additional data on the thickness of DOPC:cholesterol (7:3) bilayers reported by Nagle
et al.[359] of 3.99 nm appears to be larger than the value we report here. We believe
that this is due to the condensing effect produced by the presence of DOPS[358].
The results of the area per lipid and thickness of membrane bilayers we have
investigated are in good agreement with experimental values. Hence, the validity of MD
simulations reported here has been established, regarding the structural characteristics
of the membrane.
5.2.1.2 Radial distribution functions of certain atomic species
As described in section 3.2.2.2, normalized radial distribution functions (RDF) g12(r)
for two different species ’1’ and ’2’ have been investigated. We have considered several
relevant RDFs between highlighted sites of molecules (see Fig. 5.3) and involved sites
of the CD and the HVR together with the corresponding molecular structure of amino
acids of KRas-4B (see Fig. 5.6 and Fig. 5.7).
The selected g(r)s are reported in Fig. 5.8-Fig. 5.11.
In three panels of Fig. 5.8, HBs between GTP and active sites of specific amino acids
of the CD have been observed. The clear first coordination shell which located around
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Fig. 5.6 Two mutated sites in structures of the oncogenic KRas-4B-Far/KRas-4B-FMe
and the active amino acids of KRas-4B with their side chains framed. All highlighted
and colored in red sites will be inferred in the following text.
1.75 Å shall be essentially attributed to HBs between selected atom sites indicated
in the Fig. 5.3, Fig. 5.6 and Fig. 5.7. The typical signature of oxygen-hydrogen HB
is 1.8 Å[100]. For the oncogenic KRas-4B systems, GTP tends to bind its the CD
through HBs and no HBs between GTP and lipids have been observed. We could see
that GTP prefers binding to the CD of the oncogenic KRas-4B proteins regardless of
carboxymethylation at site Cys-185 before anchoring to the inner membrane leaflet. In
particular, for the wild-type KRas-4B-Far, HBs between GTP and the CD are much
stronger (∼ 15-fold) than HB between GTP and lipids. By analyzing Fig. 5.8, we
could propose that in oncogenic systems, GTP preferentially binds with the CD of
KRas and locates away from lipid bilayers. However, in the wild-type system, GTP
may prefer to locate at the interface but much closer to the CD. Especially strong
interactions between GTP and the CD of the KRas-4B-FMe indicate less efficient
nucleotide exchange for this mutant (see panel "C").
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Fig. 5.7 Selected active sites of the CD (cyan) and the HVR (green) of the KRas-4B
structure are depicted in red color. Thereinto, HArg−CD donates the cationic hydrogen
atoms from the guanidinium (RNHC(NH2)+2 ) of arginine of the CD that share the
same atom type, HLys−CD and HHV R represent the cationic ammonium (RNH3+) from
lysine of the CD and of the HVR. OGlu−CD and OAsp−CD represent oxygen atoms of
the anionic carboxylate (RCOO−) of glutamate amino acid of the CD and Aspartate
amino acid of the CD, respectively. OHV R represents all oxygen atoms of the anionic
carboxylate (RCOO−) of the HVR. OGln−CD and OGln−CD donate active oxygen and
hydrogen atoms of the side chain of glutamine amino acid of the CD. Moreover, Ophos
and Hphos donate two active oxygen atoms and one hydrogen atom of the phosphate
group from PHOS. All highlighted and colored in red sites will be inferred in the
following text.
To further analyze the effect of the side chain of the CD, calculations were performed
and reported in Fig. 5.9. We have revealed that the CD is able to associate head groups
of lipids at the atomic level which proves that the CD of KRas-4B plays a role in binding
to bilayers for all cases. In the g(r)s, when the two selected oxygen and hydrogen
sites are ionized, the location of the first shell usually is smaller than 1.8 Å, here we
call the contribution of the first shell is from the so-called salt − bridge[361, 362] and
the coupling of salt-bridges was reported to be of general importance to the stability
and function of proteins. A salt-bridge has two components: a hydrogen bond and an
electrostatic interaction and of all the non-covalent interactions, salt-bridges are among
the strongest. Here we report that the first shell of g(r) of salt-bridges between OCD
and Hdops locates at 1.65 Å for three systems. Also in panel "C", we could obtain that
HB between the cationic ammonium (RNH3+) from lysine of the CD of KRas-4B-FMe
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Fig. 5.8 Selected RDFs for active atoms of GTP with selected sites of the CD and active
oxygen atoms of head groups of lipids (’O2L’). ’Hgtp’ and ’Ogtp’ represent hydrogen
and oxygen atoms from phosphorus group of GTP.
and anionic oxygen atoms from DOPS is much stronger than demethylated KRas-4B
isoforms.
Consecutively, RDFs related to the HVR have been displayed (Fig. 5.10). There
we can see that the HVR is able to form stable HBs/salt-bridges with the CD, lipids,
and PHOS. Obviously, carboxymethylation and mutations show their influence on the
interactions of the HVR, DOPS, and PHOS as it can be observed in panels "D" and
"F". With the first shell located at 1.65 Å, salt-bridge between OHV R and Hdops is
much weaker for the oncogenic KRas-4B-FMe comparing with the demethylated ones.
After phosphorylation (as shown in Fig. 5.6), for the oncogenic KRas-4B proteins
Ophos could form stable salt-bridges with hydrogen atoms of cationic ammonium from
the HVR (HHV R). For the wild-type KRas-4B-Far, only weak HB exits between HHV R
and oxygen atom from the side chain of site Ser-181. Different preferential interactions
between the HVR and lipids and the CD could play a role in the different behaviors
of three types of KRas-4B and its conformational shifting. As pointed out in Refs.
[363, 364], we observed that the CD and the HVR also participate in PM binding but
engaging differently during the process.
From Fig. 5.3 we can expect that in oncogenic system FAR will form strong
and long-lasting salt-bridges with PHOS through negatively charged Ofar of FAR
interacting strongly with the positively charged Hdops of DOPS.
We have also investigated meaningful RDFs of active sites of FAR with PHOS, CD,
and lipid molecules (see Fig. 5.11).
For the mutated KRas-4B-FMe, typical HB is observed between the carbonyl
oxygen of the ester group of Cys-181 (Ofme) and positive hydrogen of the hydroxyl
group of Tyr from the CD (HTyr−CD). FAR can interact with cholesterol through
typical HB and DOPS through strong salt-bridge for the wild-type KRas-4B-Far which
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Fig. 5.9 Selected RDFs for selected sites of the CD with head groups of lipids. In all
panels of this figure, as indicated in panel "A", we use three colors to represent three
systems in order to avoid the duplication and repetition, same as Fig. 5.10. Thereinto,
HCD from panel "A" refers to the averaged value of HArg−CD and HLys−CD.
guarantees that the wild-type KRas-4B-Far can anchor into anionic membrane bilayers
easily during its GTP-bound state. For the oncogenic KRas-4B-Far, long-lasting
salt-bridge has been observed between positively charged Ofar and negatively charged
Hdops and typical HBs are found between oxygen and hydrogen atoms from FAR and
PHOS, indicating that KRas-4B-Far possess the stronger ability to pull the negatively
charged POPS lipids together, leading to the clustering of the POPS lipids around
itself than other two proteins[349]. In order to monitor the interactions between FAR
and PHOS for the oncogenic KRas-4B-Far system, we display the time evolution of
selected atom-atom distances in Fig. 5.12 regarding the strong salt-bridge observed in
Fig. 5.11, panel "D".
From Fig. 5.12 we can verify that long-lasting and strong salt-bridges do exist
between active sites between FAR and PHOS for the oncogenic KRas-4B-Far protein.
O1Pphos and O2Pphos could shift to form salt-bridge with Hfar, but only one of them
could interact with Hfar hauling the typical HB distance, with one of them favored
by Hfar because of the conformational restrictions in the structure even though both
of them share one negative charge. After analyzing production trajectories carefully,
we have found that Ofar, Hphos, Hfar, O1Pphos/O2Pphos and other relevant atoms
could form a very stable 7-membered ring (see Fig. 5.13) which endows the oncogenic
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Fig. 5.10 Selected RDFs for selected sites of the HVR with atoms of lipids and the
CD. Here Opt−CD and Hpt−HV R represent oxygen and hydrogen atoms of the peptide
bonds from the CD and the HVR. And OCD stands for oxygen atoms of OGlu−CD and
OAsp−CD from the CD.
KRas-4B-Far a specific structure in its tail which may play a role in its other activities,
such as, anchoring membranes or reacting with other proteins in vivo. This stable
7-membered ring in the structure of the mutated KRas-4B-Far also involves a 4-
amino-acid-long sequence in the HVR (Sp-K-T-K) and the farnesylated Cysteine at
the site-185 (Cys-185), thereinto, Sp of the 4-amino-acid-long sequence stands for the
phosphorylated Ser-181. Our observation agrees with the hypothesis conjectured by
S.Dharmaiah[145] that the 5-amino-acid-long sequence motif in the HVR of wild-type
KRAS4B-FMe (K-S-K-T-K) may enable PDEδ to bind the prenylated KRas-4B-FMe
(see section 1.3). So is this special structure of the 7-membered ring responsible for the
different interactions of wild-type KRas-Far and KRas-FMe with PDEδ reported in
Ref. [145]? An investigation of the interactions within the 5-amino-acid-long sequence
motif (K-S-K-T-K) of the wild-type KRAS4B-FMe should be conducted, which is
beyond the scope of this Thesis.
5.2.1.3 Preferential localization of KRas-4B on membranes
Along with the simulation time, tracking the movement of different domains of KRas-4B
and GTP along with the membrane normal could give us the direct information of
how does the KRas-4B proteins and GTP molecule regulate. We report in Fig. 5.14
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Fig. 5.11 Selected RDFs related to selected sites of FAR.
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Fig. 5.6). And the corresponding snapshot is shown in Fig. 5.13.
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PHOS
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Fig. 5.13 Snapshot of long-lasting salt-bridges indicated as black lines of dashes between
FAR and PHOS. The atoms forming the FAR and PHOS moiety are: carbon (cyan),
oxygen (red), hydrogen (white), nitrogen (blue) and phosphorus (brown).
the Z-axis positions of the centers of FAR and GTP from the center of lipids (i.e. z =
0) using the second half of 1000 ns simulation for all cases.
After a thorough inspection of Fig. 5.14 and Fig. 5.15 a list of remarkable
observations are as follows:
1. In all cases the inner leaflet with KRas-4B binding to the membrane tends to be
slightly thicker and tails hold 0.2 nm more stretched-out than the other leaflet.
2. When the wild-type KRas-4B-Far is in its configuration 1 (see Fig. 5.15), the
HVR and FAR tend to wander around 3.90 nm in parallel along with the XY
plane at the interface of the membrane, whereas in configuration 2 the HVR
locates roughly 0.5 nm closer to the membrane center while FAR anchoring to the
membrane, located around z = 1.73 nm. GTP buries itself in the interface located
around z = 2.39 nm whereas the CD is mainly placed above the membrane XY
plane at z = 4.48 nm.
3. For the oncogenic KRas-4B-Far, FAR is revealed to be anchoring constantly into
the anionic membrane as a function of the simulation time locating around 1.37
nm with the HVR locating around 3.56 nm away from the membrane center
along with the membrane normal direction. GTP keeps binding with the CD and
stays around 5.16 nm from the membrane center while the CD diffuses roughly
4.7 nm away.
4. For the oncogenic KRas-4B-FMe, the HVR interacts with lipids and the CD
moiety, FAR flipped away from the surface of the membrane with an averaged
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Fig. 5.14 Localisation of the KRas-4B domains and GTP with respect to the center
of the membrane along with the membrane normal as a function of simulation time.
Geometric centers of the CD, the HVR, FAR, GTP, and phosphorus atoms of DOPC
lipids from both leaflets are indicated as triangle down in orange, star in green, triangle
up in violet and circle in turquoise, respectively. The four favored configurations
described here are reported in Fig. 5.15.
location of 3.82 nm. The FAR doesn’t insert into the membrane bilayer. Instead, it
is exposed and available for antibody recognition. No spontaneous FAR insertion
was observed during the simulations, suggesting that the phosphorylation at
Ser-181 prohibits FAR insertion into the lipid bilayer.
5. For the demethylated KRas-4B proteins FAR is able to anchor to the cholesterol-
enriched (30%) membrane bilayers without much difficulty. The HVR is reported
to be 0.86 nm closer to the interface than the CD with FAR binding the CD moiety
(also shown in configuration 4), in which the HVR is sandwiched between the
effector binding site of the CD and the membrane. Comparing to the oncogenic
KRas-4B-Far, the PHOS group strengthens the auto-inhibition of KRas-4B-FMe
by the HVR, the same as the wild-type GDP-bound KRas-4B suggested by in
vitro and in silico observations[365].
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Configuration 1: Configuration 2:
Configuration 3: Configuration 4:
wt. KRAS4B-Far wt. KRAS4B-Far
onc. KRAS4B-Far onc. KRAS4B-FMe
Fig. 5.15 Four preferential configurations of three KRas-4B-membrane systems.
6. According to Ref.[143], phosphorylation of Ser-181 prohibits spontaneous FAR
membrane insertion for the methylated KRas-4B-FMe which is consistent with
our results of the oncogenic KRas-4B-FMe system. However, the prohibition
effect of phosphorylation has been diminished for the demethylated KRas-4B-Far
proteins.
7. GTP of the wild-type KRas-4B system locates always at the interfacial region
while GTP chooses to bind the CD region of the oncogenic KRas-4B proteins.
From g(r)s reported in section 5.2.1.2, it is revealed that in the stable state we
have observed, GTP serves as a bridge between the CD and lipids through pure
HBs and salt-bridges between Hgtp and negatively charged oxygen in the CD’s
side chain and head groups of lipids.
8. Comparing to the wild-type KRas-4B-Far, the locations of the HVR from the
oncogenic KRas-4B proteins studied in this Thesis are 0.22 nm higher along with
the membrane normal, weakening the HVR interactions with the related the CD,
increasing the fluctuations of the CD, and thus resulting in the population of
exposing binding site for each oncogenic case.
We have obtained the localization of different moieties of KRas-4B by computing
the distance between their geometric centers with the center of the membrane in our
models and reported the results in Table 5.3.
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Table 5.3 Averaged values of z-locations of FAR, HVR, CD, GTP during the last 500
ns simulations, among them, for the wt. KRas-4B-Far system, values of location of
FAR from configuration 1 and 2 have been provided. Estimated errors in parenthesis.
Systems FAR GTP HVR the CD
wt. KRas-4B-Far 3.9(0.48)/1.73(0.23) 2.40(0.17) 3.93(0.25) 4.48(0.13)
onc. KRas-4B-Far 1.37(0.18) 5.16(0.60) 3.56(0.19) 4.70(0.28)
onc. KRas-4B-FMe 3.82(0.36) 5.07(0.94) 3.84(0.24) 4.70(0.41)
FAR of the wild-type KRas-4B-Far is able to regulate between configuration 1
and 2 easily and the reason might be the corresponding small free energy barriers
between these two stable states. It is clear that for the methylated KRas-4B-FMe, the
FAR cannot bind the membrane in the presence of PHOS, showing a blocking effect.
However, for the demethylated KRas-4B-Far proteins (wild-type and mutated) PHOS
could help FAR inserting more deeply and stably into the membrane, indicating a high
free energy barrier for FAR departure from the membrane.
Based on an experimental research[348] of GppNHp (a purine nucleotide) bound
the wild-type KRas-4B-FMe, the HVR of the KRas-4B-FMe appears to be ∼ 1.5 nm
closer than the CD of KRas-4B-FMe to the plane of the L-α-PC:DOPS:cholesterol
(3:1:1) monomer lipid when the KRas-4B-FMe anchors into the membrane in trimer
units. In our wild-type demethylated model, the HVR has two preferred localization
on the membrane: around 4 nm (configuration 1) and 3.5 nm (configuration 2) from
the center of the membrane, while the CD locates stably near the interface of the
anionic membrane bridged through GTP molecule. the HVR locates ∼ 0.5 nm closer
than the CD when FAR solvated by water molecules and ∼ 1.0 nm closer than the CD
when FAR anchoring to the membrane which is smaller than the value from Ref.[348],
likely due to interactions between the HVRs and interfaces of membranes could be
influenced in the trimer.
However, in the oncogenic KRas-4B-Far system FAR keeps anchoring deeply into
the system while the HVR is buried near the interface. the HVR stays close to interface
and the CD locates 0.22 nm further away from the membrane center than the CD
of wild-type case. the CD acts much more actively which gains more accessibility to
expose its binding sites for interacting with its upstream regulators and downstream
effectors. The interaction between PHOS and DOPS lipid from the oncogenic KRas-
4B-Far system, such as Ofar and Hdops (see Fig. 5.11), is formidable, almost 12-fold
stronger than the same interaction from the wild-type KRas-4B-Far system, which
leads FAR of the oncogenic KRas-4B-Far anchoring the membrane during all the
simulation time.
These observations indicate that the wild-type KRas-4B-Far can easily anchor
into and departs from the anionic inside membrane and be released from the anionic
membrane without crossing too high free energy barriers to reach the next stable state,
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however for the oncogenic KRas-4B-Far during the whole simulation time, we haven’t
observed any tendency of FAR to leave the membrane. However, the oncogenic KRas-
4B-Far might face much higher free energy barriers in order to release its C-terminus
tail from the anionic membranes. This permanent anchoring is undoubtedly a key
factor to keep the protein in its active stay. It helps GTP-bound KRas-4B always
anchor to the membrane, and to stay in its active state.
In addition to the aforementioned GTP/GDP binding, the activation of KRas-4B
signaling still requires proper membrane-localization, post-translation, and interaction
with effector proteins[350]. When the wild-type KRas-4B-Far being in its GTP-bound
state doesn’t mean it is always in its active state. When FAR wonders near the
interface, the membrane-interacting the HVR diffuses near the CD and helps bury
the effector biding sites of the CD to the membrane surface. And our observation
on the wild-type system has a good agreement with the results reported in Ref.[365]
which indicates that demethylation does not affect the CD and the HVR’s behavior for
the wild-type KRas-4B. For the oncogenic KRas-4B-Far, it always stays in its active
state along with the simulation time, its the CD moiety fluctuates more freely and
liberates its the HVR binding with the membrane surface, exposing the effector binding
sites (see Fig. 5.15). Our data points out that methylation makes a difference in the
influence of phosphorylation at Ser-181 on the structural mechanisms of KRas-4B-FMe
and KRas-4B-Far.
It is common knowledge that the all-atom MD simulation usually won’t start in
the global stable state. Along with the simulation, several local stable states will be
visited and might include the global stable state. In order to explore conformational
states that selected CVs have explored and to understand the structural specifics of
KRas-4B-Far binding to the membranes in its GTP-bound form, we have used the
enhanced well-tempered metadynamics to sample the conformational transitions of
the active KRas-4B along with the membrane normal.
5.3 Well-tempered metadynamics simulations of the con-
formational transitions of KRas-4B
5.3.1 Study on the convergence of the simulations
In this Chapter, FEL of anionic membrane-anchored (wild-type and mutated) KRas-4B-
Far proteins have been investigated for the first time, using well-tempered metadynamics
in order to elucidate the joint effect of PHOS and G12D on the KRas-4B-membrane
binding.
The convergence of well-tempered metadynamics simulations depends on the
number of transition events between states and sampling of all physically interesting
regions of the CV[366]. The challenge of well-tempered metadynamics is well known,
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especially when applied to protein-bilayers systems with hundreds of thousands of
atoms, in order to sample all relevant conformations and the full range of CVs.
It is usual to monitor the size of the hills of the Gaussian kernels deposited along
with the simulation. As the simulation progresses and the bias added grows, the
Gaussian height is progressively reduced. We can visualize the decrease of the Gaussian
height during the simulation. In the long term, the Gaussian height becomes smaller
and smaller while the system diffuses in the entire CVs space. The height of the biased
potential decreased accordingly along with the simulation runs, as indicated in Fig.
5.16. In all cases, a quasi-flat profile is already seen after 600 ns, although some high
spikes are appearing due to large fluctuations in the values of CVs when covering all
configurational space.
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Fig. 5.16 Well-tempered Metadynamics hills height as a function of time in two cases.
The fact that the Gaussian height is decreasing to zero should not be used as a
measure of convergence of metadynamics simulation. By inspecting Fig. 5.17 of the
well-tempered metadynamics trajectories of the two CVs ("gtp" and "far") along with
the simulation time span of our simulations, we can see that the two systems were both
initialized in one of their meta-stable states. After ∼ 0.1 ns, the systems were pushed
by the metadynamics bias potential to visit another local minimum. As simulations
continue, the bias potential fills the underlying free energy landscape, and CVs are able
to diffuse in possible phase space along with the final 1050 ns simulation time span.
We can clearly identify that for both systems GTP has diffused efficiently in the
full collective variable space but the center of the membrane. No permeation for
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Fig. 5.17 Time evolution of two CVs as a function of time in different states for two
systems.
GTP has been observed which indicates the corresponding free energy barrier shall
be too high for GTP to cross the membrane bilayer from one leaflet to another and
KRas-4B’s existence does not have any impact on GTP’s permeation. Given the
different simulation parameters, for the oncogenic KRas-4B-Far system, FAR visited
all the possible space in one leaflet. However, for wild-type KRas-4B-Far system, FAR
only reached out in the CV space of around 8.5 nm away from the membrane center
along with the membrane normal direction, which is enough for our aim of exploring
FAR departure from the membrane and describing its FELs along with its CV space
because of the bias employed in the well-tempered metadynamics runs.
Besides reporting phase space that CVs visited during the simulation, convergence
can be evaluated in different ways including by monitoring the stability of free energy
barriers between different states or by plotting integrated free energy profiles along
with the simulation time. Following the previous work in section 4.2.2.2, we checked
convergence by two ways: (1) reporting the time cumulative average of 1D free energy
profiles along with the simulation time, and (2) calculating the free-energy difference
between the two local minima in the one-dimensional free energy along with each CV
as a function of simulation time.
At convergence, the reconstructed free energy profiles should be similar, apart from
a constant offset. From the results of Fig. 5.18, we can see that the integrated 1D
free energy profiles are very similar after a simulation time of 800 ns for the CV of
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Fig. 5.18 Time cumulative free energy profiles. Lower panels correspond to the wild-type
system and upper ones to the oncogenic case. Labels such as ’A, B, ...X’ correspond
to the relevant basins along with the CV within the free energy profile and will be
described below in Fig. 5.19. Here we would like to point out that basins with the
same labels in section 5.3.1 are different from section 5.3.2.
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Fig. 5.19 Convergence of well-tempered metadynamics based on the free energy barriers
between two chosen basins. The selected basins (’A’,. . . ,’Y’) have been defined in Fig.
5.18.
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"gtp" and 950 ns for the CV of "far" in the oncogenic system. For the wild-type system,
convergence was realized much sooner: since 600 ns for "gtp" and 700 ns for "far".
To assess the convergence of the simulation more quantitatively, we have calculated
the free energy barriers (∆F ) between two selected free energy basins representing two
meta-stable configurations for KRas-4B-Far as a function of simulation time, whose
results are reported in Fig. 5.19. As we can see, ∆F between the two chosen free
energy basins tends to be similar after long cumulative time spans which lead us to
fully converged free energies for the two CVs considered in this Chapter. The estimated
free energy profiles and corresponding ∆F s do not change significantly in the final
part of our simulations which also suggests that the simulations were fully converged.
5.3.2 2D free energy landscapes
We are interested in the free energy barriers of FAR and GTP binding to the anionic
membrane: this information is stored in the free energy landscape. FELs are dynam-
ical so that conformational states can change in response to intra-/extra-molecular
events[154, 367], such as the localizations of the FAR and GTP. Two sets of 2D FELs
of the oncogenic and wild-type KRas-4B-Far binding to anionic membrane composed
of DOPC:DOPS:cholesterol (28:7:15) based on two selected CVs defined above are
reported in Figs. 5.20 and 5.21, respectively. Each meta-stable state can be indexed by
a pair of CVs. Several regions with clear minima are present in the FELs and clearly,
no GTP permeation crossing membrane has been observed in both cases. Minima of
the two FELs both locate when GTP is bound to the KRas-4B-Far protein in the inner
leaflet. When GTP moves to the outer leaflet, minima correspond to GTP located at
the interface of the anionic membrane. Since the range of CV space represented in
Figs. 5.20 and 5.21 is rather wide, we will focus especially in the characterization of
free energy barriers between the particular states of localizations of FAR (represented
by "far" in FELs) and GTP (represented by "gtp" in FELs) along with the membrane
normal binding to the membrane and fully solvated by water molecules. Let us note
that in both well-tempered metadynamics simulations HVR has not been considered
as a CV due to the high expense of computational resources, however, its effect of
binding to the membrane interfaces could be shown through the free energy profiles of
FAR which we will discuss below.
Since the present 2D FELs include a wide variety of (meta-)stable states related
to conformational and structural changes and the free energy surface as a function of
CVs is a natural outcome of well-tempered metadynamics method, methods that allow
researchers to trace the minimum free energy path (MFEP) with high accuracy and
that could be successfully employed to describe complex bio-molecular processes are
highly needed in this field. MFEP can be determined by iteratively refine a pathway
connecting stable states that converges to the minimum free energy trajectories between
them. MFEP could also be obtained through the Path Collective Variables (PCVs)
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description coupled with metadynamics[368]. Alternatively to biased-MD simulation
methods, certain spontaneous binding events can also be achieved through extensive
standard MD simulations, for example, running for µs to ms simulation time[369, 370].
From MFEP we can extract information associated with the most probable trajectories
in the CV space followed by the system involving between (meta-)stable states and
it also allows us the determination of local and global transition states, as it was
described in Chapter 4.
In a different fashion to the method, we adopted in section 4.2.2.2, here we choose
to trace the minimum free energy paths along with the FEL using the R-package
metadynminer[239]. As we introduced the R-package metadynminer in section 2.4,
it reads HILLS files from PLUMED, calculates free energy surface by fast Bias Sum
algorithm, finds minima and analyses transition paths by Nudged Elastic Band method.
Several MFEPs have been depicted in Figs. 5.20 and 5.21 where the global minimum
is set equal to zero. The coordinates of minimum free energy paths are included in
Table 5.5.
Our results suggest that there are many local and global stable states along with
the 2D FEL with two CVs indexed for each system. For the oncogenic KRas-4B-Far
protein, the most stable state and five more meta-stable states have been revealed and
shown in Table 5.4.
Table 5.4 Minima on the FEL of the oncogenic KRas-4B-Far (coordinates given in
nm, free energy in kJ/mol). Here each letter refers to one meta-stable state, with A
standing for the global state when FAR is anchoring deeply into the membrane and
GTP locates near the interface. Here locations of minima of FEL of Fig. 5.20 were
obtained by using metadynminer package.
States CV1(gtp) CV2(far) Free energy
A -2.28 -1.37 0.00
B 2.28 -1.15 12.85
C -5.08 -1.72 15.00
D -1.81 -4.00 34.28
E -1.93 -9.59 36.56
F -7.77 -1.49 41.59
As we pointed out earlier, all-atom MD simulations usually won’t start at the
global minimum so that along with the simulation several local stable states will be
visited, normally including the global minimum. Comparing with Fig. 5.18, we can
observe that in the time span of 1000 ns of MD simulations, the oncogenic GTP-bound
KRas-4B-Far kept staying at its meta-stable state C, not in its global state A, mainly
due to relative high free energy barrier between the states C and A. One should be
aware that locations reported in Fig. 5.18 and Table 5.3 are the geometric centers of
FAR and GTP whose value could be slightly different from the results of the mass
center of GTP and FAR from Table. 5.4. FAR of the oncogenic KRas-4B-Far tends to
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Fig. 5.20 2D free energy landscapes F(gtp, far) (kJ/mol) for the oncogenic KRas-4B-Far
system. Several stable configurations (A, B, C, D, E, and F) are indicated. All MFEPs
between two selected basins are depicted in purple and the coordinates of the transition
path have been reported in Table 5.5.
anchor 0.2 nm deeper (state B) into the "internal" regions of the membrane bilayer when
GTP diffuses in the interface of the other leaflet comparing with the most favorable
state A when GTP and FAR bind to the inner leaflet of the membrane.
Taken all these remarks into consideration, we propose the stable or meta-stable
configurations that the oncogenic KRas-4B-Far may adopt when binding to anionic
membrane: in the state A, FAR anchors into the "internal" regions of the membrane
when GTP binds the interface and binds the CD moiety, as well; in the state C, FAR
anchors into the "internal" regions of the membrane when GTP only binds the CD
moiety; in the state D, FAR is solvated by water molecules and GTP only binds the
membrane interface; in the state E, FAR reaches out further away from the lipids;
and in the state F, GTP is only solvated by water while FAR keeps anchoring to the
membrane.
126 | Structural and energetic aspects on the anchoring of wild-type and oncogenic
KRas-4B proteins at model cell membranes
From 2D FEL of the mutated KRas-4B-Far system, we can estimate the values of
the free energy barriers between selected (meta-)stable configurations reported in this
section:
1. While FAR anchoring to the membrane, GTP dissociates from the most stable
state A then binds to the CD moiety (state C), requiring crossing a free energy
barrier of 27.04 kJ/mol, and from a meta-stable state C to the global state A
needs crossing a barrier of 12.04 kJ/mol which is much lower.
2. The difference between the states D and E is most likely due to the HVR’s
location: HVR binding the head groups of lipids (state D) and HVR solvated in
the aqueous region (state E). The estimated free energy barrier ∆F from the
state D to the state E is of 17.20 kJ/mol required for the HVR departure from
our model membrane bilayer.
3. GTP diffuses from binding to the CD of the mutated KRas-4B-Far (state C)
to being solvated in the water region (state F) with a high barrier ∆F of 27.51
kJ/mol along with the MFEP (not reported in this section) which explains GTP’s
high affinity of the CD of the mutated KRas-4B-Far.
4. We estimated a free energy barrier of 42.44 kJ/mol from the state A to the state
D. For the oncogenic KRas-4B-Far, the FAR’s affinity of the anionic membrane
is extremely high. Thereupon, the release of FAR from the anionic membrane
becomes unlikely because of the high ∆F , accordingly, it is very easy for FAR
anchoring back into the bilayer (configuration shifts from the state D to the state
A) with a barrier of 8.16 kJ/mol.
5. When GTP moves in the outer membrane leaflet, only one local stable state B is
identified in the related 2D FEL, and we can obtain from the 2D FEL that it is
very difficult for FAR to depart from the anionic membrane, indicating GTP’s
huge impact on the mutated system.
After locating local minima from the 2D FEL, by changing parameters while
calculating transition paths, we are able to refine the path and eventually obtain the
MFEPs. Detailed coordinates of MFEPs are reported in Table 5.5.
Accordingly, the FEL of the wild-type KRas-4B-Far system has been calculated
and analyzed from data reported in Fig. 5.21.
Measuring the value of the free energy directly from the 2D FEL of the wild-type
KRas-4B-Far system, two most stable states and four more meta-stable states have
been identified and shown in Table 5.6, important MEFPs are shown in Fig. 5.21.
We could also estimate the values of free energy barriers between the significant
states of the wild-type KRas-4B-Far system, and the main features are summarized as
follows:
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Table 5.5 Coordinates of segments forming selected paths for the oncogenic and wild-
type KRas-4B-Far systems. Along with each path 8 locations of fespot are displayed.
Minimum free energy paths
onc. KRas-4B-Far wt. KRas-4B-Far
Stable states path x path y fespot Stable states path x path y fespot
C -5.08 -1.72 15.00 C -3.35 -0.97 5.14
-4.82 -1.24 19.50 -3.36 -1.07 7.00
-4.03 -1.34 27.04 -3.80 -1.10 8.61
-2.68 -1.67 11.55 -3.79 -1.18 8.02
-2.29 -1.55 1.39 -3.77 -1.25 7.68
-2.00 -1.59 1.79 -3.76 -1.41 6.69
-1.89 -1.64 0.36 -3.76 -1.63 4.06
-2.01 -1.61 1.78 -3.78 -1.77 2.48
-2.19 -1.49 0.65 -3.75 -1.88 1.92
A -2.28 -1.37 0.00 B -3.94 -1.93 1.92
-2.05 -1.44 2.48 -3.80 -1.93 2.02
-2.07 -1.69 2.25 -3.77 -1.99 2.53
-1.92 -1.61 0.36 -3.95 -2.27 9.43
-1.98 -1.78 4.48 -3.64 -2.61 10.76
-1.98 -1.97 8.38 -4.05 -3.00 8.29
-1.99 -2.34 24.97 -3.94 -3.48 0.04
-1.95 -2.86 35.40 -3.96 -3.50 0.04
-1.63 -3.33 42.44 -3.93 -3.49 0.04
D -1.81 -4.00 34.28 A -4.06 -3.49 0.00
-1.75 -3.93 34.28 -3.71 -3.75 6.27
-1.62 -4.04 41.80 -3.92 -3.98 7.10
-2.28 -5.03 47.22 -4.07 -4.26 10.73
-2.11 -5.36 44.82 -3.92 -4.78 13.13
-1.98 -6.43 40.92 -3.88 -5.04 15.57
-2.06 -7.54 51.48 -3.73 -5.30 16.93
-2.38 -8.51 45.08 -3.75 -5.51 20.10
-2.05 -9.13 42.67 -3.76 -5.67 20.04
E -1.93 -9.59 36.56 F -3.82 -5.91 15.25
1. Differently to the case of the oncogenic KRas-4B-Far, two meta-stable states
D and E are established when GTP and FAR move in different leaflets, with a
barrier ∆F of 11.02 kJ/mol.
2. When GTP and FAR are bound to the inner leaflet, a barrier of 10.76 kJ/mol is
likely to be crossed by FAR shifting from the global stable state A to another
stable state B while GTP keeps bound to the CD, and the barrier for FAR’s
release from the membrane is about 8.84 kJ/mol. Both values are similar to
barriers between states D and E, suggesting GTP doesn’t have much influence
on FAR’s movement for the wild-type case.
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Fig. 5.21 2D free energy landscapes F(gtp, far) (kJ/mol) of the wild-type KRas-4B
system. Seven meta-stable configurations are indicated here. MFEPs between different
two basins are depicted in purple and the relevant coordinates have been reported in
Table 5.5.
3. Shifting from the state B to the state C can be realized if a free energy barrier
of 6.69 kJ/mol is surmounted.
4. When the system shifts its states from A to F, the crossing of a free energy
barrier of 20.10 kJ/mol corresponds to the energy needed for the HVR to be
released from the anionic membrane when FAR is solvated in the aqueous region.
5. There are several meta-stable states when GTP locates ∼2 nm away from the
membrane center, indicating the existence of multiple configurations when GTP
is around head groups of lipids, which may play a role in KRas-4B-Far’s signal
transduction and interactions with other proteins in vivo.
6. For the wild-type KRas-4B-Far system, the location of GTP does not play a role
in FAR’s movement along with the membrane normal directions. FAR has the
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Table 5.6 Minima on the FEL of the wild-type KRas-4B-Far. Here each letter refers to
one meta-stable state, among which A stands for the global state which is set to zero.
Here locations of minima of FEL of Fig. 5.21 were obtained by using metadynminer
package.
States CV1(gtp) CV2(far) Free energy
A -4.06 -3.49 0.00
B -3.94 -1.93 1.92
C -3.35 -0.97 5.14
D 2.53 -1.40 8.70
E 2.17 -3.52 8.75
F -3.82 -5.91 15.25
ability to anchor to and be released from the anionic membrane whether GTP is
bound to the interface of the outer leaflet; bound to the CD moiety by crossing
low barriers (from observation of well-tempered metadynamics simulation), or
when GTP is bound to the interface of the inner leaflet (Fig. 5.14 from all-atom
MD simulation).
From the 2D FEL we can locate the two most stable states as the state A (FAR
diffuses in the water region while GTP is bound to the CD moiety of the wild-type
KRas-4B-Far) and the state B (FAR anchored to the membrane while GTP keeps being
bound to the CD). To our surprise, two configurations "1" and "2" reported in Fig. 5.15
do not belong to any (meta-)stable state detected by the well-tempered metadynamics
method. Two reasons for this lack of matching might be: (a) as pointed out earlier,
MD simulations, especially for big complex biological systems, start more likely in
one of its meta-state stable states and only during the extremely long simulation time
spans other local stable states can be visited, including its global stable state (states A
and B); (b) Well-tempered metadynamics simulation with the same two CVs should be
extended for another 1 µs or even much longer which is very expensive to conduct. We
expect that in such extended simulations MD and metadynamics simulations would
describe similar results of stable states.
5.3.3 One-dimensional free energy profiles
It is also possible to calculate one-dimensional free energies from the two-dimensional
well-tempered metadynamics simulation. The calculation of 1D free energy profiles
could allow us to directly check how does the free energy change along with one CV
which can be directly compared to experimental findings. 1D free energy profile F(s1)
for both systems (oncogenic, wild-type) after integrating out the second CV s2, as it is
defined in Eq. 4.1, have been represented in Fig. 5.22.
A newly adopted scientific method should be consistent with validation. Here we
have the opportunity to validate the results of MFEP generated by metadynminer, in
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Fig. 5.22 1D integrated free energy profiles of GTP and FAR along with the membrane
normal direction. Oncogenic case (top) and wild-type case (bottom). Basins marked
with the same letters as in Fig. 5.18. Minima in four panels are set equal to zero. The
minimum in each of the four figures has been set to zero.
comparison with 1D-free energy profiles generated using the well known PLUMED pack-
age. We also calculated the 1D free energy profile using the R-package metadynminer
and results are presented in Fig. 5.22, as well. As we could see for both systems, free
energy profiles related to GTP generated by metadynminer contain a degree of noise
and interference, but the locations of basins, the corresponding barriers, and values of
free energies are quite similar to energy profiles calculated with PLUMED. Hence, the
equivalence of 1CV integrated free energy profiles and the related ones generated from
MFEP profiles (Table 5.5) establish a good degree of internal consistency.
From plots in Fig. 5.22 we can obtain meaningful free energy barriers related to
particular processes related to movements of GTP and FAR along with the Z-axis. Here
we choose to calculate barriers precisely calculated using PLUMED which contains
less noise. The main findings are highlighted as follows:
1. In the case of the for the oncogenic KRas-4B-Far system, when diffusing in a
leaflet together with FAR, GTP needs 30.53 kJ/mol to move from the interface
of the bilayer to outside, in order to bind with the CD moiety. However, only a
free energy barrier of 7.74 kJ/mol is required for the wild-type case.
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2. Similar barriers that need to be surmounted for GTP to dissociate from the
CD to be solvated by water molecules are of 33.98 kJ/mol and 35.36 kJ/mol
for oncogenic and wild-type system, respectively, indicating mutation at G12D
doesn’t have a significant influence on GTP’s movement.
3. The displacement of GTP from the interface of the outer leaflet of the membrane
to the aqueous region requires about 49.74 kJ/mol (onc.) and 23.53 kJ/mol
(wt.), and numbers corresponding to the protein-populated leaflet are about
49.49 kJ/mol (onc.) and 30.56 kJ/mol (wt.).
4. In the same fashion, free energy needed for FAR release from the membrane to
be solvated in the aqueous region is of 46.01 kJ/mol for the oncogenic case and
of 15.16 kJ/mol for wild-type case, respectively.
5. In its GTP-bound state, the wild-type KRas-4B-Far could easily change its
configurations between the state H (KRas-4B anchoring to the membrane by
FAR aligning with lipid molecules of the membrane) and the state G (interacting
with the lipids’ interface by its the HVR while FAR diffusing in the water region).
In order to decline interactions between FAR and lipids, FAR crosses a barrier of
8.44 kJ/mol to reach the state H from the state G, and a barrier of 8.98 kJ/mol
to shift from the state H to G.
6. Here we are presenting two stable states for the wild-type KRas-4B. The wild-
type KRas-4B-Far interacts with the membrane firmly through its the HVR and
FAR moieties. However, once its FAR dissociates from the membrane it has the
ability to anchor back and act as a switch, which ensures its normal function.
7. In the oncogenic case, comparing the free energy profiles, relative to the wild-type
protein, PHOS at Ser-181 strongly favors FAR anchoring to the membrane while
GTP is located at the interface. This is consistent with our MD simulation
results. This provides additional support to our statement that increasing its
hydrophobic density through the carboxymethylation at Cys-185 does not always
favor its protein recruitment to the PM when PHOS gets involved in the KRas-4B
structure.
In 2017, Y.Zhou et al.[366] published their results of metadynamics simulations of
K-Ras in plasma membranes on the conformational changes using CV1 (the C-atom
RMSD of residue 177-182 from a helical reference structure) and CV2 (one end-to-end
distance involving the C-atom of residue 176 and 184) at the 1 µs timescale. Herein,
PHOS at Ser-181 of mutated KRas-G12V was found to favor a specific orientation
state.
To the best of our best knowledge, (well-tempered) metadynamics simulations to
calculate the localization of different moieties of the KRas-4B-Far proteins had not been
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investigated until now. The results reported in this Chapter have been the first-hand
publication about FELs of the GTP-bound wild-type/oncogenic KRas-4B-Far binding
to anionic membrane systems.
5.4 Conclusions
KRas-4B belongs to a family of small GTPase that regulates cell growth, differentiation,
and survival which is frequently mutated in cancer cells such as lung, colon, and
pancreatic cancers. However, the structural mechanisms at the atomic level of the
KRas-4B-membrane association are not fully understood. Many important results have
been reported and most efforts have been focused on the methylated KRas-4B-FMe
protein after decades of research. However, there is a relatively high abundance of
KRas-4B-Far (wild-type and oncogenic) in tumors. In this Chapter observations of
three wild-type and mutated KRas-4B proteins obtained by using molecular dynamics
simulations coupled with the up-to-date free energy landscapes for two cases have been
presented, hoping to inspire and dynamize contributions in this research field.
Firstly, we conducted MD simulations of three systems of the GTP-bound KRas-4B
(the oncogenic KRas-4B-FMe, KRas-4B-Far, and the wild-type KRas-4B-Far) binding
cell membranes constituted by DOPC (56%), DOPS (14%) and cholesterol (30%)
including KCl ionic solution at 310.15 K and at the fixed pressure of 1 atm. Three sets
of continuous MD simulations all reached a scale of 1000 ns. Each oncogenic KRas-4B
protein contains two mutations: G12D and phosphorylation at its Ser-181 site. Our
main interest was focused on the local structures and localizations of different moieties
of the KRas-4B proteins. As a general fact, the KRas-4B association with the PM
requires the FAR’s penetration into the membrane and the HVR’s interactions with
lipids in order to allow KRas-4B a proper localization in the membrane. After the
systematic analysis of meaningful data, we noted relevant differences between different
cases. We observed that for the wild-type KRas-4B-Far, demethylated Cys-185 allows
FAR spontaneously to insert into and depart from the anionic membrane bilayer
without much difficulty along with the simulation; the oncogenic KRas-4B-Far keeps
anchoring to the membrane and staying in its active site in order to bind upstream
regulators and downstream effectors; and the oncogenic KRas-4B-FMe stays in the
state of auto-inhibition by the HVR in which the HVR is sandwiched between the
effector binding site of the CD and the membrane, blocking the signal transduction
pathways. In order to explain our observations, microscopic properties such as the area
per lipid, lipid thickness, radial distribution functions, penetrations of FAR, GTP, etc.
to the membrane, and deuterium order parameter have been evaluated. Interactions,
such as HBs and long-lived salt-bridges between different active sites of GTP, the CD,
the HVR, and lipids, have revealed that to play a central role in the stabilization of
the KRas-4B membrane proteins. Among the two mutations in the two oncogenic
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KRas-4B protein structures, the effect of G12D mutation on the localization of FAR
and GTP of the KRas-4B systems is still unknown. However, PHOS has an important
influence on the behavior of the oncogenic KRas-4B proteins. Furthermore, PTMs
such as carboxymethylation always play a role in KRas-4B’s localization on the PM.
By investigating penetrations along with the membrane normal of different moieties of
the KRas-4B structures, we have revealed that bigger distances of the CD from the
membrane center along with the membrane normal direction of the oncogenic KRas-4B
proteins, relative to the wild-type one, help to expose the binding site of the CD to
bind upstream regulators and downstream effectors, finally populating their active
state for the mutated proteins.
To the best of our knowledge, the free energy profiles of GTP binding to anionic
membrane bilayers have been reported for the first time, giving first-hand information
about FELs of the GTP-bound wild-type/oncogenic KRas-4B-Far binding to anionic
membrane systems. With the help of well-tempered metadynamics simulations, we
have calculated 2D free energy landscapes and the 1D free energy profiles along with
one CV. We have located global and local stable states of the two systems that have
been chosen to elucidate the joint effect of PHOS and G12D on the KRas-4B-membrane
binding. Two CVs have been taken into consideration to describe the conformational
changes along with the free energy paths. CV1 is the distance "gtp" between the center
of mass of GTP and the center of mass of the membrane, and CV2 is the distance "far"
between the FAR group of Cys-185 and the center of mass of the membrane along
with the direction normal.
Our results indicate that for the GTP-bound oncogenic KRas-4B-Far, a free energy
barrier of 42.44 kJ/mol has been estimated which explains that the release of the FAR
moiety of the oncogenic KRas-4B-Far from the anionic membrane becomes unlikely
because of the high ∆F . Correspondingly, a barrier of 10.76 kJ/mol is likely to be
crossed for FAR of the wild-type KRas-4B-Far shifting from anchoring to the PM to
being solvated by water while GTP keeps binding to the CD. Differently to one local
stable state for the oncogenic KRas-4B-Far, two local stable states are established
when GTP and FAR move in the different leaflets for the wild-type case. Likely, when
FAR of the wild-type case shifts from ∼4 nm to 6 nm away from the membrane center,
we have estimated a free energy barrier of 20.10 kJ/mol corresponding to the energies
needed for the HVR dissociating from the anionic membrane.
From the calculation of 1D integrated free energy profiles of both systems, important
observations have been presented. When diffusing in the inner leaflet with FAR, GTP
needs 30.53 kJ/mol to move from the interface of the bilayer to bind with the CD
moiety for the oncogenic KRas-4B-Far system, whereas 7.74 kJ/mol free energy is
required for the wild-type case. Similar barriers that need to be surmounted for GTP
to dissociate from the CD to be solvated by water molecules are of 33.98 kJ/mol and
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35.36 kJ/mol for oncogenic and wild-type system, respectively, indicating mutation at
G12D doesn’t have a significant influence on GTP’s movement.
Most importantly, the free energy needed for FAR release from the membrane to
be solvated in the aqueous region is of 46.01 kJ/mol for the oncogenic case and of
15.16 kJ/mol for wild-type case, respectively. In its GTP-bound state, the wild-type
KRas-4B-Far could easily change its configurations between the state H (KRas-4B
anchoring to the membrane by FAR aligning with lipid molecules of the membrane) and
the state G (interacting with the lipids’ interface by its the HVR while FAR diffusing
in the water region). In order to decline interactions between FAR and lipids, FAR
crosses a barrier of 8.44 kJ/mol to shift from the state G to the state H. Comparison of
free energy profiles, relative to the wild-type protein, PHOS at Ser-181 strongly favors
FAR anchoring to the membrane while GTP locates in the interface for the oncogenic
case, consistent with the MD simulation results. This provides additional support to
our suggestion that adding its hydrophobic density through the carboxymethylation
at Cys-185 does not always favor its protein recruitment to the PM when PHOS gets
involved in the KRas-4B structure.
Chapter 6
Conclusions and prospect
6.1 General conclusions
In this Thesis we have performed all-atom molecular dynamics and well-tempered
metadynamics simulations of different cell membrane model systems. In what follows,
we will summarize the main conclusions of this Thesis.
In Chapter 3, a series of molecular dynamics simulations of different lipid bilayer
membranes in an aqueous ionic solution of NaCl with an embedded molecule have been
performed by MD using the CHARMM36 force field. Among them, cholesterol with
different concentrations (30% and 50%) has been considered. In our preliminary study
on tryptophan’s adsorption to DPPC bilayer membrane at 310.15 K, our data revealed
the existence of a strong first coordination shell and a milder second coordination
shell for the tryptophan-water association, which translated to deep minima in the
corresponding PMFs, with energy barriers of less than 1 kcal/mol. Conversely, the
binding of tryptophan to DPPC involves a single coordination shell for the two sites of
possible association and energy barriers much lower than for the former TRP-water, i.e.
of the order of 1 kcal/mol. Tryptophan shows a clear tendency to stay close to DPPC,
during the periods of time about 3 times longer than for the TRP-water association.
Continuing our preliminary study, the temperature was increased from 310.15 K
to 323.15 K for three systems at three cholesterol concentrations (0, 30, and 50%) at
liquid-crystalline phase conditions. We noted relevant changes in local structure and
dynamics of tryptophan only for cholesterol concentrations above 30%. The binding
of tryptophan to DPPC involved coordination shells for the different sites of possible
association (charged oxygens ’O2’ and ’O8’ of DPPC versus the two tagged hydrogens in
TRP, namely ’H1’ and ’H2’). Also, the distribution functions of tryptophan-cholesterol
revealed stable hydrogen-bonding configurations. These data indicate that tryptophan
is able to establish stable interactions with all classes of solvating particles (water,
DPPC, and cholesterol) including a sort of bridge between DPPC and cholesterol
species. The typical hydrogen-bond distances between tryptophan and other species
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have been found between 1.7-2.0 Å, in good agreement with experimental data obtained
from fluorescence measurements[100]. Tryptophan’s self-diffusion coefficients have been
found to be of the order of 1-10×10−7 cm2/s and they are strongly dependent on the
presence of cholesterol in the system. The computed spectral densities, in excellent
agreement with experimental infrared and Raman data from Leyton et al.[99], allowed
us to reveal the degree of participation of each atomic site of tryptophan to the
complete spectrum of the molecule. Considering the importance of studying DPPC
lipids, we kept using DPPC bilayer to study the binding free energies of small molecules:
serotonin, histidine, tyrosine, melatonin, and tryptophan at the condition of 323.15 K
and 1 atm. Our data revealed the existence of a strong first coordination shell and a
milder second coordination shell for small molecule-water structure, which correspond
to two minima in the corresponding PMFs, with energy barriers for the TRP-water
association of the order of 1-2 kcal/mol. Conversely, the binding to DPPC involves a
single coordination shell for the two sites of possible association (oxygens ’O2’ and ’O8’
of DPPC versus hydrogens in the small-molecules) and energy barriers between 0.5-3
kcal/mol. Throughout our simulation runs, we did not observe any event of permeation
of a small-molecule across the DPPC membrane. Concerning the essentiality of the
two amino acids reported in the present work (histidine, tryptophan), we observed
that tryptophan is able to enter the interfacial membrane, whereas histidine is not.
Interestingly, tyrosine, a non-essential amino acid shows the highest free energy barriers,
indicating that it is the most stable molecule for DPPC binding. Serotonin has revealed
to be a molecule anchored at the membrane and with a low propensity to be solvated
by water, whereas its derivative melatonin is able to equally interact with water and
DPPC, showing similarly strong free energy barriers.
The result of this work has been published in the following three works:
- Jordi Martí, Huixia Lu. Molecular Dynamics of Di-palmitoyl-phosphatidyl-choline
Biomembranes in Ionic Solution: Adsorption of the Precursor Neurotransmitter Tryp-
tophan. Procedia Computer Science, 2017, 180C, 1242-1250
- Huixia Lu, Jordi Martí. Effects of cholesterol on the binding of the precursor neuro-
transmitter tryptophan to zwitterionic membranes. The Journal of Chemical Physics,
2018, 149, 164906(1-9)
- Huixia Lu, Jordi Martí. Binding free energies of small-molecules in phospholipid
membranes: amino acids, serotonin, and melatonin. Chemical Physics Letters, 2018,
712, 190-195
Due to its medical purposes, we have investigated the dynamics of melatonin binding
to the cell membranes in Chapter 4. Results of all-atom molecular dynamics simulations
of a bilayer membrane composed of DMPC at three cholesterol concentrations (0%,
30% and 50%) including a single MEL molecule in aqueous NaCl ionic solution at
303 K and the fixed pressure of 1 atm have been reported. Our main interest was
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firstly focused on the local structure and angular distributions of MEL, especially when
associated with DMPC and cholesterol molecules. Typical hydrogen-bonds through
different sites between MEL-DMPC and MEL-cholesterol have been observed. Two
relevant MEL structures have been observed from angular distributions: "folded" and
"extended" configurations. We defined three different dihedral angles to account for the
two preferential angular configurations. Dihedral Ψ defined in Fig. 4.6 has revealed to
be a meaningful order parameter (i.e. may act as a reliable reaction coordinate) to
describe the dynamics of MEL, with preferential angles of ∼ 1.42 rad and ∼ 2.96 rad.
We suggest that introducing cholesterol into the system could help MEL change from its
folded configuration to the extended configuration more easily, using hydrogen-bonds
between MEL-DMPC and MEL-cholesterol. The self-diffusion coefficient of MEL
was found to be of the order of 10−7 cm2/s and the presence of cholesterol in the
system has little influence on it. The spectral densities of MEL computed in this
work are in overall good agreement with experimental Raman and infrared data and
have revealed the degree of participation of each atomic site of MEL to complete its
whole molecular spectrum giving some clues to understand the microscopic origin of
molecular vibrations and also giving evidence of the good reliability of the model we
adopted in the present work. Nevertheless, in the time span of 200 ns of auxiliary MD
simulations, we did not record any spontaneous crossing of MEL through the DMPC
membrane. Our findings agree that in order to observe trans-membrane crossings of
such small solutes in the time length of a simulation at the atomic level of description,
they needed to run trajectories of 10 µs at low temperatures (310 to 330 K) or to
increase the temperatures to more than 400 K (for simulation times of 1 µs).
Continuously, we conducted the first quantitative characterization to date of the
binding states of MEL at model DMPC-cholesterol phospholipid cell membranes
through the calculation of free energy landscapes. With the help of well-tempered
metadynamics simulations, we have calculated 2D free energy landscapes and located
the binding stable states and several (local and global) transition states of the system.
Two CVs have been considered: dihedral angle Ψ and the distance z between the
center of mass of MEL and the center of the lipid bilayer (given by z = 0). Our
results indicate that MEL can be bound to the internal side of the membrane, at
distances z ∼ 1− 2 nm, and in several stable state configurations where the dihedral
|Ψ| = 1.17 rad and |Ψ| = π rad. Through the calculation of the minimum free energy
paths, we have observed that the most probable trajectory of MEL is along with the
interface of the membrane, changing its conformation between extended and folded
configurations by means of surmounting free energy barriers of about 15-20 kJ/mol. In
addition, the methodology employed in the present work allowed us to locate several
global and local TS of the system and to estimate the values of their free energy
barriers. When cholesterol is added to the system, it helps pull MEL escape from the
interface of the membrane to being solvated by water/sodium chloride molecules more
138 | Conclusions and prospect
easily by decreasing its corresponding free energy barriers. The effect is more marked
as the concentration of cholesterol rises. The energetic cost for MEL to leave the
interface of the membrane and to be fully solvated by water/sodium chloride molecules
(z-distances around 4 nm), has been estimated to be of 10 ∼ 25 kJ/mol. The less
common situation was found to be with MEL accessing regions around the center of the
membrane, process requiring to cross free energy barriers above 40 kJ/mol. We believe
that the findings presented in this chapter could be of practical use in designing new
reaction coordinates (for instance coordination numbers of MEL) for multidimensional,
more accurate free energy calculations able to explore a wide variety of relevant small
solute species of biochemical interest such as amino acids, neurotransmitters, drugs or
hormones.
This work has appeared in the following publications:
- Huixia Lu, Jordi Martí. Binding and dynamics of melatonin at the interface of
phosphatidylcholine-cholesterol membranes. PloS one, 2019, 14(11), e0224624.
- Huixia Lu, Jordi Martí. Cellular absorption of small molecules: free energy landscapes
of melatonin binding at phospholipid membranes. Scientific Reports, 2020, 10, 9235.
https://doi.org/10.1038/s41598-020-65753-z
In this Thesis we have also studied the regulation of oncogenic KRas-4B activity
when binding to the membrane. Most efforts have been focused on the methylated KRas-
4B-FMe protein after decades of research. However, there is a relatively high abundance
of KRas-4B-Far (wild-type and oncogenic) in tumors. In Chapter 5 observations of
three wild-type and mutated KRas-4B proteins obtained by using molecular dynamics
simulations coupled with the up-to-date free energy landscapes for two cases have been
presented, hoping to inspire and dynamize contributions in this research field.
Firstly, we conducted MD simulations of three systems of GTP-bound KRas-
4B (oncogenic KRas-4B-FMe, KRas-4B-Far, and wild-type KRas-4B-Far) binding
cell membranes constituted by DOPC (56%), DOPS (14%) and cholesterol (30%)
including KCl ionic solution at 310.15 K and the fixed pressure of 1 atm. Three sets of
continuous MD simulations all reached a scale of 1000 ns. Two mutations of G12D
and phosphorylation at its Ser-181 site have been considered for mutated KRas-4B
proteins. Our main interest was focused on the local structures and localizations of
different moieties of KRas-4B proteins. The association of KRas-4B with the PM
requires the FAR’s penetration into the membrane and the HVR’s interactions with
lipids to allow KRas-4B a proper localization in the membrane. We observed that for
wild-type KRas-4B-Far, demethylated Cys-185 allows FAR spontaneously to insert into
and departure from the anionic membrane bilayer without much difficulty along with
the simulation; oncogenic KRas-4B-Far keeps anchoring to the membrane and staying
in its active site to bind upstream regulators and downstream effectors; and oncogenic
KRas-4B-FMe stays in the auto-inhibition by the HVR state in which the HVR is
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sandwiched between the effector binding site of the CD and the membrane, blocking
the signal transduction pathways. In order to explain our observations, microscopic
properties such as the area per lipid, lipid thickness, radial distribution functions,
penetrations of FAR, GTP, etc. to the membrane, and deuterium order parameter have
been evaluated. Interactions, such as HBs and long-lived salt-bridges between different
active sites of GTP, the CD, the HVR, and lipids, have revealed that to play a central
role in the stabilization of KRas-4B membrane proteins. Among the two mutations
in the two oncogenic KRas-4B protein structures, the effect of G12D mutation on
the localization of FAR and GTP of KRas-4B systems is still unknown. However,
PHOS has an important influence on the behavior of oncogenic KRas-4B proteins.
Furthermore, PTMs such as carboxymethylation always play a role in KRas-4B’s
localization on the PM. By investigating penetrations along the membrane normal of
different moieties of the KRas-4B structures, we have revealed that bigger distances of
the CD from the membrane center along the membrane normal direction of oncogenic
KRas-4B proteins, relative to the wild-type one, help to expose the binding site of the
CD to bind upstream regulators and downstream effectors, finally populating their
active state for the mutated proteins.
To the best of our knowledge, the free energy profiles of GTP binding to anionic
membrane bilayers have been reported for the first time, giving first-hand information
about FELs of GTP-bound wild-type/oncogenic KRas-4B-Far binding to anionic
membrane systems. With the help of well-tempered metadynamics simulations, we
have calculated 2D free energy landscapes and the 1D free energy profiles along with
one CV. We have located global and meta-stable states of the two systems that have
been chosen to elucidate the joint effect of PHOS and G12D on the KRas-4B-membrane
binding. Two CVs have been taken into consideration to describe the conformational
changes along free energy paths. CV1 is the distance "gtp" between the center of
mass of GTP and the center of mass of the membrane, and CV2 is the distance "far"
between the FAR group of Cys-185 and the center of mass of the membrane along the
direction normal. Our results indicate that for GTP-bound oncogenic KRas-4B-Far, a
free energy barrier of 42.44 kJ/mol has been estimated which explains that the release
of the FAR moiety of oncogenic KRas-4B-Far from the anionic membrane becomes
unlikely because of the high ∆F . Correspondingly, a barrier of 10.76 kJ/mol is likely
to be crossed for FAR of wild-type KRas-4B-Far shifting from anchoring to the PM to
being solvated by water while GTP keeps binding to the CD. Differently to one local
stable state for oncogenic KRas-4B-Far, two local stable states are established when
GTP and FAR move in the different leaflets for the wild-type case. Likely, when FAR
of the wild-type case shifts from ∼4 nm to 6 nm away from the membrane center, we
have estimated a free energy barrier of 20.10 kJ/mol corresponding to the energies
needed for the HVR dissociating from the anionic membrane.
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From the calculation of 1D integrated free energy profiles of both systems, important
observations have been presented. When diffusing in the inner leaflet with FAR, GTP
needs 30.53 kJ/mol to move from the interface of the bilayer to bind with the CD
moiety for oncogenic KRas-4B-Far system, whereas 7.74 kJ/mol free energy is required
for the wild-type case. Similar barriers that need to be surmounted for GTP to
dissociate from the CD to be solvated by water molecules are of 33.98 kJ/mol and
35.36 kJ/mol for oncogenic and wild-type system, respectively, indicating mutation at
G12D doesn’t influence GTP’s movement. Most importantly, the free energy needed
for FAR release from the membrane to be solvated in the aqueous region is of 46.01
kJ/mol for the oncogenic case and 15.16 kJ/mol for wild-type case, respectively. In
its GTP-bound state, wild-type KRas-4B-Far could easily change its configurations
between the state H (KRas-4B anchoring to the membrane by FAR aligning with lipid
molecules of the membrane) and the state G (interacting with the interface of the
membrane by its the HVR while FAR diffusing in the aqueous region). In order to
decline interactions between FAR and lipids, FAR crosses a barrier of 8.44 kJ/mol
to shift from state G to state H. Comparison of free energy profiles, relative to the
wild-type protein, PHOS at Ser-181 strongly favors FAR anchoring to the membrane
while GTP locates in the interface for the oncogenic case, consistent with the MD
simulation results. This provides additional support to our suggestion that adding its
hydrophobic density through the carboxymethylation at Cys-185 does not always favor
its protein recruitment to the PM when PHOS gets involved in the KRas-4B structure.
Results will be reported in the following works:
- Huixia Lu, Jordi Martí. Anchoring mechanisms of oncogenic KRas-4B proteins
at cell membranes. In preparation.
- Huixia Lu, Jordi Martí. Influence of cholesterol in the anchoring of mutated KRas-4B
proteins in model cell membranes. In preparation.
6.2 Perspectives of future work
In this Thesis we studied several membrane systems, especially KRas-4B-Far and
KRas-4B-FMe binding to anionic bilayers, which allowed us to perform an in-depth
study of the dynamics and free energy landscapes of these model cell membrane
systems. We should keep in mind, by comparing the results of MD and well-tempered
metadynamics simulations, that the favored configurations of the studied system
observed by MD may not directly correspond to the global minimum of the 2D
free energy landscape obtained from the well-tempered metadynamics simulation.
Consequently, to increase the accuracy of the results of MD simulations, simulations
from different starting configurations for the same protein-membrane system should
be taken into consideration.
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Concerning metadynamics simulations, when we compared the energetic properties
between oncogenic and wild-type KRas-4B-Far systems, the 2D free energy landscapes
of GDP-bound wild-type KRas-4B-FMe and GTP-bound oncogenic KRas-4B-FMe
were not considered. But surely it is worth to be explored. Hence, a natural way
to continue the research carried out in the present Thesis would be to perform 1 µs
metadynamics simulations of methylated KRas-4B-FMe and compare their output
with the corresponding results from MD simulations.
Despite the failures in developing anti-KRas therapies, targeting KRas remains
one of the most promising directions in KRas-related cancer research. The design of
small molecules that disrupt KRas-4B-regulators/effectors interactions may provide
chemical probes and therapeutic agents for cancer treatment. A small drug named
by FGTI-2734 reported in a recent research[371] inhibits the membrane association
of mutated KRas protein, but not the wild-type ones, in pancreatic, lung, and colon
human cancer cells. After further preclinical and clinical studies, a direct KRAS
inhibitor-FGTI-2734 (structure shown in Fig. 6.1) may be on the horizon.
DBD
Config. 1 Config. 2
Fig. 6.1 Structures of FGTI-2734 and DBD shown here. In the two configurations
(Config. 1 and 2), DBD is depicted in orange, whereas the remaining moieties are
depicted with the same color prescriptions as in Fig. 5.2.
142 | Conclusions and prospect
The substance 3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxide (DBD) has been
usually applied in the treatment of Alzheimer disease[372, 373], in neurocognitive
disorders[372] and in diabetes mellitus[374], among others. Considering DBD shares
part of the molecular structure of FGTI-2734, we have started to analyze the effect
of DBD molecules on oncogenic KRas-4B’s binding to anionic membranes composed
of DOPC/DOPS/cholesterol by conducting MD simulations. From Fig. 6.1 we can
obtain that the HVR’s autoinhibition might be induced with a large dose of DBD
(Config. 2: four DBD molecules adopted in the system) comparing to the small dose
case (Config. 1: only one DBD molecule adopted in the system). Longer time scales in
MD simulations and a more detailed analysis should be conducted for more accurate
results.
Appendix A
Related publications
The papers published in international peer-reviewed journals that have been the basis
of this Thesis are:
– Martí J., Lu H. Molecular dynamics of di-palmitoyl-phosphatidyl-choline biomem-
branes in ionic solution: adsorption of the precursor neurotransmitter tryptophan.
Procedia computer science. 2017 Jun 9;108(C):1242-50.
– Lu H., Martí J. Effects of cholesterol on the binding of the precursor neurotrans-
mitter tryptophan to zwitterionic membranes. The Journal of chemical physics.
2018 Oct 28;149(16):164906.
– Lu H., Marti J. Binding free energies of small-molecules in phospholipid mem-
branes: Aminoacids, serotonin and melatonin. Chemical Physics Letters. 2018
Nov 16;712:190-5.
– Lu H., Martí J. Binding and dynamics of melatonin at the interface of phosphatidyl-
choline-cholesterol membranes. PloS one. 2019;14(11).
– Lu H., Martí J. Cellular absorption of small molecules: free energy landscapes
of melatonin binding at phospholipid membranes. Scientific Reports, 2020; 10,
9235. https://doi.org/10.1038/s41598-020-65753-z
– Lu H., Martí J. Anchoring mechanisms of oncogenic KRas-4B proteins at cell
membranes. In preparation.
– Lu, H., Martí, J. Influence of cholesterol in the anchoring of mutated KRas-4B
proteins in model cell membranes. In preparation.
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